'fucoside'
(id=1834471 ; fe=fucoside ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=733 creation date=2015-07-30 touchdate=2025-06-19 20:11:40.000) ≈ 3292 relations sortantes
- fucoside --
r_associated #0: 60 / 1 ->
fucosidase
n1=fucoside | n2=fucosidase | rel=r_associated | relid=0 | w=60
- fucoside --
r_associated #0: 45 / 0.75 ->
fucose
n1=fucoside | n2=fucose | rel=r_associated | relid=0 | w=45
- fucoside --
r_associated #0: 27 / 0.45 ->
en:fucoside
n1=fucoside | n2=en:fucoside | rel=r_associated | relid=0 | w=27
- fucoside --
r_associated #0: 20 / 0.333 ->
en:fucose
n1=fucoside | n2=en:fucose | rel=r_associated | relid=0 | w=20
- fucoside --
r_associated #0: 15 / 0.25 ->
dystrophie endo-épithéliale de Fuchs
n1=fucoside | n2=dystrophie endo-épithéliale de Fuchs | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
dystrophie endothéliale de Fuchs
n1=fucoside | n2=dystrophie endothéliale de Fuchs | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
dystrophie épithéliale de Fuchs
n1=fucoside | n2=dystrophie épithéliale de Fuchs | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
endothélio-Descemétite de Fuchs
n1=fucoside | n2=endothélio-Descemétite de Fuchs | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
Fuchs
n1=fucoside | n2=Fuchs | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
Fuchs (dystrophie endoépithéliale de)
n1=fucoside | n2=Fuchs (dystrophie endoépithéliale de) | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
Fuchs (dystrophie endothéliale de)
n1=fucoside | n2=Fuchs (dystrophie endothéliale de) | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
Fuchs (dystrophie épithéliale de)
n1=fucoside | n2=Fuchs (dystrophie épithéliale de) | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
Fuchs (syndrome de)
n1=fucoside | n2=Fuchs (syndrome de) | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
fuchsine
n1=fucoside | n2=fuchsine | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
fucosidose
n1=fucoside | n2=fucosidose | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
fugue
n1=fucoside | n2=fugue | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
muco-oculo-cutané (syndrome)
n1=fucoside | n2=muco-oculo-cutané (syndrome) | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
processus pathologique
n1=fucoside | n2=processus pathologique | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
syndrome
n1=fucoside | n2=syndrome | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
syndrome de Fuchs
n1=fucoside | n2=syndrome de Fuchs | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 15 / 0.25 ->
syndrome muco-oculo-cutané
n1=fucoside | n2=syndrome muco-oculo-cutané | rel=r_associated | relid=0 | w=15
- fucoside --
r_associated #0: 10 / 0.167 ->
chimie
n1=fucoside | n2=chimie | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
en:cervicocranial syndrome
n1=fucoside | n2=en:cervicocranial syndrome | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
en:Fuchs syndrome
n1=fucoside | n2=en:Fuchs syndrome | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
en:fuchs' syndrome
n1=fucoside | n2=en:fuchs' syndrome | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
en:fucosidase
n1=fucoside | n2=en:fucosidase | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
en:fucosidosis
n1=fucoside | n2=en:fucosidosis | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
en:historical aspects qualifier
n1=fucoside | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
en:in blood
n1=fucoside | n2=en:in blood | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
en:in urine
n1=fucoside | n2=en:in urine | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
syndrome de
n1=fucoside | n2=syndrome de | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
syndrome de barré et liéou
n1=fucoside | n2=syndrome de barré et liéou | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
syndrome de Barré-Liéou
n1=fucoside | n2=syndrome de Barré-Liéou | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
syndrome de fuchs
n1=fucoside | n2=syndrome de fuchs | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 10 / 0.167 ->
syndrome sympathique cervical postérieur
n1=fucoside | n2=syndrome sympathique cervical postérieur | rel=r_associated | relid=0 | w=10
- fucoside --
r_associated #0: 5 / 0.083 ->
alpha-L-fucosidase
n1=fucoside | n2=alpha-L-fucosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
alpha-mannosidose
n1=fucoside | n2=alpha-mannosidose | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
aspartylglucosaminurie
n1=fucoside | n2=aspartylglucosaminurie | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
défauts de la dégradation des glycoprotéines
n1=fucoside | n2=défauts de la dégradation des glycoprotéines | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
déficit en alpha-fucosidase
n1=fucoside | n2=déficit en alpha-fucosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
déficit en alpha-L-fucosidase
n1=fucoside | n2=déficit en alpha-L-fucosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
déficit en alpha-l-fucosidase
n1=fucoside | n2=déficit en alpha-l-fucosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
déficit en alpha-mannosidase
n1=fucoside | n2=déficit en alpha-mannosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
déficits en mannosidase
n1=fucoside | n2=déficits en mannosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
dysostosis multiplex
n1=fucoside | n2=dysostosis multiplex | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:'cloudy' or 'pink' blood (lipemia)
n1=fucoside | n2=en:'cloudy' or 'pink' blood (lipemia) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:'compensated hypothyroidism' with increased tsh and normal t4
n1=fucoside | n2=en:'compensated hypothyroidism' with increased tsh and normal t4 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:'rectilinear profiles' ultrastructurally in cells
n1=fucoside | n2=en:'rectilinear profiles' ultrastructurally in cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:1,25-dihydroxyvitamin d was elevated in childhood but deficient in adulthood
n1=fucoside | n2=en:1,25-dihydroxyvitamin d was elevated in childhood but deficient in adulthood | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:1.61- and 1.76-mb microduplication of 3q29
n1=fucoside | n2=en:1.61- and 1.76-mb microduplication of 3q29 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:2-aminoadipic aciduria
n1=fucoside | n2=en:2-aminoadipic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:2-hydroxyglutaric aciduria
n1=fucoside | n2=en:2-hydroxyglutaric aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:2-oxoadipic aciduria
n1=fucoside | n2=en:2-oxoadipic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:2,8-dihydroxyadenine (dha) urinary stones
n1=fucoside | n2=en:2,8-dihydroxyadenine (dha) urinary stones | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:21-hydroxylase deficiency
n1=fucoside | n2=en:21-hydroxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:3-hydroxyacyl-coa dehydrogenase deficiency
n1=fucoside | n2=en:3-hydroxyacyl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:3-methylglutaconic aciduria
n1=fucoside | n2=en:3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:3-methylglutaconic aciduria (3-mgc)
n1=fucoside | n2=en:3-methylglutaconic aciduria (3-mgc) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:3-methylglutaconic aciduria type 1
n1=fucoside | n2=en:3-methylglutaconic aciduria type 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:3-methylglutaconic aciduria type 3
n1=fucoside | n2=en:3-methylglutaconic aciduria type 3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:3-methylglutaconic aciduria type 5
n1=fucoside | n2=en:3-methylglutaconic aciduria type 5 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:3-methylglutaconic aciduria type iv
n1=fucoside | n2=en:3-methylglutaconic aciduria type iv | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:3-methylglutaric aciduria
n1=fucoside | n2=en:3-methylglutaric aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:3-methylglutaric aciduria (3-mga)
n1=fucoside | n2=en:3-methylglutaric aciduria (3-mga) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:4-hydroxycyclohexylacetic aciduria (adults)
n1=fucoside | n2=en:4-hydroxycyclohexylacetic aciduria (adults) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:4-hydroxyphenylacetic aciduria
n1=fucoside | n2=en:4-hydroxyphenylacetic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:4-hydroxyphenylactic aciduria
n1=fucoside | n2=en:4-hydroxyphenylactic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:4-hydroxyphenyllactic aciduria
n1=fucoside | n2=en:4-hydroxyphenyllactic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd)
n1=fucoside | n2=en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:4-hydroxyphenylpyruvic aciduria
n1=fucoside | n2=en:4-hydroxyphenylpyruvic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:5 alpha steroid reductase 2 deficiency
n1=fucoside | n2=en:5 alpha steroid reductase 2 deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:5-alpha-reductase-2 enzyme deficiency
n1=fucoside | n2=en:5-alpha-reductase-2 enzyme deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:5-hiaa csf may be normal or decreased
n1=fucoside | n2=en:5-hiaa csf may be normal or decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:5-oxoprolinase deficiency
n1=fucoside | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:5' 10' methylenetetrahydrofolate reductase deficiency
n1=fucoside | n2=en:5' 10' methylenetetrahydrofolate reductase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:85-90% dgs patients have deletion of 22q11.2
n1=fucoside | n2=en:85-90% dgs patients have deletion of 22q11.2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:a small minority of patients have translocations and inversions involving 16p13.3
n1=fucoside | n2=en:a small minority of patients have translocations and inversions involving 16p13.3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:a subset of group b patients have absence of pc protein and mrna
n1=fucoside | n2=en:a subset of group b patients have absence of pc protein and mrna | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abacterial leukocyturia
n1=fucoside | n2=en:abacterial leukocyturia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aberrant gamma-interferon-mediated inflammation
n1=fucoside | n2=en:aberrant gamma-interferon-mediated inflammation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abetalipoproteinemia (lab finding)
n1=fucoside | n2=en:abetalipoproteinemia (lab finding) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal acylcarnitine profiles
n1=fucoside | n2=en:abnormal acylcarnitine profiles | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal bone marrow karyotype, t(8,21)
n1=fucoside | n2=en:abnormal bone marrow karyotype, t(8,21) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal cardiolipin subspecies composition
n1=fucoside | n2=en:abnormal cardiolipin subspecies composition | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal cartilage collagen on em
n1=fucoside | n2=en:abnormal cartilage collagen on em | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal cholesterol homeostasis
n1=fucoside | n2=en:abnormal cholesterol homeostasis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal columnization of chondrocytes
n1=fucoside | n2=en:abnormal columnization of chondrocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal dystrophin on muscle biopsy
n1=fucoside | n2=en:abnormal dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal eeg in 25% hospitalized patients
n1=fucoside | n2=en:abnormal eeg in 25% hospitalized patients | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal electrophoretic mobility of type ii collagen
n1=fucoside | n2=en:abnormal electrophoretic mobility of type ii collagen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii)
n1=fucoside | n2=en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal fecal fat
n1=fucoside | n2=en:abnormal fecal fat | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal glycosylation of serum transferrin, type 1 pattern
n1=fucoside | n2=en:abnormal glycosylation of serum transferrin, type 1 pattern | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal igfr1 function
n1=fucoside | n2=en:abnormal igfr1 function | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal isoelectric focusing of serum transferrin
n1=fucoside | n2=en:abnormal isoelectric focusing of serum transferrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin)
n1=fucoside | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal isoelectric focusing of serum transferrin (type 1 pattern)
n1=fucoside | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient)
n1=fucoside | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) loss of complete n-glycans
n1=fucoside | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) loss of complete n-glycans | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal isoelectric focusing of serum transferrin (type 2 pattern)
n1=fucoside | n2=en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal karyotype in 3 patients involving distal 6p
n1=fucoside | n2=en:abnormal karyotype in 3 patients involving distal 6p | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal karyotype in single reported female patient 46, xx,r(18)(p14q23)
n1=fucoside | n2=en:abnormal karyotype in single reported female patient 46, xx,r(18)(p14q23) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal lipid profile
n1=fucoside | n2=en:abnormal lipid profile | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver enzymes (1 patient)
n1=fucoside | n2=en:abnormal liver enzymes (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver enzymes (in some patients)
n1=fucoside | n2=en:abnormal liver enzymes (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver enzymes (rare)
n1=fucoside | n2=en:abnormal liver enzymes (rare) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver enzymes during illness
n1=fucoside | n2=en:abnormal liver enzymes during illness | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver enzymes in those with hepatic cysts or fibrosis
n1=fucoside | n2=en:abnormal liver enzymes in those with hepatic cysts or fibrosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver enzymes, episodic
n1=fucoside | n2=en:abnormal liver enzymes, episodic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver enzymes, intermittent
n1=fucoside | n2=en:abnormal liver enzymes, intermittent | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver enzymes, intermittent (1 patient)
n1=fucoside | n2=en:abnormal liver enzymes, intermittent (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver function test
n1=fucoside | n2=en:abnormal liver function test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver function tests (in some patients)
n1=fucoside | n2=en:abnormal liver function tests (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver function tests (less common)
n1=fucoside | n2=en:abnormal liver function tests (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver function tests (sgot, sgpt)
n1=fucoside | n2=en:abnormal liver function tests (sgot, sgpt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal liver function tests during pregnancy, resolves postpartum
n1=fucoside | n2=en:abnormal liver function tests during pregnancy, resolves postpartum | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal myelination in sural nerve biopsies
n1=fucoside | n2=en:abnormal myelination in sural nerve biopsies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal n-glycosylation of transferrin
n1=fucoside | n2=en:abnormal n-glycosylation of transferrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal nasal potential difference
n1=fucoside | n2=en:abnormal nasal potential difference | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal nuclear morphology
n1=fucoside | n2=en:abnormal nuclear morphology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal oral glucose tolerance
n1=fucoside | n2=en:abnormal oral glucose tolerance | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio)
n1=fucoside | n2=en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal phospholipid profile
n1=fucoside | n2=en:abnormal phospholipid profile | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia
n1=fucoside | n2=en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal response to human chorionic gonadotropin indicates decreased testosterone
n1=fucoside | n2=en:abnormal response to human chorionic gonadotropin indicates decreased testosterone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal schilling test (not normalized by addition of intrinsic factor)
n1=fucoside | n2=en:abnormal schilling test (not normalized by addition of intrinsic factor) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal secretin test
n1=fucoside | n2=en:abnormal secretin test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal serum glycoproteins
n1=fucoside | n2=en:abnormal serum glycoproteins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal serum lipoprotein levels (in 3 of 10 patients)
n1=fucoside | n2=en:abnormal serum lipoprotein levels (in 3 of 10 patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal serum liver enzyme levels
n1=fucoside | n2=en:abnormal serum liver enzyme levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal serum protein electrophoresis (elevated alpha-2 band)
n1=fucoside | n2=en:abnormal serum protein electrophoresis (elevated alpha-2 band) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal serum transferrin pattern (in some patients)
n1=fucoside | n2=en:abnormal serum transferrin pattern (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation)
n1=fucoside | n2=en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem
n1=fucoside | n2=en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal transaminases (1 patient)
n1=fucoside | n2=en:abnormal transaminases (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal transferrin isoelectric focusing (ief)
n1=fucoside | n2=en:abnormal transferrin isoelectric focusing (ief) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd)
n1=fucoside | n2=en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal urinary compounds
n1=fucoside | n2=en:abnormal urinary compounds | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides)
n1=fucoside | n2=en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal urinary oligosaccharides
n1=fucoside | n2=en:abnormal urinary oligosaccharides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormal urinary organic acids
n1=fucoside | n2=en:abnormal urinary organic acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormally low cerebrospinal fluid cystatin c
n1=fucoside | n2=en:abnormally low cerebrospinal fluid cystatin c | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins
n1=fucoside | n2=en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absence of beta-ureidopropionase activity and protein in liver biopsy
n1=fucoside | n2=en:absence of beta-ureidopropionase activity and protein in liver biopsy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absence of cd59 expression on red cells
n1=fucoside | n2=en:absence of cd59 expression on red cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absence of chylomicrons in lymph and plasma
n1=fucoside | n2=en:absence of chylomicrons in lymph and plasma | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absence of cpt ii protein
n1=fucoside | n2=en:absence of cpt ii protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absence of emerin by immunohistochemistry on muscle biopsy
n1=fucoside | n2=en:absence of emerin by immunohistochemistry on muscle biopsy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absence of hepatic udp-glucuronyl-transferase
n1=fucoside | n2=en:absence of hepatic udp-glucuronyl-transferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absence of outer dynein arms
n1=fucoside | n2=en:absence of outer dynein arms | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absence of peroxidase staining in neutrophils and monocytes
n1=fucoside | n2=en:absence of peroxidase staining in neutrophils and monocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent 7-dehydrocholesterol
n1=fucoside | n2=en:absent 7-dehydrocholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent alkyl-dhap synthase activity
n1=fucoside | n2=en:absent alkyl-dhap synthase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent anti-insulin receptor antibodies
n1=fucoside | n2=en:absent anti-insulin receptor antibodies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent axonal flare response after intradermal histamine injection
n1=fucoside | n2=en:absent axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent axonal flare response to intradermal histamine injection
n1=fucoside | n2=en:absent axonal flare response to intradermal histamine injection | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent ch50 activity in complete c4 deficiency
n1=fucoside | n2=en:absent ch50 activity in complete c4 deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent dystrophin on muscle biopsy
n1=fucoside | n2=en:absent dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees
n1=fucoside | n2=en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent igg2 subclass
n1=fucoside | n2=en:absent igg2 subclass | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent or abnormal thyroglobulin
n1=fucoside | n2=en:absent or abnormal thyroglobulin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent or severely reduced levels of serum immunoglobulins
n1=fucoside | n2=en:absent or severely reduced levels of serum immunoglobulins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent platelet agglutination in presence of ristocetin
n1=fucoside | n2=en:absent platelet agglutination in presence of ristocetin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent pro alpha 2(i) chain synthesis (fibroblasts)
n1=fucoside | n2=en:absent pro alpha 2(i) chain synthesis (fibroblasts) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent tyrosinase activity
n1=fucoside | n2=en:absent tyrosinase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986
n1=fucoside | n2=en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent/hypoplastic coccyx
n1=fucoside | n2=en:absent/hypoplastic coccyx | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent/hypoplastic paranasal sinuses
n1=fucoside | n2=en:absent/hypoplastic paranasal sinuses | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent/reduced free proteins and absent total protein s
n1=fucoside | n2=en:absent/reduced free proteins and absent total protein s | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:absent/reduced protein s and normal total proteins in heterozygote
n1=fucoside | n2=en:absent/reduced protein s and normal total proteins in heterozygote | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:accumulation of cholesterol esters in various tissues
n1=fucoside | n2=en:accumulation of cholesterol esters in various tissues | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:accumulation of guanidinoacetate in brain
n1=fucoside | n2=en:accumulation of guanidinoacetate in brain | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:accumulation of neutral lipids (triglycerides) in leukocytes, muscle cells, fibroblasts, and cardiomyocytes
n1=fucoside | n2=en:accumulation of neutral lipids (triglycerides) in leukocytes, muscle cells, fibroblasts, and cardiomyocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:accumulation of shortened dolichol-linked oligosaccharides in patient fibroblasts
n1=fucoside | n2=en:accumulation of shortened dolichol-linked oligosaccharides in patient fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids
n1=fucoside | n2=en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts
n1=fucoside | n2=en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts
n1=fucoside | n2=en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acetyl-coa: carboxylase deficiency
n1=fucoside | n2=en:acetyl-coa: carboxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acetylcholinesterase staining reveals nerve trunk hypertrophy
n1=fucoside | n2=en:acetylcholinesterase staining reveals nerve trunk hypertrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acid cholesteryl ester hydrolase deficiency, type 2
n1=fucoside | n2=en:acid cholesteryl ester hydrolase deficiency, type 2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acid phosphatase deficiency
n1=fucoside | n2=en:acid phosphatase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acrocallosal syndrome
n1=fucoside | n2=en:acrocallosal syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acrodermatitis enteropathica
n1=fucoside | n2=en:acrodermatitis enteropathica | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acth normal
n1=fucoside | n2=en:acth normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acute hyperammonemia
n1=fucoside | n2=en:acute hyperammonemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acute-phase reactants during fever
n1=fucoside | n2=en:acute-phase reactants during fever | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acyl-coa dehydrogenase, short-chain deficiency
n1=fucoside | n2=en:acyl-coa dehydrogenase, short-chain deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency
n1=fucoside | n2=en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:acylglycinuria
n1=fucoside | n2=en:acylglycinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:adenine phosphoribosyltransferase deficiency
n1=fucoside | n2=en:adenine phosphoribosyltransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:adenosine deaminase deficiency
n1=fucoside | n2=en:adenosine deaminase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:adenosine monophosphate deaminase deficiency
n1=fucoside | n2=en:adenosine monophosphate deaminase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:adenylosuccinase deficiency (finding)
n1=fucoside | n2=en:adenylosuccinase deficiency (finding) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:adenylosuccinate lyase deficiency (disorder)
n1=fucoside | n2=en:adenylosuccinate lyase deficiency (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:adrenal gland hyperplasia ii
n1=fucoside | n2=en:adrenal gland hyperplasia ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:adrenal hyperplasia, congenital, type 5
n1=fucoside | n2=en:adrenal hyperplasia, congenital, type 5 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:adrenocorticotropic hormone, increased
n1=fucoside | n2=en:adrenocorticotropic hormone, increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:adult g6pd deficiency of leukocytes syndrome
n1=fucoside | n2=en:adult g6pd deficiency of leukocytes syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:affected mother has normal plasma zinc levels and is not zinc-deficient
n1=fucoside | n2=en:affected mother has normal plasma zinc levels and is not zinc-deficient | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk)
n1=fucoside | n2=en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:agammaglobulinemia
n1=fucoside | n2=en:agammaglobulinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:al awadi syndrome
n1=fucoside | n2=en:al awadi syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alanine aminotransferase increased
n1=fucoside | n2=en:alanine aminotransferase increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:albinotic fundus
n1=fucoside | n2=en:albinotic fundus | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:albuminuria
n1=fucoside | n2=en:albuminuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aldolase a deficiency
n1=fucoside | n2=en:aldolase a deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aldosterone concentration below normal
n1=fucoside | n2=en:aldosterone concentration below normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aldosterone level increased above normal
n1=fucoside | n2=en:aldosterone level increased above normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alkaline phosphatase decreased
n1=fucoside | n2=en:alkaline phosphatase decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alkaline phosphatase normal
n1=fucoside | n2=en:alkaline phosphatase normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alkaline phosphatase serum increased
n1=fucoside | n2=en:alkaline phosphatase serum increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alkaptonuria
n1=fucoside | n2=en:alkaptonuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:allanson pantzar mcleod syndrome
n1=fucoside | n2=en:allanson pantzar mcleod syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma
n1=fucoside | n2=en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:allgrove syndrome
n1=fucoside | n2=en:allgrove syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha 1 foetoprotein amniotic fluid increased
n1=fucoside | n2=en:alpha 1 foetoprotein amniotic fluid increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha fetoprotein increased
n1=fucoside | n2=en:alpha fetoprotein increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha ketoadipic aciduria
n1=fucoside | n2=en:alpha ketoadipic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha-1 antitrypsin deficiency
n1=fucoside | n2=en:alpha-1 antitrypsin deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha-2-antitrypsin deficiency
n1=fucoside | n2=en:alpha-2-antitrypsin deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha-fetoprotein deficiency
n1=fucoside | n2=en:alpha-fetoprotein deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha-fetoprotein normal
n1=fucoside | n2=en:alpha-fetoprotein normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts
n1=fucoside | n2=en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha-hydroxyadipic aciduria alpha-aminoadipic aciduria
n1=fucoside | n2=en:alpha-hydroxyadipic aciduria alpha-aminoadipic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha-mannosidosis
n1=fucoside | n2=en:alpha-mannosidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha-methylacyl-coa racemase deficiency
n1=fucoside | n2=en:alpha-methylacyl-coa racemase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alpha, alpha-trehalase deficiency
n1=fucoside | n2=en:alpha, alpha-trehalase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:alstrom syndrome
n1=fucoside | n2=en:alstrom syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:amelogenesis imperfecta - recessive - rough
n1=fucoside | n2=en:amelogenesis imperfecta - recessive - rough | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:amelogenesis imperfecta and gingival hyperplasia syndrome
n1=fucoside | n2=en:amelogenesis imperfecta and gingival hyperplasia syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminoaciduria
n1=fucoside | n2=en:aminoaciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminoaciduria (1 patient)
n1=fucoside | n2=en:aminoaciduria (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminoaciduria (in some patients)
n1=fucoside | n2=en:aminoaciduria (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminoaciduria (less common)
n1=fucoside | n2=en:aminoaciduria (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminoaciduria (rare)
n1=fucoside | n2=en:aminoaciduria (rare) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminoaciduria, intermittent
n1=fucoside | n2=en:aminoaciduria, intermittent | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminoaciduria, mild (in some patients)
n1=fucoside | n2=en:aminoaciduria, mild (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminoacylase 1 deficiency
n1=fucoside | n2=en:aminoacylase 1 deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminoadipic semialdehyde synthase (aass) deficiency
n1=fucoside | n2=en:aminoadipic semialdehyde synthase (aass) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aminomethyltransferase deficiency
n1=fucoside | n2=en:aminomethyltransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:amorphous hyaline substance (skin biopsy and visceral organs)
n1=fucoside | n2=en:amorphous hyaline substance (skin biopsy and visceral organs) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:amylo-1,6-glucosidase deficiency
n1=fucoside | n2=en:amylo-1,6-glucosidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme)
n1=fucoside | n2=en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016)
n1=fucoside | n2=en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anaphase loss or nondisjunction with trisomies, tetrasomies, monosomies
n1=fucoside | n2=en:anaphase loss or nondisjunction with trisomies, tetrasomies, monosomies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:androgens increased
n1=fucoside | n2=en:androgens increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anemia, hypochromic microcytic, with iron overload
n1=fucoside | n2=en:anemia, hypochromic microcytic, with iron overload | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aneuploidy of the x chromosome
n1=fucoside | n2=en:aneuploidy of the x chromosome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:angiokeratoma
n1=fucoside | n2=en:angiokeratoma | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:angiokeratoma corporis diffusum
n1=fucoside | n2=en:angiokeratoma corporis diffusum | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anhidrosis
n1=fucoside | n2=en:anhidrosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anomalies of cholesterol levels
n1=fucoside | n2=en:anomalies of cholesterol levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anterior beaking of thoracic and lumbar vertebrae
n1=fucoside | n2=en:anterior beaking of thoracic and lumbar vertebrae | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anti-ds dna antibody
n1=fucoside | n2=en:anti-ds dna antibody | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anti-factor viii positive
n1=fucoside | n2=en:anti-factor viii positive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anti-iga antibodies commonly present
n1=fucoside | n2=en:anti-iga antibodies commonly present | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anti-ssb positive
n1=fucoside | n2=en:anti-ssb positive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:anti-tissue transglutaminase antibodies (anti-ttg)
n1=fucoside | n2=en:anti-tissue transglutaminase antibodies (anti-ttg) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:antineutrophil antibody positivity
n1=fucoside | n2=en:antineutrophil antibody positivity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:antineutrophil cytoplasmic antibody
n1=fucoside | n2=en:antineutrophil cytoplasmic antibody | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:antiphospholipid antibody
n1=fucoside | n2=en:antiphospholipid antibody | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:antiribonuclear protein positive
n1=fucoside | n2=en:antiribonuclear protein positive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:antithrombin iii decreased
n1=fucoside | n2=en:antithrombin iii decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:antithrombin iii deficiency
n1=fucoside | n2=en:antithrombin iii deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:antley-bixler syndrome, autosomal dominant
n1=fucoside | n2=en:antley-bixler syndrome, autosomal dominant | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:appropriately increased serum 1,25-dihydroxyvitamin d3
n1=fucoside | n2=en:appropriately increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aprt deficiency measured in erythrocyte lysate
n1=fucoside | n2=en:aprt deficiency measured in erythrocyte lysate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:arginine:glycine amidinotransferase deficiency
n1=fucoside | n2=en:arginine:glycine amidinotransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:argininemia
n1=fucoside | n2=en:argininemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:argininosuccinic aciduria
n1=fucoside | n2=en:argininosuccinic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:arginosuccinate lyase deficiency
n1=fucoside | n2=en:arginosuccinate lyase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:arterial tortuosity syndrome
n1=fucoside | n2=en:arterial tortuosity syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:arthrogryposis multiplex congenita, neurogenic type (disorder)
n1=fucoside | n2=en:arthrogryposis multiplex congenita, neurogenic type (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:arylsulfatase a deficiency
n1=fucoside | n2=en:arylsulfatase a deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:arylsulfatase b deficiency in fibroblasts and white blood cells
n1=fucoside | n2=en:arylsulfatase b deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:arylsulfatase deficiency without mld
n1=fucoside | n2=en:arylsulfatase deficiency without mld | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aspartylglycosaminuria
n1=fucoside | n2=en:aspartylglycosaminuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aspects of mortality statistics
n1=fucoside | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:aspects of radionuclide imaging
n1=fucoside | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:associated with serum anti-phospholipid antibodies in about 50% of patients
n1=fucoside | n2=en:associated with serum anti-phospholipid antibodies in about 50% of patients | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:at least 2 complementation groups
n1=fucoside | n2=en:at least 2 complementation groups | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ataxia telangiectasia syndrome
n1=fucoside | n2=en:ataxia telangiectasia syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ataxia with vitamin e deficiency
n1=fucoside | n2=en:ataxia with vitamin e deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia
n1=fucoside | n2=en:ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ateliotic dwarfism without insulinopenia
n1=fucoside | n2=en:ateliotic dwarfism without insulinopenia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:atrial abnormalities on electrocardiogram
n1=fucoside | n2=en:atrial abnormalities on electrocardiogram | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:atrophoderma vermiculatum
n1=fucoside | n2=en:atrophoderma vermiculatum | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autoinflammation, lipodystrophy and dermatosis syndrome
n1=fucoside | n2=en:autoinflammation, lipodystrophy and dermatosis syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive asexual dwarfism
n1=fucoside | n2=en:autosomal recessive asexual dwarfism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive distal osteolysis syndrome
n1=fucoside | n2=en:autosomal recessive distal osteolysis syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive ichthyosis
n1=fucoside | n2=en:autosomal recessive ichthyosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive idiopathic familial dystonia
n1=fucoside | n2=en:autosomal recessive idiopathic familial dystonia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive inheritance
n1=fucoside | n2=en:autosomal recessive inheritance | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive muscular dystrophy with limb girdle distribution
n1=fucoside | n2=en:autosomal recessive muscular dystrophy with limb girdle distribution | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive ocular albinism
n1=fucoside | n2=en:autosomal recessive ocular albinism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive primary microcephaly
n1=fucoside | n2=en:autosomal recessive primary microcephaly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive scid
n1=fucoside | n2=en:autosomal recessive scid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive sideroblastic anemia
n1=fucoside | n2=en:autosomal recessive sideroblastic anemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive spastic paraplegia type 11
n1=fucoside | n2=en:autosomal recessive spastic paraplegia type 11 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:autosomal recessive trait
n1=fucoside | n2=en:autosomal recessive trait | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:axonemes show normal structure
n1=fucoside | n2=en:axonemes show normal structure | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:azoospermia/oligospermia (present at diagnosis)
n1=fucoside | n2=en:azoospermia/oligospermia (present at diagnosis) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:azotemia
n1=fucoside | n2=en:azotemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:b lymphocytopenia
n1=fucoside | n2=en:b lymphocytopenia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat
n1=fucoside | n2=en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:balanced/unbalanced chromosomal translocation t(2,13)(q36,q11)
n1=fucoside | n2=en:balanced/unbalanced chromosomal translocation t(2,13)(q36,q11) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:baller-gerold syndrome
n1=fucoside | n2=en:baller-gerold syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ballooned neurons
n1=fucoside | n2=en:ballooned neurons | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bardet-biedl syndrome
n1=fucoside | n2=en:bardet-biedl syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:basal ganglia disease, biotin-responsive
n1=fucoside | n2=en:basal ganglia disease, biotin-responsive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:becker generalized myotonia
n1=fucoside | n2=en:becker generalized myotonia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:behr syndrome
n1=fucoside | n2=en:behr syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:behrens baumann dust syndrome
n1=fucoside | n2=en:behrens baumann dust syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:beta-aminoisobutyricaciduria
n1=fucoside | n2=en:beta-aminoisobutyricaciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:beta-galactosidase deficiency
n1=fucoside | n2=en:beta-galactosidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:beta-galactosidase deficiency in fibroblasts and white blood cells
n1=fucoside | n2=en:beta-galactosidase deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:beta-glucuronidase deficiency in fibroblasts and leukocytes
n1=fucoside | n2=en:beta-glucuronidase deficiency in fibroblasts and leukocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:beta-hydroxyisobutyryl coa deacylase deficiency
n1=fucoside | n2=en:beta-hydroxyisobutyryl coa deacylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:beta-ureidopropionase deficiency
n1=fucoside | n2=en:beta-ureidopropionase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bicarbonaturia
n1=fucoside | n2=en:bicarbonaturia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bietti crystalline corneoretinal dystrophy
n1=fucoside | n2=en:bietti crystalline corneoretinal dystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bile contains cholesterol crystals
n1=fucoside | n2=en:bile contains cholesterol crystals | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bile shows increased cholesterol/phospholipid ratio
n1=fucoside | n2=en:bile shows increased cholesterol/phospholipid ratio | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bilirubin conjugated increased
n1=fucoside | n2=en:bilirubin conjugated increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bilirubin may or may not be increased
n1=fucoside | n2=en:bilirubin may or may not be increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:biotinidase deficiency
n1=fucoside | n2=en:biotinidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bleeding time normal
n1=fucoside | n2=en:bleeding time normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:blood glucose normal
n1=fucoside | n2=en:blood glucose normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:blood pyruvic acid increased
n1=fucoside | n2=en:blood pyruvic acid increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:blood urea nitrogen increased
n1=fucoside | n2=en:blood urea nitrogen increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:blunted cortisol response to adrenocorticotropic hormone (acth)
n1=fucoside | n2=en:blunted cortisol response to adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bone marrow hypoplasia (in some patients)
n1=fucoside | n2=en:bone marrow hypoplasia (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:borderline elevated low-density lipoprotein
n1=fucoside | n2=en:borderline elevated low-density lipoprotein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bothnia retinal dystrophy
n1=fucoside | n2=en:bothnia retinal dystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bowen-conradi syndrome
n1=fucoside | n2=en:bowen-conradi syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:brachydactyly syndrome type b
n1=fucoside | n2=en:brachydactyly syndrome type b | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate)
n1=fucoside | n2=en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:breastfed offspring have transient decrease of plasma zinc levels
n1=fucoside | n2=en:breastfed offspring have transient decrease of plasma zinc levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:broad chest
n1=fucoside | n2=en:broad chest | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:broad tissue deposition of amylopectin-like material
n1=fucoside | n2=en:broad tissue deposition of amylopectin-like material | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:brody myopathy
n1=fucoside | n2=en:brody myopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:bromosulfophthalein test - secondary rise at 90 minutes
n1=fucoside | n2=en:bromosulfophthalein test - secondary rise at 90 minutes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:brown-vialetto-van laere syndrome
n1=fucoside | n2=en:brown-vialetto-van laere syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:butyryl-coa dehydrogenase deficiency
n1=fucoside | n2=en:butyryl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:butyrylcholinesterase deficiency
n1=fucoside | n2=en:butyrylcholinesterase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:c-band karyotype shows 'railroad track' appearance
n1=fucoside | n2=en:c-band karyotype shows 'railroad track' appearance | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:calcium normal
n1=fucoside | n2=en:calcium normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:calciuria
n1=fucoside | n2=en:calciuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:canavan disease
n1=fucoside | n2=en:canavan disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:carbamoyl-phosphate synthetase i deficiency
n1=fucoside | n2=en:carbamoyl-phosphate synthetase i deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:carbohydrate metabolism, inborn errors
n1=fucoside | n2=en:carbohydrate metabolism, inborn errors | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:carbohydrate-deficient glycoprotein syndrome
n1=fucoside | n2=en:carbohydrate-deficient glycoprotein syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:carboxypeptidase n deficiency
n1=fucoside | n2=en:carboxypeptidase n deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cardiomegaly
n1=fucoside | n2=en:cardiomegaly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:carnitine deficiency
n1=fucoside | n2=en:carnitine deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:carnitine palmitoyltransferase i deficiency (fibroblast, liver, leukocytes)
n1=fucoside | n2=en:carnitine palmitoyltransferase i deficiency (fibroblast, liver, leukocytes) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:carnitine palmitoyltransferase ii deficiency (25% of controls)
n1=fucoside | n2=en:carnitine palmitoyltransferase ii deficiency (25% of controls) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11)
n1=fucoside | n2=en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:catalase deficiency
n1=fucoside | n2=en:catalase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:caused by mutations in the alpha-l-fucosidase gene (fuca1, 230000.0001)
n1=fucoside | n2=en:caused by mutations in the alpha-l-fucosidase gene (fuca1, 230000.0001) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cd4/cd8 ratio decreased
n1=fucoside | n2=en:cd4/cd8 ratio decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cd4+/cd8+ ratio is reversed
n1=fucoside | n2=en:cd4+/cd8+ ratio is reversed | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cd4+/cd8+ ratio often reversed
n1=fucoside | n2=en:cd4+/cd8+ ratio often reversed | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cell studies show increased dna breakage
n1=fucoside | n2=en:cell studies show increased dna breakage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation
n1=fucoside | n2=en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cells show increased sensitivity to ionizing radiation
n1=fucoside | n2=en:cells show increased sensitivity to ionizing radiation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cellular arrest at g2 of the cell cycle
n1=fucoside | n2=en:cellular arrest at g2 of the cell cycle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebellar ataxia ectodermal dysplasia
n1=fucoside | n2=en:cerebellar ataxia ectodermal dysplasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebellar ataxia, cayman type
n1=fucoside | n2=en:cerebellar ataxia, cayman type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebral atrophy
n1=fucoside | n2=en:cerebral atrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy
n1=fucoside | n2=en:cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebral degeneration in generalized lipidoses
n1=fucoside | n2=en:cerebral degeneration in generalized lipidoses | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebral lipidosis
n1=fucoside | n2=en:cerebral lipidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebroretinal microangiopathy with calcifications and cysts (disorder)
n1=fucoside | n2=en:cerebroretinal microangiopathy with calcifications and cysts (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebrospinal fluid lymphocytosis
n1=fucoside | n2=en:cerebrospinal fluid lymphocytosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebrospinal fluid oligoclonal bands
n1=fucoside | n2=en:cerebrospinal fluid oligoclonal bands | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cerebrotendinous xanthomatosis
n1=fucoside | n2=en:cerebrotendinous xanthomatosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ceruloplasmin decreased
n1=fucoside | n2=en:ceruloplasmin decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ceruloplasmin deficiency
n1=fucoside | n2=en:ceruloplasmin deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cervical platyspondyly
n1=fucoside | n2=en:cervical platyspondyly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva
n1=fucoside | n2=en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii)
n1=fucoside | n2=en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:charcot-marie-tooth disease type 4
n1=fucoside | n2=en:charcot-marie-tooth disease type 4 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chemically induced
n1=fucoside | n2=en:chemically induced | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chemically-induced lipidosis
n1=fucoside | n2=en:chemically-induced lipidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:childhood hypophosphatasia (disorder)
n1=fucoside | n2=en:childhood hypophosphatasia (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:childhood myocerebrohepatopathy spectrum
n1=fucoside | n2=en:childhood myocerebrohepatopathy spectrum | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chitty hall baraitser syndrome
n1=fucoside | n2=en:chitty hall baraitser syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cholesterol ester storage disease
n1=fucoside | n2=en:cholesterol ester storage disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cholesterol low
n1=fucoside | n2=en:cholesterol low | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cholesterol normal
n1=fucoside | n2=en:cholesterol normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chondrodysplasia punctata syndrome
n1=fucoside | n2=en:chondrodysplasia punctata syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chondroitin 4-, 6-sulfate excretion in urine
n1=fucoside | n2=en:chondroitin 4-, 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chondroitin 6-sulfate excretion in urine
n1=fucoside | n2=en:chondroitin 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism
n1=fucoside | n2=en:chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosomal breakage and abnormalities of the juxtacentromeric regions of chromosomes 1, 9, and 16
n1=fucoside | n2=en:chromosomal breakage and abnormalities of the juxtacentromeric regions of chromosomes 1, 9, and 16 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosomal instability
n1=fucoside | n2=en:chromosomal instability | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosomal mosaicism in cultured cells
n1=fucoside | n2=en:chromosomal mosaicism in cultured cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding
n1=fucoside | n2=en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosomal rearrangement
n1=fucoside | n2=en:chromosomal rearrangement | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus
n1=fucoside | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin kappa light chain (147200, 2p12) locus
n1=fucoside | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin kappa light chain (147200, 2p12) locus | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus
n1=fucoside | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosome 11q23.3 deletion
n1=fucoside | n2=en:chromosome 11q23.3 deletion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosome deletion extending from 8q24.11 to 8q24.13
n1=fucoside | n2=en:chromosome deletion extending from 8q24.11 to 8q24.13 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division)
n1=fucoside | n2=en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chromosome inversion - inv2(p12q14) in 2 patients
n1=fucoside | n2=en:chromosome inversion - inv2(p12q14) in 2 patients | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chronic hypercapnia
n1=fucoside | n2=en:chronic hypercapnia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chronic hypoxemia
n1=fucoside | n2=en:chronic hypoxemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chylomicron retention disease
n1=fucoside | n2=en:chylomicron retention disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:chylomicronemia, refractory fasting
n1=fucoside | n2=en:chylomicronemia, refractory fasting | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cilia may also be static, with slow activity
n1=fucoside | n2=en:cilia may also be static, with slow activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cilia show inner and outer dynein arm defects
n1=fucoside | n2=en:cilia show inner and outer dynein arm defects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cilia show nonflexible and hyperkinetic beating of axonemes
n1=fucoside | n2=en:cilia show nonflexible and hyperkinetic beating of axonemes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:citrin deficiency
n1=fucoside | n2=en:citrin deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:citrullinemia
n1=fucoside | n2=en:citrullinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:classical phenylketonuria
n1=fucoside | n2=en:classical phenylketonuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cleft lip/palate-ectodermal dysplasia syndrome
n1=fucoside | n2=en:cleft lip/palate-ectodermal dysplasia syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:coagulopathy (inr = 2.2 - 3.5)
n1=fucoside | n2=en:coagulopathy (inr = 2.2 - 3.5) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:coarse metachromatic granules in white blood cells
n1=fucoside | n2=en:coarse metachromatic granules in white blood cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cohen syndrome
n1=fucoside | n2=en:cohen syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:combined malonic and methylmalonic aciduria
n1=fucoside | n2=en:combined malonic and methylmalonic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:complex organic aciduria
n1=fucoside | n2=en:complex organic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:complication aspects
n1=fucoside | n2=en:complication aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital
n1=fucoside | n2=en:congenital | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital adrenal hyperplasia
n1=fucoside | n2=en:congenital adrenal hyperplasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency
n1=fucoside | n2=en:congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital alpha-2-antiplasmin deficiency
n1=fucoside | n2=en:congenital alpha-2-antiplasmin deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital amegakaryocytic thrombocytopenia
n1=fucoside | n2=en:congenital amegakaryocytic thrombocytopenia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital bowing of long bone
n1=fucoside | n2=en:congenital bowing of long bone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital cataracts, facial dysmorphism, and neuropathy
n1=fucoside | n2=en:congenital cataracts, facial dysmorphism, and neuropathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital disorder of glycosylation type ia
n1=fucoside | n2=en:congenital disorder of glycosylation type ia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital disorder of glycosylation type ic
n1=fucoside | n2=en:congenital disorder of glycosylation type ic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital disorder of glycosylation type ig
n1=fucoside | n2=en:congenital disorder of glycosylation type ig | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital dyserythropoietic anemia, type i
n1=fucoside | n2=en:congenital dyserythropoietic anemia, type i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital dyserythropoietic anemia, type ii
n1=fucoside | n2=en:congenital dyserythropoietic anemia, type ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital dysplasia
n1=fucoside | n2=en:congenital dysplasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital leptin deficiency
n1=fucoside | n2=en:congenital leptin deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital muscular dystrophy with infantile cataract and hypogonadism syndrome
n1=fucoside | n2=en:congenital muscular dystrophy with infantile cataract and hypogonadism syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital pancreatic enterokinase deficiency
n1=fucoside | n2=en:congenital pancreatic enterokinase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital plasminogen activator inhibitor deficiency type 1
n1=fucoside | n2=en:congenital plasminogen activator inhibitor deficiency type 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital sucrase-isomaltase deficiency
n1=fucoside | n2=en:congenital sucrase-isomaltase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:congenital transferrin deficiency
n1=fucoside | n2=en:congenital transferrin deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:contiguous gene deletion syndrome
n1=fucoside | n2=en:contiguous gene deletion syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:continuous urinary iodine loss
n1=fucoside | n2=en:continuous urinary iodine loss | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:coombs positive hemolytic anemia
n1=fucoside | n2=en:coombs positive hemolytic anemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:corpus callosum agenesis neuronopathy
n1=fucoside | n2=en:corpus callosum agenesis neuronopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cortisol does not decrease on dexamethasone suppression test
n1=fucoside | n2=en:cortisol does not decrease on dexamethasone suppression test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cortisone reductase deficiency
n1=fucoside | n2=en:cortisone reductase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:coxa valga
n1=fucoside | n2=en:coxa valga | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:craniodiaphyseal dysplasia
n1=fucoside | n2=en:craniodiaphyseal dysplasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:creatine decreased
n1=fucoside | n2=en:creatine decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:creatine kinase levels may normalize with disease progression
n1=fucoside | n2=en:creatine kinase levels may normalize with disease progression | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:creatine kinase normal between episodes
n1=fucoside | n2=en:creatine kinase normal between episodes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:creatine phosphokinase increased
n1=fucoside | n2=en:creatine phosphokinase increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:creatine phosphokinase serum increased
n1=fucoside | n2=en:creatine phosphokinase serum increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:crigler-najjar syndrome
n1=fucoside | n2=en:crigler-najjar syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:crisponi syndrome
n1=fucoside | n2=en:crisponi syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cryptophthalmos syndrome
n1=fucoside | n2=en:cryptophthalmos syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:csf pleocytosis, particularly of lymphocytes
n1=fucoside | n2=en:csf pleocytosis, particularly of lymphocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ctrp disease terminology
n1=fucoside | n2=en:ctrp disease terminology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material
n1=fucoside | n2=en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cutaneous anergy
n1=fucoside | n2=en:cutaneous anergy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cutis laxa, autosomal recessive
n1=fucoside | n2=en:cutis laxa, autosomal recessive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cystathionine beta-synthase deficiency disease
n1=fucoside | n2=en:cystathionine beta-synthase deficiency disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cystathioninemia
n1=fucoside | n2=en:cystathioninemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cystathioninuria (lab finding)
n1=fucoside | n2=en:cystathioninuria (lab finding) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cystinosis
n1=fucoside | n2=en:cystinosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytochrome c oxidase deficiency in skeletal muscle and brain
n1=fucoside | n2=en:cytochrome c oxidase deficiency in skeletal muscle and brain | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytochrome p450 enzyme deficiency
n1=fucoside | n2=en:cytochrome p450 enzyme deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytochrome-c oxidase deficiency
n1=fucoside | n2=en:cytochrome-c oxidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytogenetic breakpoints range from 10q23.3-q26.2
n1=fucoside | n2=en:cytogenetic breakpoints range from 10q23.3-q26.2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytogenetic deletion of chromosome 17p13.3
n1=fucoside | n2=en:cytogenetic deletion of chromosome 17p13.3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytogenetic deletion of chromosome 19q13
n1=fucoside | n2=en:cytogenetic deletion of chromosome 19q13 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter))
n1=fucoside | n2=en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1
n1=fucoside | n2=en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytoplasmic lamellar concentric inclusions
n1=fucoside | n2=en:cytoplasmic lamellar concentric inclusions | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients)
n1=fucoside | n2=en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:cytosolic phosphoenolpyruvate carboxykinase deficiency
n1=fucoside | n2=en:cytosolic phosphoenolpyruvate carboxykinase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:d-2-hydroxyglutaric aciduria
n1=fucoside | n2=en:d-2-hydroxyglutaric aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deafness, congenital, with inner ear agenesis, microtia, and microdontia
n1=fucoside | n2=en:deafness, congenital, with inner ear agenesis, microtia, and microdontia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deafness, progressive, with stapes fixation
n1=fucoside | n2=en:deafness, progressive, with stapes fixation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deafness, sensorineural, and male infertility
n1=fucoside | n2=en:deafness, sensorineural, and male infertility | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decrease or absence of cathepsin d (ctsd) protein immunostaining
n1=fucoside | n2=en:decrease or absence of cathepsin d (ctsd) protein immunostaining | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decrease plasma serine (fasting)
n1=fucoside | n2=en:decrease plasma serine (fasting) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d)
n1=fucoside | n2=en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf
n1=fucoside | n2=en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased acetyl-coa carboxylase activity
n1=fucoside | n2=en:decreased acetyl-coa carboxylase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased acid beta galactosidase protein and activity
n1=fucoside | n2=en:decreased acid beta galactosidase protein and activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased acid sphingomyelinase activity
n1=fucoside | n2=en:decreased acid sphingomyelinase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased acid sphingomyelinase activity (less than 5%)
n1=fucoside | n2=en:decreased acid sphingomyelinase activity (less than 5%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activities of multiple sulfatases
n1=fucoside | n2=en:decreased activities of multiple sulfatases | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex
n1=fucoside | n2=en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase
n1=fucoside | n2=en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of 2-oxoacid dehydrogenases
n1=fucoside | n2=en:decreased activity of 2-oxoacid dehydrogenases | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts)
n1=fucoside | n2=en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%)
n1=fucoside | n2=en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of 3-methylglutaconyl-coa hydratase
n1=fucoside | n2=en:decreased activity of 3-methylglutaconyl-coa hydratase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase
n1=fucoside | n2=en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of aromatic l-amino acid decarboxylase (aadc)
n1=fucoside | n2=en:decreased activity of aromatic l-amino acid decarboxylase (aadc) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of coenzyme q10-dependent respiratory chain complexes
n1=fucoside | n2=en:decreased activity of coenzyme q10-dependent respiratory chain complexes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of complement factor d
n1=fucoside | n2=en:decreased activity of complement factor d | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of cytochrome c oxidase in muscle and fibroblasts
n1=fucoside | n2=en:decreased activity of cytochrome c oxidase in muscle and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of cytosolic acetoacetyl-coa thiolase (acat2, 100678)
n1=fucoside | n2=en:decreased activity of cytosolic acetoacetyl-coa thiolase (acat2, 100678) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of dihydrofolate reductase
n1=fucoside | n2=en:decreased activity of dihydrofolate reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of galactocerebrosidase
n1=fucoside | n2=en:decreased activity of galactocerebrosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes
n1=fucoside | n2=en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase
n1=fucoside | n2=en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of mitochondrial complex i
n1=fucoside | n2=en:decreased activity of mitochondrial complex i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of mitochondrial complex ii (succinate dehydrogenase)
n1=fucoside | n2=en:decreased activity of mitochondrial complex ii (succinate dehydrogenase) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of mitochondrial respiratory chain complex i
n1=fucoside | n2=en:decreased activity of mitochondrial respiratory chain complex i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of mitochondrial respiratory complexes
n1=fucoside | n2=en:decreased activity of mitochondrial respiratory complexes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v
n1=fucoside | n2=en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of mitochondrial respiratory complexes i, iii, and iv
n1=fucoside | n2=en:decreased activity of mitochondrial respiratory complexes i, iii, and iv | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of nadph oxidase
n1=fucoside | n2=en:decreased activity of nadph oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of phosphoglycerate kinase 1
n1=fucoside | n2=en:decreased activity of phosphoglycerate kinase 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of ppt1
n1=fucoside | n2=en:decreased activity of ppt1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of pyruvate decarboxylase (e1 component)
n1=fucoside | n2=en:decreased activity of pyruvate decarboxylase (e1 component) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of pyruvate dehydrogenase complex
n1=fucoside | n2=en:decreased activity of pyruvate dehydrogenase complex | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values
n1=fucoside | n2=en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh
n1=fucoside | n2=en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of the pdh phosphatase
n1=fucoside | n2=en:decreased activity of the pdh phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of the pyruvate dehydrogenase (pdh) complex
n1=fucoside | n2=en:decreased activity of the pyruvate dehydrogenase (pdh) complex | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of the pyruvate dehydrogenase complex (highly variable, 1-70% of controls)
n1=fucoside | n2=en:decreased activity of the pyruvate dehydrogenase complex (highly variable, 1-70% of controls) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of thiopurine s-methyltransferase
n1=fucoside | n2=en:decreased activity of thiopurine s-methyltransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of thymidine phosphorylase
n1=fucoside | n2=en:decreased activity of thymidine phosphorylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of triosephosphate isomerase
n1=fucoside | n2=en:decreased activity of triosephosphate isomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased activity of tyrosine hydroxylase
n1=fucoside | n2=en:decreased activity of tyrosine hydroxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased adenosylcobalamin
n1=fucoside | n2=en:decreased adenosylcobalamin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased adiponectin
n1=fucoside | n2=en:decreased adiponectin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased agt activity
n1=fucoside | n2=en:decreased agt activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control)
n1=fucoside | n2=en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased alpha-n-acetylgalactosaminidase protein
n1=fucoside | n2=en:decreased alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased aminoacylase-1 activity
n1=fucoside | n2=en:decreased aminoacylase-1 activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased amount and activity of mitochondrial complexes i and iv
n1=fucoside | n2=en:decreased amount and activity of mitochondrial complexes i and iv | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased antithrombin iii (rare)
n1=fucoside | n2=en:decreased antithrombin iii (rare) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased apoa-i and apoa-ii
n1=fucoside | n2=en:decreased apoa-i and apoa-ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts
n1=fucoside | n2=en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased asparagine levels (in some patients)
n1=fucoside | n2=en:decreased asparagine levels (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased atp synthase in muscle, heart, liver, and brain
n1=fucoside | n2=en:decreased atp synthase in muscle, heart, liver, and brain | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased axonal flare response after intradermal histamine injection
n1=fucoside | n2=en:decreased axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased b cells
n1=fucoside | n2=en:decreased b cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased beta-galactosidase activity
n1=fucoside | n2=en:decreased beta-galactosidase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased beta-glucocerebrosidase protein and activity
n1=fucoside | n2=en:decreased beta-glucocerebrosidase protein and activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased beta-glucosidase protein and activity
n1=fucoside | n2=en:decreased beta-glucosidase protein and activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes
n1=fucoside | n2=en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased beta-oxidation of pristanic acid
n1=fucoside | n2=en:decreased beta-oxidation of pristanic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased beta-thromboglobulin
n1=fucoside | n2=en:decreased beta-thromboglobulin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased blood levels of cationic amino acids
n1=fucoside | n2=en:decreased blood levels of cationic amino acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased c3 activity
n1=fucoside | n2=en:decreased c3 activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased c3 antigen
n1=fucoside | n2=en:decreased c3 antigen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased carnitine in serum, muscle, heart, and liver
n1=fucoside | n2=en:decreased carnitine in serum, muscle, heart, and liver | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased carnitine palmitoyltransferase ii (cpt2) activity
n1=fucoside | n2=en:decreased carnitine palmitoyltransferase ii (cpt2) activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased cerebrospinal fluid folic acid
n1=fucoside | n2=en:decreased cerebrospinal fluid folic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased cholesterol (less common)
n1=fucoside | n2=en:decreased cholesterol (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased ciliary motility
n1=fucoside | n2=en:decreased ciliary motility | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased circulating aldosterone level
n1=fucoside | n2=en:decreased circulating aldosterone level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased circulating cortisol level
n1=fucoside | n2=en:decreased circulating cortisol level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased circulating renin level
n1=fucoside | n2=en:decreased circulating renin level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased clot retraction
n1=fucoside | n2=en:decreased clot retraction | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased cobalamin in liver, kidney, and cultured fibroblasts
n1=fucoside | n2=en:decreased cobalamin in liver, kidney, and cultured fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased complement factor d
n1=fucoside | n2=en:decreased complement factor d | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased conversion of beta-carotene to vitamin a (retinol)
n1=fucoside | n2=en:decreased conversion of beta-carotene to vitamin a (retinol) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased copper, iron, zinc
n1=fucoside | n2=en:decreased copper, iron, zinc | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal)
n1=fucoside | n2=en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased coq10 levels in lymphoblasts or fibroblasts
n1=fucoside | n2=en:decreased coq10 levels in lymphoblasts or fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased cortisol-binding globulin
n1=fucoside | n2=en:decreased cortisol-binding globulin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased cpt1 activity
n1=fucoside | n2=en:decreased cpt1 activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg)
n1=fucoside | n2=en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa)
n1=fucoside | n2=en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf 5-hydroxyindoleacetic acid (5hiaa)
n1=fucoside | n2=en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf arginine
n1=fucoside | n2=en:decreased csf arginine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf ferritin despite normal serum ferritin levels
n1=fucoside | n2=en:decreased csf ferritin despite normal serum ferritin levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf folate
n1=fucoside | n2=en:decreased csf folate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf glycine
n1=fucoside | n2=en:decreased csf glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf homovanillic acid (hva)
n1=fucoside | n2=en:decreased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf hypocretin
n1=fucoside | n2=en:decreased csf hypocretin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf methyltetrahydrofolate (mthf)
n1=fucoside | n2=en:decreased csf methyltetrahydrofolate (mthf) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf pyridoxal
n1=fucoside | n2=en:decreased csf pyridoxal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf pyridoxal 5-prime-phosphate (plp)
n1=fucoside | n2=en:decreased csf pyridoxal 5-prime-phosphate (plp) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf serine
n1=fucoside | n2=en:decreased csf serine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate
n1=fucoside | n2=en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle
n1=fucoside | n2=en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased decr enzyme activity
n1=fucoside | n2=en:decreased decr enzyme activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased dermal hydroxylysine content
n1=fucoside | n2=en:decreased dermal hydroxylysine content | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity
n1=fucoside | n2=en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity
n1=fucoside | n2=en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased dna excision repair
n1=fucoside | n2=en:decreased dna excision repair | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased dna polymerase-gamma (polg, 174763) activity
n1=fucoside | n2=en:decreased dna polymerase-gamma (polg, 174763) activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased eno3 activity
n1=fucoside | n2=en:decreased eno3 activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg)
n1=fucoside | n2=en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values
n1=fucoside | n2=en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased erythrocyte plasmalogen
n1=fucoside | n2=en:decreased erythrocyte plasmalogen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased expression of glycosylphosphatidylinositol-anchored membrane proteins
n1=fucoside | n2=en:decreased expression of glycosylphosphatidylinositol-anchored membrane proteins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells
n1=fucoside | n2=en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased expression of gpi-anchored proteins on blood cells
n1=fucoside | n2=en:decreased expression of gpi-anchored proteins on blood cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased factor xi
n1=fucoside | n2=en:decreased factor xi | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased fbp1 enzyme activity
n1=fucoside | n2=en:decreased fbp1 enzyme activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased fibrillin-1 immunostaining in the dermis
n1=fucoside | n2=en:decreased fibrillin-1 immunostaining in the dermis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased fibrinogen (in some patients)
n1=fucoside | n2=en:decreased fibrinogen (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased fibroblast alpha-mannosidase
n1=fucoside | n2=en:decreased fibroblast alpha-mannosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased fibroblast arylsulfatase a
n1=fucoside | n2=en:decreased fibroblast arylsulfatase a | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased fibroblast beta-hexosaminidase
n1=fucoside | n2=en:decreased fibroblast beta-hexosaminidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased fibroblast iduronate sulfatase
n1=fucoside | n2=en:decreased fibroblast iduronate sulfatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased formation of complex (tri-, tetra-antennary) n-glycans
n1=fucoside | n2=en:decreased formation of complex (tri-, tetra-antennary) n-glycans | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased free t(3)/free t(4)
n1=fucoside | n2=en:decreased free t(3)/free t(4) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased fumarate hydratase activity
n1=fucoside | n2=en:decreased fumarate hydratase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased galactokinase activity
n1=fucoside | n2=en:decreased galactokinase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased glomerular filtration rate (gfr)
n1=fucoside | n2=en:decreased glomerular filtration rate (gfr) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased glutamine in bodily fluids
n1=fucoside | n2=en:decreased glutamine in bodily fluids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased glycerol kinase activity
n1=fucoside | n2=en:decreased glycerol kinase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased grhpr activity
n1=fucoside | n2=en:decreased grhpr activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased gtp cyclohydrolase i activity (about 20% of normal)
n1=fucoside | n2=en:decreased gtp cyclohydrolase i activity (about 20% of normal) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased hdl cholesterol
n1=fucoside | n2=en:decreased hdl cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169)
n1=fucoside | n2=en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased hepatic gaba transaminase activity
n1=fucoside | n2=en:decreased hepatic gaba transaminase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased hepatic udp-glucuronyl-transferase activity
n1=fucoside | n2=en:decreased hepatic udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased hexokinase activity in red blood cells
n1=fucoside | n2=en:decreased hexokinase activity in red blood cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased high molecular weight plasma factor viii/ vwf multimers
n1=fucoside | n2=en:decreased high molecular weight plasma factor viii/ vwf multimers | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf
n1=fucoside | n2=en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased iga, igg, igm
n1=fucoside | n2=en:decreased iga, igg, igm | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased insulin receptor binding
n1=fucoside | n2=en:decreased insulin receptor binding | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased intracellular fmr protein
n1=fucoside | n2=en:decreased intracellular fmr protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased ldl cholesterol
n1=fucoside | n2=en:decreased ldl cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased lecithin:cholesterol acyltransferase mass and activity
n1=fucoside | n2=en:decreased lecithin:cholesterol acyltransferase mass and activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased leptin
n1=fucoside | n2=en:decreased leptin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of cellular and mitochondrial fes-containing proteins
n1=fucoside | n2=en:decreased levels of cellular and mitochondrial fes-containing proteins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of certain coagulation factors
n1=fucoside | n2=en:decreased levels of certain coagulation factors | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of coenzyme q10 in skeletal muscle (5-35%)
n1=fucoside | n2=en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of component x protein of the pdh complex
n1=fucoside | n2=en:decreased levels of component x protein of the pdh complex | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of cpt2 protein
n1=fucoside | n2=en:decreased levels of cpt2 protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of csf hypocretin (hcrt, 602358)
n1=fucoside | n2=en:decreased levels of csf hypocretin (hcrt, 602358) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of plasma factor viii
n1=fucoside | n2=en:decreased levels of plasma factor viii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of plasma factor viii in patients with type 2n
n1=fucoside | n2=en:decreased levels of plasma factor viii in patients with type 2n | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of plasma vwf antigen
n1=fucoside | n2=en:decreased levels of plasma vwf antigen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of serum vitamin b12
n1=fucoside | n2=en:decreased levels of serum vitamin b12 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased levels of the e2 subunit protein
n1=fucoside | n2=en:decreased levels of the e2 subunit protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased lipid-linked oligosaccharides (llo)
n1=fucoside | n2=en:decreased lipid-linked oligosaccharides (llo) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased liver homogentisate 1,2-dioxygenase activity
n1=fucoside | n2=en:decreased liver homogentisate 1,2-dioxygenase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased long-chain fatty acid oxidation
n1=fucoside | n2=en:decreased long-chain fatty acid oxidation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes
n1=fucoside | n2=en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased metabolism of thiopurine drugs
n1=fucoside | n2=en:decreased metabolism of thiopurine drugs | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased methionine synthase activity
n1=fucoside | n2=en:decreased methionine synthase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased methylcobalamin (mecbl)
n1=fucoside | n2=en:decreased methylcobalamin (mecbl) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased methylmalonyl-coa mutase activity
n1=fucoside | n2=en:decreased methylmalonyl-coa mutase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial complex iii activity (in fibroblasts of 1 patient)
n1=fucoside | n2=en:decreased mitochondrial complex iii activity (in fibroblasts of 1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts)
n1=fucoside | n2=en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial complex iii activity (skeletal muscle, fibroblasts)
n1=fucoside | n2=en:decreased mitochondrial complex iii activity (skeletal muscle, fibroblasts) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial complex iii activity in liver and fibroblasts
n1=fucoside | n2=en:decreased mitochondrial complex iii activity in liver and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial complex iii activity in muscle
n1=fucoside | n2=en:decreased mitochondrial complex iii activity in muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial complex iii activity seen in muscle
n1=fucoside | n2=en:decreased mitochondrial complex iii activity seen in muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial complex v assembly
n1=fucoside | n2=en:decreased mitochondrial complex v assembly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial nadp(h)
n1=fucoside | n2=en:decreased mitochondrial nadp(h) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial respiratory chain complex (2p21del)
n1=fucoside | n2=en:decreased mitochondrial respiratory chain complex (2p21del) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle
n1=fucoside | n2=en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased monoamine oxidase a activity
n1=fucoside | n2=en:decreased monoamine oxidase a activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased mucosal alkaline phosphatase
n1=fucoside | n2=en:decreased mucosal alkaline phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes
n1=fucoside | n2=en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased nasal nitric oxide
n1=fucoside | n2=en:decreased nasal nitric oxide | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased nasal nitric oxide (in some patients)
n1=fucoside | n2=en:decreased nasal nitric oxide (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased natural killer cells
n1=fucoside | n2=en:decreased natural killer cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased neopterin and biopterin in csf
n1=fucoside | n2=en:decreased neopterin and biopterin in csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased neopterin and biopterin in urine
n1=fucoside | n2=en:decreased neopterin and biopterin in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased nk cells (in some patients)
n1=fucoside | n2=en:decreased nk cells (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased number of igf1 receptors (igf1r, 147370) on cell surface
n1=fucoside | n2=en:decreased number of igf1 receptors (igf1r, 147370) on cell surface | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased numbers of t regulatory cells
n1=fucoside | n2=en:decreased numbers of t regulatory cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent alpha-n-acetylgalactosaminidase activity
n1=fucoside | n2=en:decreased or absent alpha-n-acetylgalactosaminidase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent alpha-n-acetylgalactosaminidase protein
n1=fucoside | n2=en:decreased or absent alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent apolipoprotein a-i
n1=fucoside | n2=en:decreased or absent apolipoprotein a-i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent ciliary motility
n1=fucoside | n2=en:decreased or absent ciliary motility | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent d-bifunctional protein activity and protein
n1=fucoside | n2=en:decreased or absent d-bifunctional protein activity and protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent dihydropteridine reductase activity
n1=fucoside | n2=en:decreased or absent dihydropteridine reductase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent dihydropyrimidine dehydrogenase activity
n1=fucoside | n2=en:decreased or absent dihydropyrimidine dehydrogenase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent gch1 activity
n1=fucoside | n2=en:decreased or absent gch1 activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent glycogen branching enzyme activity
n1=fucoside | n2=en:decreased or absent glycogen branching enzyme activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent histidase activity
n1=fucoside | n2=en:decreased or absent histidase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent peroxisome acyl-coa oxidase activity and protein
n1=fucoside | n2=en:decreased or absent peroxisome acyl-coa oxidase activity and protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent pts activity
n1=fucoside | n2=en:decreased or absent pts activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid
n1=fucoside | n2=en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent serum ceruloplasmin
n1=fucoside | n2=en:decreased or absent serum ceruloplasmin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent serum citrulline
n1=fucoside | n2=en:decreased or absent serum citrulline | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent steroid sulfatase activity
n1=fucoside | n2=en:decreased or absent steroid sulfatase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or absent udp-glucuronyl-transferase activity
n1=fucoside | n2=en:decreased or absent udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or increased serum testosterone
n1=fucoside | n2=en:decreased or increased serum testosterone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or low-normal serum parathyroid hormone (pth)
n1=fucoside | n2=en:decreased or low-normal serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or normal plasma insulin
n1=fucoside | n2=en:decreased or normal plasma insulin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or normal serum c3
n1=fucoside | n2=en:decreased or normal serum c3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or normal serum factor b
n1=fucoside | n2=en:decreased or normal serum factor b | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased or normal serum factor i
n1=fucoside | n2=en:decreased or normal serum factor i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased palmitate oxidation
n1=fucoside | n2=en:decreased palmitate oxidation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased peroxisomal fatty acid beta-oxidation
n1=fucoside | n2=en:decreased peroxisomal fatty acid beta-oxidation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased phgdh activity (fibroblasts)
n1=fucoside | n2=en:decreased phgdh activity (fibroblasts) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased phk activity in liver
n1=fucoside | n2=en:decreased phk activity in liver | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values)
n1=fucoside | n2=en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values)
n1=fucoside | n2=en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased phytanic acid oxidase activity
n1=fucoside | n2=en:decreased phytanic acid oxidase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma and urinary guanidinoacetate (gaa)
n1=fucoside | n2=en:decreased plasma and urinary guanidinoacetate (gaa) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma and urinary ornithine
n1=fucoside | n2=en:decreased plasma and urinary ornithine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma apolipoprotein b (apob, 107730)
n1=fucoside | n2=en:decreased plasma apolipoprotein b (apob, 107730) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma apolipoprotein c-ii
n1=fucoside | n2=en:decreased plasma apolipoprotein c-ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma arginine
n1=fucoside | n2=en:decreased plasma arginine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma esterified cholesterol
n1=fucoside | n2=en:decreased plasma esterified cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma free carnitine
n1=fucoside | n2=en:decreased plasma free carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma glycine
n1=fucoside | n2=en:decreased plasma glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma gonadotrophin
n1=fucoside | n2=en:decreased plasma gonadotrophin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma hdl (<1/10 of normal levels)
n1=fucoside | n2=en:decreased plasma hdl (<1/10 of normal levels) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma lpl levels (in some patients)
n1=fucoside | n2=en:decreased plasma lpl levels (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma lysine, glutamic acid, and glutamine
n1=fucoside | n2=en:decreased plasma lysine, glutamic acid, and glutamine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma serine
n1=fucoside | n2=en:decreased plasma serine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma total and free carnitine
n1=fucoside | n2=en:decreased plasma total and free carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma total cholesterol
n1=fucoside | n2=en:decreased plasma total cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma triglycerides
n1=fucoside | n2=en:decreased plasma triglycerides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasma zinc levels
n1=fucoside | n2=en:decreased plasma zinc levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasmalogens
n1=fucoside | n2=en:decreased plasmalogens | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasminogen activity
n1=fucoside | n2=en:decreased plasminogen activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased plasminogen antigen
n1=fucoside | n2=en:decreased plasminogen antigen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased platelet derived growth factor
n1=fucoside | n2=en:decreased platelet derived growth factor | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased prpp synthetase activity in erythrocytes and fibroblasts
n1=fucoside | n2=en:decreased prpp synthetase activity in erythrocytes and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased pyruvate carboxylase (pc) activity (less than 5%)
n1=fucoside | n2=en:decreased pyruvate carboxylase (pc) activity (less than 5%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased red cell pyruvate kinase activity
n1=fucoside | n2=en:decreased red cell pyruvate kinase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased renal calcium excretion
n1=fucoside | n2=en:decreased renal calcium excretion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased respiratory chain complex iii activity in multiple tissues
n1=fucoside | n2=en:decreased respiratory chain complex iii activity in multiple tissues | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999)
n1=fucoside | n2=en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased s-ado:saicar ratio
n1=fucoside | n2=en:decreased s-ado:saicar ratio | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased scad activity
n1=fucoside | n2=en:decreased scad activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased secretion of igf1 in response to gh administration
n1=fucoside | n2=en:decreased secretion of igf1 in response to gh administration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum 18-ohb
n1=fucoside | n2=en:decreased serum 18-ohb | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum 25-hydroxyvitamin d
n1=fucoside | n2=en:decreased serum 25-hydroxyvitamin d | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum acth
n1=fucoside | n2=en:decreased serum acth | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum alpha-2 macroglobulin levels
n1=fucoside | n2=en:decreased serum alpha-2 macroglobulin levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum and muscle coenzyme q
n1=fucoside | n2=en:decreased serum and muscle coenzyme q | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum and salivary lactoferrin has been described in 1 family
n1=fucoside | n2=en:decreased serum and salivary lactoferrin has been described in 1 family | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum androgens
n1=fucoside | n2=en:decreased serum androgens | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum b12 levels
n1=fucoside | n2=en:decreased serum b12 levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum bun
n1=fucoside | n2=en:decreased serum bun | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum c3 (atypical hus)
n1=fucoside | n2=en:decreased serum c3 (atypical hus) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum carnitine in acute stage
n1=fucoside | n2=en:decreased serum carnitine in acute stage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum ceruloplasmin
n1=fucoside | n2=en:decreased serum ceruloplasmin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum cholesterol (in some)
n1=fucoside | n2=en:decreased serum cholesterol (in some) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum cobalamin
n1=fucoside | n2=en:decreased serum cobalamin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum complement factor h
n1=fucoside | n2=en:decreased serum complement factor h | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum factor b (atypical hus)
n1=fucoside | n2=en:decreased serum factor b (atypical hus) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum factor h (atypical hus)
n1=fucoside | n2=en:decreased serum factor h (atypical hus) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum factor i (atypical hus)
n1=fucoside | n2=en:decreased serum factor i (atypical hus) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum ferritin
n1=fucoside | n2=en:decreased serum ferritin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum follicle-stimulating hormone (fsh)
n1=fucoside | n2=en:decreased serum follicle-stimulating hormone (fsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum free thyroxine
n1=fucoside | n2=en:decreased serum free thyroxine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum glucosyltransferase (ggt) activity
n1=fucoside | n2=en:decreased serum glucosyltransferase (ggt) activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum haptoglobin
n1=fucoside | n2=en:decreased serum haptoglobin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum haptoglobin (in some patients)
n1=fucoside | n2=en:decreased serum haptoglobin (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum iga
n1=fucoside | n2=en:decreased serum iga | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum igm
n1=fucoside | n2=en:decreased serum igm | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum insulin-like growth factor-1 (igf1, 147440)
n1=fucoside | n2=en:decreased serum insulin-like growth factor-1 (igf1, 147440) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum insulin-like growth factor-1 (igf1)
n1=fucoside | n2=en:decreased serum insulin-like growth factor-1 (igf1) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum iron (in some patients)
n1=fucoside | n2=en:decreased serum iron (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum l-transferrin (heterozygous patient)
n1=fucoside | n2=en:decreased serum l-transferrin (heterozygous patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum leptin
n1=fucoside | n2=en:decreased serum leptin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum levels of maoa products
n1=fucoside | n2=en:decreased serum levels of maoa products | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum luteinizing hormone (lh)
n1=fucoside | n2=en:decreased serum luteinizing hormone (lh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum rt3
n1=fucoside | n2=en:decreased serum rt3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum thiamine pyrophosphate
n1=fucoside | n2=en:decreased serum thiamine pyrophosphate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum thyroid-stimulating hormone (tsh)
n1=fucoside | n2=en:decreased serum thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum thyroxine (t4)
n1=fucoside | n2=en:decreased serum thyroxine (t4) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum trypsinogen
n1=fucoside | n2=en:decreased serum trypsinogen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased serum vitamin a
n1=fucoside | n2=en:decreased serum vitamin a | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity
n1=fucoside | n2=en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased sulfite oxidase activity
n1=fucoside | n2=en:decreased sulfite oxidase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased sulfite oxidase activity in fibroblasts
n1=fucoside | n2=en:decreased sulfite oxidase activity in fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased switched memory b cells
n1=fucoside | n2=en:decreased switched memory b cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased switched memory b cells (in some patients)
n1=fucoside | n2=en:decreased switched memory b cells (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased t cells
n1=fucoside | n2=en:decreased t cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased telomerase activity
n1=fucoside | n2=en:decreased telomerase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased telomere length in lymphocytes
n1=fucoside | n2=en:decreased telomere length in lymphocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased testosterone level
n1=fucoside | n2=en:decreased testosterone level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased tetrahydrobiopterin (bh4) in csf
n1=fucoside | n2=en:decreased tetrahydrobiopterin (bh4) in csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased tetrasialo-transferrin
n1=fucoside | n2=en:decreased tetrasialo-transferrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased tetrasialotransferrin levels
n1=fucoside | n2=en:decreased tetrasialotransferrin levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased thrombospondin
n1=fucoside | n2=en:decreased thrombospondin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased thyroxine level
n1=fucoside | n2=en:decreased thyroxine level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased tissue and serum alkaline phosphatase
n1=fucoside | n2=en:decreased tissue and serum alkaline phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased tissue total and free carnitine
n1=fucoside | n2=en:decreased tissue total and free carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid
n1=fucoside | n2=en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased transferrin increased serum iron
n1=fucoside | n2=en:decreased transferrin increased serum iron | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased triiodothyronine level
n1=fucoside | n2=en:decreased triiodothyronine level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased ubiquinone-10
n1=fucoside | n2=en:decreased ubiquinone-10 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased udp-glcnac
n1=fucoside | n2=en:decreased udp-glcnac | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased urinary calcium and phosphate excretion
n1=fucoside | n2=en:decreased urinary calcium and phosphate excretion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased urinary excretion of uromodulin
n1=fucoside | n2=en:decreased urinary excretion of uromodulin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma)
n1=fucoside | n2=en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased urinary sulfate
n1=fucoside | n2=en:decreased urinary sulfate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased urocanic acid in blood, urine, and skin cells
n1=fucoside | n2=en:decreased urocanic acid in blood, urine, and skin cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased uros activity (1 patient)
n1=fucoside | n2=en:decreased uros activity (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased very long-chain acyl-coa dehydrogenase protein and activity
n1=fucoside | n2=en:decreased very long-chain acyl-coa dehydrogenase protein and activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased von willebrand factor
n1=fucoside | n2=en:decreased von willebrand factor | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased whole blood serotonin
n1=fucoside | n2=en:decreased whole blood serotonin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased xanthine dehydrogenase activity
n1=fucoside | n2=en:decreased xanthine dehydrogenase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:decreased-absent intestinal mucosa lactase activity
n1=fucoside | n2=en:decreased-absent intestinal mucosa lactase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defect in chylomicron secretion
n1=fucoside | n2=en:defect in chylomicron secretion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defect in dna repair
n1=fucoside | n2=en:defect in dna repair | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defect in double-stranded dna repair
n1=fucoside | n2=en:defect in double-stranded dna repair | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defect in mitochondrial and peroxisomal fission
n1=fucoside | n2=en:defect in mitochondrial and peroxisomal fission | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defect in n- and o-glycosylation
n1=fucoside | n2=en:defect in n- and o-glycosylation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defect in oxidative phosphorylation
n1=fucoside | n2=en:defect in oxidative phosphorylation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defect in post-translational modification of lysosomal enzymes
n1=fucoside | n2=en:defect in post-translational modification of lysosomal enzymes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defect in retrograde intraflagellar transport in cilia
n1=fucoside | n2=en:defect in retrograde intraflagellar transport in cilia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defective (ca2+) mobilization in t cells
n1=fucoside | n2=en:defective (ca2+) mobilization in t cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defective bile acid metabolism
n1=fucoside | n2=en:defective bile acid metabolism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defective dna repair
n1=fucoside | n2=en:defective dna repair | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defective dna repair after ultraviolet radiation damage
n1=fucoside | n2=en:defective dna repair after ultraviolet radiation damage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defective glcnac-pi synthesis
n1=fucoside | n2=en:defective glcnac-pi synthesis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defective mitochondrial respiratory enzyme activity
n1=fucoside | n2=en:defective mitochondrial respiratory enzyme activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defective t-cell proliferative responses (in some patients)
n1=fucoside | n2=en:defective t-cell proliferative responses (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defects in glycoprotein degradation
n1=fucoside | n2=en:defects in glycoprotein degradation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:defects in mitochondrial oxidative phosphorylation
n1=fucoside | n2=en:defects in mitochondrial oxidative phosphorylation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of (s)-2-hydroxy-acid oxidase
n1=fucoside | n2=en:deficiency of (s)-2-hydroxy-acid oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 2-hydroxyglutarate dehydrogenase
n1=fucoside | n2=en:deficiency of 2-hydroxyglutarate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 3-hydroxybutyrate dehydrogenase
n1=fucoside | n2=en:deficiency of 3-hydroxybutyrate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 3-hydroxybutyryl-coa epimerase
n1=fucoside | n2=en:deficiency of 3-hydroxybutyryl-coa epimerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 3-hydroxyisobutyrate dehydrogenase
n1=fucoside | n2=en:deficiency of 3-hydroxyisobutyrate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 3'-nucleotidase
n1=fucoside | n2=en:deficiency of 3'-nucleotidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 3alpha-hydroxycholanate dehydrogenase
n1=fucoside | n2=en:deficiency of 3alpha-hydroxycholanate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 3alpha-hydroxysteroid dehydrogenase
n1=fucoside | n2=en:deficiency of 3alpha-hydroxysteroid dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 3beta-hydroxysteroid dehydrogenase
n1=fucoside | n2=en:deficiency of 3beta-hydroxysteroid dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 4-hydroxy-2-oxoglutarate aldolase
n1=fucoside | n2=en:deficiency of 4-hydroxy-2-oxoglutarate aldolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of 5'-nucleotidase
n1=fucoside | n2=en:deficiency of 5'-nucleotidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of a-ase
n1=fucoside | n2=en:deficiency of a-ase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acetate-coa ligase
n1=fucoside | n2=en:deficiency of acetate-coa ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acetoacetyl-coa reductase
n1=fucoside | n2=en:deficiency of acetoacetyl-coa reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acetyl-coa acylase
n1=fucoside | n2=en:deficiency of acetyl-coa acylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acetyl-coa deacylase
n1=fucoside | n2=en:deficiency of acetyl-coa deacylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acetyl-coa hydrolase
n1=fucoside | n2=en:deficiency of acetyl-coa hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acetylcholinesterase
n1=fucoside | n2=en:deficiency of acetylcholinesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acetylesterase
n1=fucoside | n2=en:deficiency of acetylesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acid-aminoacid ligase
n1=fucoside | n2=en:deficiency of acid-aminoacid ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acid-ammonia ligase
n1=fucoside | n2=en:deficiency of acid-ammonia ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aconitate hydratase
n1=fucoside | n2=en:deficiency of aconitate hydratase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of acylphosphatase
n1=fucoside | n2=en:deficiency of acylphosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of adenine deaminase
n1=fucoside | n2=en:deficiency of adenine deaminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of adenosinetriphosphatase (disorder)
n1=fucoside | n2=en:deficiency of adenosinetriphosphatase (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of adenosylhomocysteinase
n1=fucoside | n2=en:deficiency of adenosylhomocysteinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of adp deaminase
n1=fucoside | n2=en:deficiency of adp deaminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of alanine dehydrogenase
n1=fucoside | n2=en:deficiency of alanine dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of alanine-trna ligase
n1=fucoside | n2=en:deficiency of alanine-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aldehyde dehydrogenase (nad^+^)
n1=fucoside | n2=en:deficiency of aldehyde dehydrogenase (nad^+^) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aldehyde oxidase
n1=fucoside | n2=en:deficiency of aldehyde oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aldehyde reductase
n1=fucoside | n2=en:deficiency of aldehyde reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aldehyde-lyase
n1=fucoside | n2=en:deficiency of aldehyde-lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aldonolactonase
n1=fucoside | n2=en:deficiency of aldonolactonase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aldose 1-epimerase
n1=fucoside | n2=en:deficiency of aldose 1-epimerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of alkaline phosphomonoesterase
n1=fucoside | n2=en:deficiency of alkaline phosphomonoesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of alkylhalidase
n1=fucoside | n2=en:deficiency of alkylhalidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of allantoicase
n1=fucoside | n2=en:deficiency of allantoicase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of allantoinase
n1=fucoside | n2=en:deficiency of allantoinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of alpha- and beta-trypsin
n1=fucoside | n2=en:deficiency of alpha- and beta-trypsin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of alpha-1,4-glucosidase (acid maltase)
n1=fucoside | n2=en:deficiency of alpha-1,4-glucosidase (acid maltase) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of alpha-aminoacylpeptide hydrolase
n1=fucoside | n2=en:deficiency of alpha-aminoacylpeptide hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of alpha-amylase
n1=fucoside | n2=en:deficiency of alpha-amylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of alpha-dextrin endo-1,6-alpha-glucosidase
n1=fucoside | n2=en:deficiency of alpha-dextrin endo-1,6-alpha-glucosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of amidase
n1=fucoside | n2=en:deficiency of amidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of amidinotransferase
n1=fucoside | n2=en:deficiency of amidinotransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of amine oxidase
n1=fucoside | n2=en:deficiency of amine oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of amine oxidase (copper-containing)
n1=fucoside | n2=en:deficiency of amine oxidase (copper-containing) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aminoacyltransferase
n1=fucoside | n2=en:deficiency of aminoacyltransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aminopeptidase
n1=fucoside | n2=en:deficiency of aminopeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aminotransferase
n1=fucoside | n2=en:deficiency of aminotransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of ammonia-lyase
n1=fucoside | n2=en:deficiency of ammonia-lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of amp nucleosidase
n1=fucoside | n2=en:deficiency of amp nucleosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of amylase
n1=fucoside | n2=en:deficiency of amylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of amylopectin 6-glucanohydrolase
n1=fucoside | n2=en:deficiency of amylopectin 6-glucanohydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of arginine deiminase
n1=fucoside | n2=en:deficiency of arginine deiminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aromatic-l-amino-acid decarboxylase
n1=fucoside | n2=en:deficiency of aromatic-l-amino-acid decarboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of arylesterase
n1=fucoside | n2=en:deficiency of arylesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of arylsulfatase
n1=fucoside | n2=en:deficiency of arylsulfatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aspartate 4-decarboxylase
n1=fucoside | n2=en:deficiency of aspartate 4-decarboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aspartate carbamoyltransferase
n1=fucoside | n2=en:deficiency of aspartate carbamoyltransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of aspartic proteinase
n1=fucoside | n2=en:deficiency of aspartic proteinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of atp pyrophosphatase
n1=fucoside | n2=en:deficiency of atp pyrophosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of azobenzene reductase
n1=fucoside | n2=en:deficiency of azobenzene reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of benzaldehyde dehydrogenase (nadp^+^)
n1=fucoside | n2=en:deficiency of benzaldehyde dehydrogenase (nadp^+^) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of benzoylcholinesterase
n1=fucoside | n2=en:deficiency of benzoylcholinesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of beta-amylase
n1=fucoside | n2=en:deficiency of beta-amylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of beta-fructofuranosidase
n1=fucoside | n2=en:deficiency of beta-fructofuranosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of beta-glucosidase
n1=fucoside | n2=en:deficiency of beta-glucosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of betaine-aldehyde dehydrogenase
n1=fucoside | n2=en:deficiency of betaine-aldehyde dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of bisphosphoglycerate mutase
n1=fucoside | n2=en:deficiency of bisphosphoglycerate mutase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of bisphosphoglycerate phosphatase
n1=fucoside | n2=en:deficiency of bisphosphoglycerate phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carbon-carbon lyase
n1=fucoside | n2=en:deficiency of carbon-carbon lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carbon-halide lyase
n1=fucoside | n2=en:deficiency of carbon-halide lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carbon-nitrogen lyase
n1=fucoside | n2=en:deficiency of carbon-nitrogen lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carbon-oxygen lyase
n1=fucoside | n2=en:deficiency of carbon-oxygen lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carbon-sulfur lyase
n1=fucoside | n2=en:deficiency of carbon-sulfur lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carbonate dehydratase
n1=fucoside | n2=en:deficiency of carbonate dehydratase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carboxy-lyase
n1=fucoside | n2=en:deficiency of carboxy-lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carboxylesterase
n1=fucoside | n2=en:deficiency of carboxylesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carboxylic ester hydrolase
n1=fucoside | n2=en:deficiency of carboxylic ester hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of carboxypeptidase a
n1=fucoside | n2=en:deficiency of carboxypeptidase a | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of catechol oxidase
n1=fucoside | n2=en:deficiency of catechol oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cathepsin c
n1=fucoside | n2=en:deficiency of cathepsin c | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cellulase
n1=fucoside | n2=en:deficiency of cellulase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of chlorophyllase
n1=fucoside | n2=en:deficiency of chlorophyllase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cholate-coa ligase
n1=fucoside | n2=en:deficiency of cholate-coa ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cholesterol esterase
n1=fucoside | n2=en:deficiency of cholesterol esterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cholesterol oxidase
n1=fucoside | n2=en:deficiency of cholesterol oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of choline dehydrogenase
n1=fucoside | n2=en:deficiency of choline dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of choline esterase i
n1=fucoside | n2=en:deficiency of choline esterase i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of choline esterase ii (unspecific)
n1=fucoside | n2=en:deficiency of choline esterase ii (unspecific) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of chymosin
n1=fucoside | n2=en:deficiency of chymosin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of chymotrypsin
n1=fucoside | n2=en:deficiency of chymotrypsin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of chymotrypsin a and b
n1=fucoside | n2=en:deficiency of chymotrypsin a and b | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of citrate(si)-synthase
n1=fucoside | n2=en:deficiency of citrate(si)-synthase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of coenzyme-a transferase
n1=fucoside | n2=en:deficiency of coenzyme-a transferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of creatine phosphate in brain
n1=fucoside | n2=en:deficiency of creatine phosphate in brain | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cysteamine dioxygenase
n1=fucoside | n2=en:deficiency of cysteamine dioxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cysteine carboxypeptidase
n1=fucoside | n2=en:deficiency of cysteine carboxypeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cysteine proteinase
n1=fucoside | n2=en:deficiency of cysteine proteinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cysteinyl-glycine dipeptidase
n1=fucoside | n2=en:deficiency of cysteinyl-glycine dipeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cystine reductase (nadh)
n1=fucoside | n2=en:deficiency of cystine reductase (nadh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cytidine deaminase
n1=fucoside | n2=en:deficiency of cytidine deaminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cytochrome-c peroxidase
n1=fucoside | n2=en:deficiency of cytochrome-c peroxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of cytosol aminopeptidase
n1=fucoside | n2=en:deficiency of cytosol aminopeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of d-2-hydroxy-acid dehydrogenase
n1=fucoside | n2=en:deficiency of d-2-hydroxy-acid dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of d-amino-acid oxidase
n1=fucoside | n2=en:deficiency of d-amino-acid oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of d-aspartate oxidase
n1=fucoside | n2=en:deficiency of d-aspartate oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of d-lactate dehydrogenase
n1=fucoside | n2=en:deficiency of d-lactate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dehydrogenase
n1=fucoside | n2=en:deficiency of dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dehydrogluconate dehydrogenase
n1=fucoside | n2=en:deficiency of dehydrogluconate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of deoxyribonuclease i
n1=fucoside | n2=en:deficiency of deoxyribonuclease i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of deoxyribonuclease ii
n1=fucoside | n2=en:deficiency of deoxyribonuclease ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dextranase
n1=fucoside | n2=en:deficiency of dextranase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dihydroorotase
n1=fucoside | n2=en:deficiency of dihydroorotase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dihydrouracil dehydrogenase (nad^+^)
n1=fucoside | n2=en:deficiency of dihydrouracil dehydrogenase (nad^+^) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of diisopropyl-fluorophosphatase
n1=fucoside | n2=en:deficiency of diisopropyl-fluorophosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dimethylallyltranstransferase
n1=fucoside | n2=en:deficiency of dimethylallyltranstransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dioxygenase
n1=fucoside | n2=en:deficiency of dioxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dipeptidase
n1=fucoside | n2=en:deficiency of dipeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dipeptide hydrolase
n1=fucoside | n2=en:deficiency of dipeptide hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dipeptidyl peptidase i
n1=fucoside | n2=en:deficiency of dipeptidyl peptidase i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dipeptidyl-amino-peptidase i
n1=fucoside | n2=en:deficiency of dipeptidyl-amino-peptidase i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of dipeptidylpeptide hydrolase
n1=fucoside | n2=en:deficiency of dipeptidylpeptide hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of diphosphomevalonate decarboxylase
n1=fucoside | n2=en:deficiency of diphosphomevalonate decarboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of diphosphoric monoester hydrolase
n1=fucoside | n2=en:deficiency of diphosphoric monoester hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of endo-1,3(4)-beta-glucanase
n1=fucoside | n2=en:deficiency of endo-1,3(4)-beta-glucanase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of endopeptidase
n1=fucoside | n2=en:deficiency of endopeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of endoribonuclease
n1=fucoside | n2=en:deficiency of endoribonuclease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of enolase
n1=fucoside | n2=en:deficiency of enolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of enoyl-coa hydratase
n1=fucoside | n2=en:deficiency of enoyl-coa hydratase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of epimerase
n1=fucoside | n2=en:deficiency of epimerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of estradiol 6beta-monooxygenase
n1=fucoside | n2=en:deficiency of estradiol 6beta-monooxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of ether hydrolase
n1=fucoside | n2=en:deficiency of ether hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of exoribonuclease
n1=fucoside | n2=en:deficiency of exoribonuclease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of fat-soluble vitamins
n1=fucoside | n2=en:deficiency of fat-soluble vitamins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of formaldehyde dehydrogenase
n1=fucoside | n2=en:deficiency of formaldehyde dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of formamidase
n1=fucoside | n2=en:deficiency of formamidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of formate dehydrogenase
n1=fucoside | n2=en:deficiency of formate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of formate-tetrahydrofolate ligase
n1=fucoside | n2=en:deficiency of formate-tetrahydrofolate ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of formiminotetrahydrofolate cyclodeaminase
n1=fucoside | n2=en:deficiency of formiminotetrahydrofolate cyclodeaminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of formyltetrahydrofolate deformylase
n1=fucoside | n2=en:deficiency of formyltetrahydrofolate deformylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of fructokinase
n1=fucoside | n2=en:deficiency of fructokinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of fructose-bisphosphate aldolase
n1=fucoside | n2=en:deficiency of fructose-bisphosphate aldolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of galactonolactone dehydrogenase
n1=fucoside | n2=en:deficiency of galactonolactone dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of galactose dehydrogenase
n1=fucoside | n2=en:deficiency of galactose dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of gentisate 1,2-dioxygenase
n1=fucoside | n2=en:deficiency of gentisate 1,2-dioxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glucan 1,3-alpha-glucosidase
n1=fucoside | n2=en:deficiency of glucan 1,3-alpha-glucosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of gluconate 2-dehydrogenase
n1=fucoside | n2=en:deficiency of gluconate 2-dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of gluconolactonase
n1=fucoside | n2=en:deficiency of gluconolactonase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glucosamine-6-phosphate isomerase
n1=fucoside | n2=en:deficiency of glucosamine-6-phosphate isomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glucose dehydrogenase
n1=fucoside | n2=en:deficiency of glucose dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glucose oxidase
n1=fucoside | n2=en:deficiency of glucose oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glucose-1-phosphatase
n1=fucoside | n2=en:deficiency of glucose-1-phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glucose-6-phosphate isomerase
n1=fucoside | n2=en:deficiency of glucose-6-phosphate isomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glucosyltransferase 1
n1=fucoside | n2=en:deficiency of glucosyltransferase 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glutamate decarboxylase
n1=fucoside | n2=en:deficiency of glutamate decarboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glutamate dehydrogenase
n1=fucoside | n2=en:deficiency of glutamate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glutamate-ammonia ligase
n1=fucoside | n2=en:deficiency of glutamate-ammonia ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glutaminase
n1=fucoside | n2=en:deficiency of glutaminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glutarate-coa ligase
n1=fucoside | n2=en:deficiency of glutarate-coa ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glutathione reductase (nad(p)h)
n1=fucoside | n2=en:deficiency of glutathione reductase (nad(p)h) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glutathione thiolesterase
n1=fucoside | n2=en:deficiency of glutathione thiolesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glutathione-homocystine transhydrogenase
n1=fucoside | n2=en:deficiency of glutathione-homocystine transhydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glycerophosphatase
n1=fucoside | n2=en:deficiency of glycerophosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glycerophosphocholine phosphodiesterase
n1=fucoside | n2=en:deficiency of glycerophosphocholine phosphodiesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glycoprotein (gp)iib-iiia complex
n1=fucoside | n2=en:deficiency of glycoprotein (gp)iib-iiia complex | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glycosidase
n1=fucoside | n2=en:deficiency of glycosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glycosulfatase
n1=fucoside | n2=en:deficiency of glycosulfatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of glycosyltransferase
n1=fucoside | n2=en:deficiency of glycosyltransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of gmp synthase (glutamine-hydrolysing)
n1=fucoside | n2=en:deficiency of gmp synthase (glutamine-hydrolysing) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of guanine deaminase
n1=fucoside | n2=en:deficiency of guanine deaminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of halogenase
n1=fucoside | n2=en:deficiency of halogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of heparin lyase
n1=fucoside | n2=en:deficiency of heparin lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of hexose oxidase
n1=fucoside | n2=en:deficiency of hexose oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of hexosyltransferase
n1=fucoside | n2=en:deficiency of hexosyltransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of histidine decarboxylase
n1=fucoside | n2=en:deficiency of histidine decarboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of histidinol dehydrogenase
n1=fucoside | n2=en:deficiency of histidinol dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of homocysteine desulfhydrase
n1=fucoside | n2=en:deficiency of homocysteine desulfhydrase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of hyaluronate lyase
n1=fucoside | n2=en:deficiency of hyaluronate lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of hydrolase
n1=fucoside | n2=en:deficiency of hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of hydrolyase
n1=fucoside | n2=en:deficiency of hydrolyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of hydroxyacylglutathione hydrolase
n1=fucoside | n2=en:deficiency of hydroxyacylglutathione hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of hydroxymethylglutaryl-coa hydrolase
n1=fucoside | n2=en:deficiency of hydroxymethylglutaryl-coa hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of hydroxymethylglutaryl-coa reductase (nadph)
n1=fucoside | n2=en:deficiency of hydroxymethylglutaryl-coa reductase (nadph) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of hydroxymethylglutaryl-coa synthase
n1=fucoside | n2=en:deficiency of hydroxymethylglutaryl-coa synthase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of iminodipeptidase
n1=fucoside | n2=en:deficiency of iminodipeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of imp cyclohydrolase
n1=fucoside | n2=en:deficiency of imp cyclohydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of imp dehydrogenase
n1=fucoside | n2=en:deficiency of imp dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of inorganic pyrophosphatase
n1=fucoside | n2=en:deficiency of inorganic pyrophosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of inosinase
n1=fucoside | n2=en:deficiency of inosinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of inosine nucleosidase
n1=fucoside | n2=en:deficiency of inosine nucleosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of isocitrate dehydrogenase (nad^+^)
n1=fucoside | n2=en:deficiency of isocitrate dehydrogenase (nad^+^) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of isocitrate lyase
n1=fucoside | n2=en:deficiency of isocitrate lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of isoleucine-trna ligase
n1=fucoside | n2=en:deficiency of isoleucine-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of isomerase
n1=fucoside | n2=en:deficiency of isomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of isopentenyl-diphosphate delta-isomerase
n1=fucoside | n2=en:deficiency of isopentenyl-diphosphate delta-isomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of ketotetrose-phosphate aldolase
n1=fucoside | n2=en:deficiency of ketotetrose-phosphate aldolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of kynurenine 3-monooxygenase
n1=fucoside | n2=en:deficiency of kynurenine 3-monooxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of l-amino-acid oxidase
n1=fucoside | n2=en:deficiency of l-amino-acid oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of l-arabinose dehydrogenase
n1=fucoside | n2=en:deficiency of l-arabinose dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of l-asparagine amidohydrolase
n1=fucoside | n2=en:deficiency of l-asparagine amidohydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of l-gulonate dehydrogenase
n1=fucoside | n2=en:deficiency of l-gulonate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of l-lactate dehydrogenase
n1=fucoside | n2=en:deficiency of l-lactate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of l-lactate dehydrogenase (cytochrome)
n1=fucoside | n2=en:deficiency of l-lactate dehydrogenase (cytochrome) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of l-prolylglycine dipeptidase
n1=fucoside | n2=en:deficiency of l-prolylglycine dipeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of l-serine dehydratase
n1=fucoside | n2=en:deficiency of l-serine dehydratase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lactate racemase
n1=fucoside | n2=en:deficiency of lactate racemase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lactonase
n1=fucoside | n2=en:deficiency of lactonase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lactoylglutathione lyase
n1=fucoside | n2=en:deficiency of lactoylglutathione lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle
n1=fucoside | n2=en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of laminin in basement membranes
n1=fucoside | n2=en:deficiency of laminin in basement membranes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lecithinase d
n1=fucoside | n2=en:deficiency of lecithinase d | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of leucine aminopeptidase
n1=fucoside | n2=en:deficiency of leucine aminopeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of leucine-trna ligase
n1=fucoside | n2=en:deficiency of leucine-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lichenase
n1=fucoside | n2=en:deficiency of lichenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of ligase
n1=fucoside | n2=en:deficiency of ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lipophosphodiesterase ii
n1=fucoside | n2=en:deficiency of lipophosphodiesterase ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of long-chain fatty-acyl-coa hydrolase
n1=fucoside | n2=en:deficiency of long-chain fatty-acyl-coa hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of long-chain-fatty-acid-coa ligase
n1=fucoside | n2=en:deficiency of long-chain-fatty-acid-coa ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lyase
n1=fucoside | n2=en:deficiency of lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lysine racemase
n1=fucoside | n2=en:deficiency of lysine racemase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lysine-trna ligase
n1=fucoside | n2=en:deficiency of lysine-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lysolecithin acylmutase
n1=fucoside | n2=en:deficiency of lysolecithin acylmutase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lysophospholipase
n1=fucoside | n2=en:deficiency of lysophospholipase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of lysozyme
n1=fucoside | n2=en:deficiency of lysozyme | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of malate dehydrogenase
n1=fucoside | n2=en:deficiency of malate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of malate dehydrogenase (decarboxylating)
n1=fucoside | n2=en:deficiency of malate dehydrogenase (decarboxylating) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of malate dehydrogenase (oxaloacetate-decarboxylating)
n1=fucoside | n2=en:deficiency of malate dehydrogenase (oxaloacetate-decarboxylating) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of malate oxidase
n1=fucoside | n2=en:deficiency of malate oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of maleylacetoacetate isomerase
n1=fucoside | n2=en:deficiency of maleylacetoacetate isomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of mannitol dehydrogenase
n1=fucoside | n2=en:deficiency of mannitol dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of mannose-6-phosphate isomerase
n1=fucoside | n2=en:deficiency of mannose-6-phosphate isomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of metallocarboxypeptidase
n1=fucoside | n2=en:deficiency of metallocarboxypeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of metalloproteinase
n1=fucoside | n2=en:deficiency of metalloproteinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of methenyltetrahydrofolate cyclohydrolase
n1=fucoside | n2=en:deficiency of methenyltetrahydrofolate cyclohydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of methionine-trna ligase
n1=fucoside | n2=en:deficiency of methionine-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of methylaspartate mutase
n1=fucoside | n2=en:deficiency of methylaspartate mutase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of methylenetetrahydrofolate dehydrogenase (nadp^+^)
n1=fucoside | n2=en:deficiency of methylenetetrahydrofolate dehydrogenase (nadp^+^) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of methylglutaconyl-coa hydratase
n1=fucoside | n2=en:deficiency of methylglutaconyl-coa hydratase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of methyltransferase
n1=fucoside | n2=en:deficiency of methyltransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of mevaldate reductase
n1=fucoside | n2=en:deficiency of mevaldate reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts
n1=fucoside | n2=en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of monodehydroascorbate reductase (nadh)
n1=fucoside | n2=en:deficiency of monodehydroascorbate reductase (nadh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of monooxygenase
n1=fucoside | n2=en:deficiency of monooxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of mutase
n1=fucoside | n2=en:deficiency of mutase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of myo-inositol oxygenase
n1=fucoside | n2=en:deficiency of myo-inositol oxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of n-acetyl-beta-glucosaminidase
n1=fucoside | n2=en:deficiency of n-acetyl-beta-glucosaminidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of n-acetylneuraminate lyase
n1=fucoside | n2=en:deficiency of n-acetylneuraminate lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of n-methyl-l-amino-acid oxidase
n1=fucoside | n2=en:deficiency of n-methyl-l-amino-acid oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nad^+^ synthase (glutamine-hydrolysing)
n1=fucoside | n2=en:deficiency of nad^+^ synthase (glutamine-hydrolysing) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nad(p)^+^ nucleosidase
n1=fucoside | n2=en:deficiency of nad(p)^+^ nucleosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nad(p)^+^ transhydrogenase
n1=fucoside | n2=en:deficiency of nad(p)^+^ transhydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nad(p)h dehydrogenase (quinone)
n1=fucoside | n2=en:deficiency of nad(p)h dehydrogenase (quinone) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nad+ nucleosidase
n1=fucoside | n2=en:deficiency of nad+ nucleosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nadase
n1=fucoside | n2=en:deficiency of nadase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nadph-ferrihemoprotein reductase
n1=fucoside | n2=en:deficiency of nadph-ferrihemoprotein reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of naph cytochrome-c>2< reductase
n1=fucoside | n2=en:deficiency of naph cytochrome-c>2< reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nicotinate dehydrogenase
n1=fucoside | n2=en:deficiency of nicotinate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nitrate reductase
n1=fucoside | n2=en:deficiency of nitrate reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of non-specific cholinesterase
n1=fucoside | n2=en:deficiency of non-specific cholinesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nucleosidase
n1=fucoside | n2=en:deficiency of nucleosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nucleoside-diphosphatase
n1=fucoside | n2=en:deficiency of nucleoside-diphosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nucleotidase
n1=fucoside | n2=en:deficiency of nucleotidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nucleotide pyrophosphatase
n1=fucoside | n2=en:deficiency of nucleotide pyrophosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of nucleotidyltransferase
n1=fucoside | n2=en:deficiency of nucleotidyltransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of omega peptidase
n1=fucoside | n2=en:deficiency of omega peptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of oxidase
n1=fucoside | n2=en:deficiency of oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of oximinotransferase
n1=fucoside | n2=en:deficiency of oximinotransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of oxo-acid-lyase
n1=fucoside | n2=en:deficiency of oxo-acid-lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of oxoglutarate dehydrogenase (lipoamide)
n1=fucoside | n2=en:deficiency of oxoglutarate dehydrogenase (lipoamide) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of oxygenase
n1=fucoside | n2=en:deficiency of oxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of palmitoyl-coa hydrolase
n1=fucoside | n2=en:deficiency of palmitoyl-coa hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pancreatic elastase
n1=fucoside | n2=en:deficiency of pancreatic elastase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pantothenoylcysteine decarboxylase
n1=fucoside | n2=en:deficiency of pantothenoylcysteine decarboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pectin methoxylase
n1=fucoside | n2=en:deficiency of pectin methoxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pectin methylesterase
n1=fucoside | n2=en:deficiency of pectin methylesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pectinesterase
n1=fucoside | n2=en:deficiency of pectinesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pentosyltransferase
n1=fucoside | n2=en:deficiency of pentosyltransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pepsin a
n1=fucoside | n2=en:deficiency of pepsin a | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pepsin b
n1=fucoside | n2=en:deficiency of pepsin b | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of peptidase a
n1=fucoside | n2=en:deficiency of peptidase a | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of peptide hydrolase
n1=fucoside | n2=en:deficiency of peptide hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of peptidoglycan endopeptidase
n1=fucoside | n2=en:deficiency of peptidoglycan endopeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of peroxidase
n1=fucoside | n2=en:deficiency of peroxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phenylalanine 4-monooxygenase
n1=fucoside | n2=en:deficiency of phenylalanine 4-monooxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phenylpyruvate tautomerase
n1=fucoside | n2=en:deficiency of phenylpyruvate tautomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphatase
n1=fucoside | n2=en:deficiency of phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphatidate phosphatase
n1=fucoside | n2=en:deficiency of phosphatidate phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphatidylinositol (4,5) bisphosphate 5-phosphatase (ptdins(4,5)p(2) 5-phosphatase) in cultured fibroblasts
n1=fucoside | n2=en:deficiency of phosphatidylinositol (4,5) bisphosphate 5-phosphatase (ptdins(4,5)p(2) 5-phosphatase) in cultured fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoacetylglucosamine mutase
n1=fucoside | n2=en:deficiency of phosphoacetylglucosamine mutase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoadenylate 3'-nucleotidase
n1=fucoside | n2=en:deficiency of phosphoadenylate 3'-nucleotidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoamidase
n1=fucoside | n2=en:deficiency of phosphoamidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoglucomutase
n1=fucoside | n2=en:deficiency of phosphoglucomutase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphogluconate dehydrogenase
n1=fucoside | n2=en:deficiency of phosphogluconate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphogluconate dehydrogenase (decarboxylating)
n1=fucoside | n2=en:deficiency of phosphogluconate dehydrogenase (decarboxylating) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoglycerate mutase
n1=fucoside | n2=en:deficiency of phosphoglycerate mutase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoketolase
n1=fucoside | n2=en:deficiency of phosphoketolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phospholipase a>2<
n1=fucoside | n2=en:deficiency of phospholipase a>2< | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phospholipase c
n1=fucoside | n2=en:deficiency of phospholipase c | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phospholipase d
n1=fucoside | n2=en:deficiency of phospholipase d | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphomonoesterase
n1=fucoside | n2=en:deficiency of phosphomonoesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphopantothenate-cysteine ligase
n1=fucoside | n2=en:deficiency of phosphopantothenate-cysteine ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoprotein phosphatase
n1=fucoside | n2=en:deficiency of phosphoprotein phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoribosylamine-glycine ligase
n1=fucoside | n2=en:deficiency of phosphoribosylamine-glycine ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoribosylaminoimidazole carboxylase
n1=fucoside | n2=en:deficiency of phosphoribosylaminoimidazole carboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoribosylaminoimidazole-succinocarboxamide synthase
n1=fucoside | n2=en:deficiency of phosphoribosylaminoimidazole-succinocarboxamide synthase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoribosylformylglycinamidine cyclo-ligase
n1=fucoside | n2=en:deficiency of phosphoribosylformylglycinamidine cyclo-ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoribosylformylglycinamidine synthase
n1=fucoside | n2=en:deficiency of phosphoribosylformylglycinamidine synthase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoric diester hydrolase
n1=fucoside | n2=en:deficiency of phosphoric diester hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoric monoester hydrolase
n1=fucoside | n2=en:deficiency of phosphoric monoester hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphorus-oxygen lyase
n1=fucoside | n2=en:deficiency of phosphorus-oxygen lyase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphorylase phosphatase
n1=fucoside | n2=en:deficiency of phosphorylase phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphoserine phosphatase
n1=fucoside | n2=en:deficiency of phosphoserine phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of phosphotransferase
n1=fucoside | n2=en:deficiency of phosphotransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of plasmin
n1=fucoside | n2=en:deficiency of plasmin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of polygalacturonase
n1=fucoside | n2=en:deficiency of polygalacturonase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of progesterone 11alpha-monooxygenase
n1=fucoside | n2=en:deficiency of progesterone 11alpha-monooxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts
n1=fucoside | n2=en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of prolinase
n1=fucoside | n2=en:deficiency of prolinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of prolyl dipeptidase
n1=fucoside | n2=en:deficiency of prolyl dipeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of protease
n1=fucoside | n2=en:deficiency of protease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of protocatechuate 3,4-dioxygenase
n1=fucoside | n2=en:deficiency of protocatechuate 3,4-dioxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pyridoxamine-phosphate oxidase
n1=fucoside | n2=en:deficiency of pyridoxamine-phosphate oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pyrophosphotransferase
n1=fucoside | n2=en:deficiency of pyrophosphotransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of pyrroline-2-carboxylate reductase
n1=fucoside | n2=en:deficiency of pyrroline-2-carboxylate reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of quinate dehydrogenase
n1=fucoside | n2=en:deficiency of quinate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of racemase
n1=fucoside | n2=en:deficiency of racemase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of retinal isomerase
n1=fucoside | n2=en:deficiency of retinal isomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of retinyl-palmitate esterase
n1=fucoside | n2=en:deficiency of retinyl-palmitate esterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of ribonuclease
n1=fucoside | n2=en:deficiency of ribonuclease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of ribosomal cathepsin
n1=fucoside | n2=en:deficiency of ribosomal cathepsin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of ribosomal neutral proteinase
n1=fucoside | n2=en:deficiency of ribosomal neutral proteinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of ribulose-phosphate 3-epimerase
n1=fucoside | n2=en:deficiency of ribulose-phosphate 3-epimerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of saposins a, b, c, and d
n1=fucoside | n2=en:deficiency of saposins a, b, c, and d | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of sarcosine oxidase
n1=fucoside | n2=en:deficiency of sarcosine oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of serine carboxypeptidase
n1=fucoside | n2=en:deficiency of serine carboxypeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of serine proteinase
n1=fucoside | n2=en:deficiency of serine proteinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of serine-trna ligase
n1=fucoside | n2=en:deficiency of serine-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of serum properdin p factor
n1=fucoside | n2=en:deficiency of serum properdin p factor | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of shikimate dehydrogenase
n1=fucoside | n2=en:deficiency of shikimate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of squalene monooxygenase
n1=fucoside | n2=en:deficiency of squalene monooxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of steroid delta-isomerase
n1=fucoside | n2=en:deficiency of steroid delta-isomerase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of succinate dehydrogenase
n1=fucoside | n2=en:deficiency of succinate dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of succinyl-coa hydrolase
n1=fucoside | n2=en:deficiency of succinyl-coa hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of sulfatase
n1=fucoside | n2=en:deficiency of sulfatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of sulfinoalanine decarboxylase
n1=fucoside | n2=en:deficiency of sulfinoalanine decarboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of sulfite reductase
n1=fucoside | n2=en:deficiency of sulfite reductase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of sulfotransferase
n1=fucoside | n2=en:deficiency of sulfotransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of sulfuric ester hydrolase
n1=fucoside | n2=en:deficiency of sulfuric ester hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of sulfurtransferase
n1=fucoside | n2=en:deficiency of sulfurtransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of tannase
n1=fucoside | n2=en:deficiency of tannase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of thiamin pyridinylase
n1=fucoside | n2=en:deficiency of thiamin pyridinylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of thioether hydrolase
n1=fucoside | n2=en:deficiency of thioether hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of thiolester hydrolase
n1=fucoside | n2=en:deficiency of thiolester hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of threonine aldolase
n1=fucoside | n2=en:deficiency of threonine aldolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of threonine dehydratase
n1=fucoside | n2=en:deficiency of threonine dehydratase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of threonine-trna ligase
n1=fucoside | n2=en:deficiency of threonine-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of thrombin
n1=fucoside | n2=en:deficiency of thrombin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of transacylase
n1=fucoside | n2=en:deficiency of transacylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of transcarbamoylase
n1=fucoside | n2=en:deficiency of transcarbamoylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of transcarboxylase
n1=fucoside | n2=en:deficiency of transcarboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of transferase
n1=fucoside | n2=en:deficiency of transferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of transformiminase
n1=fucoside | n2=en:deficiency of transformiminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of transformylase
n1=fucoside | n2=en:deficiency of transformylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of transhydroxymethylase
n1=fucoside | n2=en:deficiency of transhydroxymethylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of triacylglycerol lipase
n1=fucoside | n2=en:deficiency of triacylglycerol lipase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of trimetaphosphatase
n1=fucoside | n2=en:deficiency of trimetaphosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of tripeptide aminopeptidase
n1=fucoside | n2=en:deficiency of tripeptide aminopeptidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of triphosphoric monoester hydrolase
n1=fucoside | n2=en:deficiency of triphosphoric monoester hydrolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of tropinesterase
n1=fucoside | n2=en:deficiency of tropinesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of true cholinesterase
n1=fucoside | n2=en:deficiency of true cholinesterase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of trypsin
n1=fucoside | n2=en:deficiency of trypsin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of tryptophan 5-monooxygenase
n1=fucoside | n2=en:deficiency of tryptophan 5-monooxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of tryptophan-trna ligase
n1=fucoside | n2=en:deficiency of tryptophan-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of tyraminase
n1=fucoside | n2=en:deficiency of tyraminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of tyrosine decarboxylase
n1=fucoside | n2=en:deficiency of tyrosine decarboxylase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of tyrosine-trna ligase
n1=fucoside | n2=en:deficiency of tyrosine-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of udpglucose dehydrogenase
n1=fucoside | n2=en:deficiency of udpglucose dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of unspecific monooxygenase
n1=fucoside | n2=en:deficiency of unspecific monooxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of uracil dehydrogenase
n1=fucoside | n2=en:deficiency of uracil dehydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of urate oxidase
n1=fucoside | n2=en:deficiency of urate oxidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of urease
n1=fucoside | n2=en:deficiency of urease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of uronolactonase
n1=fucoside | n2=en:deficiency of uronolactonase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of valine-trna ligase
n1=fucoside | n2=en:deficiency of valine-trna ligase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of w-amidase
n1=fucoside | n2=en:deficiency of w-amidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency of xylan endo-1,3-beta-xylosidase
n1=fucoside | n2=en:deficiency of xylan endo-1,3-beta-xylosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency or absence of cytochrome b(-245)
n1=fucoside | n2=en:deficiency or absence of cytochrome b(-245) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency or absence of p22-phox (608508) protein
n1=fucoside | n2=en:deficiency or absence of p22-phox (608508) protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency or absence of p22-phox protein
n1=fucoside | n2=en:deficiency or absence of p22-phox protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency or absence of p47-phox protein (type i)
n1=fucoside | n2=en:deficiency or absence of p47-phox protein (type i) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency or absence of p67-phox protein (type ii)
n1=fucoside | n2=en:deficiency or absence of p67-phox protein (type ii) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency or absence of p91-phox (300481) protein
n1=fucoside | n2=en:deficiency or absence of p91-phox (300481) protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficiency or absence of p91-phox protein
n1=fucoside | n2=en:deficiency or absence of p91-phox protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficient efflux of intracellular cholesterol
n1=fucoside | n2=en:deficient efflux of intracellular cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficient fibroblast aicar-tf activity
n1=fucoside | n2=en:deficient fibroblast aicar-tf activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase
n1=fucoside | n2=en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficient plasma alpha-lecithin:cholesterol acyltransferase (high-density) activity
n1=fucoside | n2=en:deficient plasma alpha-lecithin:cholesterol acyltransferase (high-density) activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts
n1=fucoside | n2=en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dehydration
n1=fucoside | n2=en:dehydration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dehydroepiandrosterone (dhea) at upper level of normal range
n1=fucoside | n2=en:dehydroepiandrosterone (dhea) at upper level of normal range | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye
n1=fucoside | n2=en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes
n1=fucoside | n2=en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:deletion of chromosome 18p11.2
n1=fucoside | n2=en:deletion of chromosome 18p11.2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine
n1=fucoside | n2=en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma
n1=fucoside | n2=en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes
n1=fucoside | n2=en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:demyelination
n1=fucoside | n2=en:demyelination | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:depletion of mtdna (skeletal muscle, fibroblasts)
n1=fucoside | n2=en:depletion of mtdna (skeletal muscle, fibroblasts) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dermatan and heparan sulfate excretion in urine
n1=fucoside | n2=en:dermatan and heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dermatan sulfate excretion in urine
n1=fucoside | n2=en:dermatan sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:desmosterolosis
n1=fucoside | n2=en:desmosterolosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease
n1=fucoside | n2=en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease
n1=fucoside | n2=en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dhea sulfotransferase below limit of detection
n1=fucoside | n2=en:dhea sulfotransferase below limit of detection | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dhfr deficiency
n1=fucoside | n2=en:dhfr deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:di- and trihydroxycholestanoic acid accumulation
n1=fucoside | n2=en:di- and trihydroxycholestanoic acid accumulation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:diagnosis aspect
n1=fucoside | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:diagnosis by exposing muscle biopsy to caffeine and/or halothane
n1=fucoside | n2=en:diagnosis by exposing muscle biopsy to caffeine and/or halothane | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria)
n1=fucoside | n2=en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dicarboxylic aciduria
n1=fucoside | n2=en:dicarboxylic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dicarboxylicaminoaciduria
n1=fucoside | n2=en:dicarboxylicaminoaciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:diffuse deposition of calcium oxalate in various tissues
n1=fucoside | n2=en:diffuse deposition of calcium oxalate in various tissues | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dihydrouracil dehydrogenase deficiency
n1=fucoside | n2=en:dihydrouracil dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dilated rough endoplasmic reticulum (rer)
n1=fucoside | n2=en:dilated rough endoplasmic reticulum (rer) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dimethylglycine dehydrogenase (dmgdh) deficiency
n1=fucoside | n2=en:dimethylglycine dehydrogenase (dmgdh) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:diminished lymphocyte response to phytohemaglutinin
n1=fucoside | n2=en:diminished lymphocyte response to phytohemaglutinin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:direct coombs test negative
n1=fucoside | n2=en:direct coombs test negative | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:direct hyperbilirubinemia
n1=fucoside | n2=en:direct hyperbilirubinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:disorganized growth plate cartilage
n1=fucoside | n2=en:disorganized growth plate cartilage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:disproportionate work-related increase in blood lactate and pyruvate
n1=fucoside | n2=en:disproportionate work-related increase in blood lactate and pyruvate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:disseminated intravascular coagulation
n1=fucoside | n2=en:disseminated intravascular coagulation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:distal xp22.3 segmental monosomy
n1=fucoside | n2=en:distal xp22.3 segmental monosomy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination
n1=fucoside | n2=en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material
n1=fucoside | n2=en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency
n1=fucoside | n2=en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency
n1=fucoside | n2=en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:donnai-barrow syndrome
n1=fucoside | n2=en:donnai-barrow syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dubin-johnson syndrome
n1=fucoside | n2=en:dubin-johnson syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:duplication or deletion at 11p15.5
n1=fucoside | n2=en:duplication or deletion at 11p15.5 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dyskeratosis congenita, autosomal recessive
n1=fucoside | n2=en:dyskeratosis congenita, autosomal recessive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dyskinetic ciliary motility
n1=fucoside | n2=en:dyskinetic ciliary motility | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dyslipidemia
n1=fucoside | n2=en:dyslipidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:dysostosis multiplex group
n1=fucoside | n2=en:dysostosis multiplex group | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ear, patella, short stature syndrome
n1=fucoside | n2=en:ear, patella, short stature syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome
n1=fucoside | n2=en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:echocardiogram abnormal
n1=fucoside | n2=en:echocardiogram abnormal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ectodermal dysplasia/ skin fragility syndrome
n1=fucoside | n2=en:ectodermal dysplasia/ skin fragility syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ehlers-danlos syndrome, arthrochalasia type
n1=fucoside | n2=en:ehlers-danlos syndrome, arthrochalasia type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ehlers-danlos syndrome, type vi
n1=fucoside | n2=en:ehlers-danlos syndrome, type vi | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electrocardiogram abnormal
n1=fucoside | n2=en:electrocardiogram abnormal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electrolyte disturbances from intractable diarrhea
n1=fucoside | n2=en:electrolyte disturbances from intractable diarrhea | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electrolyturia (1 patient)
n1=fucoside | n2=en:electrolyturia (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electron microscopy of foam cells shows lamellar inclusions
n1=fucoside | n2=en:electron microscopy of foam cells shows lamellar inclusions | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electron microscopy of patient respiratory cells shows absent inner and outer dynein arms
n1=fucoside | n2=en:electron microscopy of patient respiratory cells shows absent inner and outer dynein arms | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electron microscopy of patient respiratory cells shows absent outer dynein arms
n1=fucoside | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme
n1=fucoside | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms
n1=fucoside | n2=en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electron microscopy of patient respiratory cells shows defects of outer dynein arms
n1=fucoside | n2=en:electron microscopy of patient respiratory cells shows defects of outer dynein arms | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms
n1=fucoside | n2=en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links
n1=fucoside | n2=en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished
n1=fucoside | n2=en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated 1,25(oh)2 d3
n1=fucoside | n2=en:elevated 1,25(oh)2 d3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated 17-hydroxyprogesterone
n1=fucoside | n2=en:elevated 17-hydroxyprogesterone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated 2-ketoglutarate (urine)
n1=fucoside | n2=en:elevated 2-ketoglutarate (urine) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated 3-hydroxypropionic acid
n1=fucoside | n2=en:elevated 3-hydroxypropionic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated 3-methylcitric acid
n1=fucoside | n2=en:elevated 3-methylcitric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated 7-dehydrocholesterol
n1=fucoside | n2=en:elevated 7-dehydrocholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated 8-dehydrocholesterol
n1=fucoside | n2=en:elevated 8-dehydrocholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated 8(9)-cholestenol
n1=fucoside | n2=en:elevated 8(9)-cholestenol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated acth
n1=fucoside | n2=en:elevated acth | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated afp (endodermal sinus tumor)
n1=fucoside | n2=en:elevated afp (endodermal sinus tumor) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated alkaline phosphatase
n1=fucoside | n2=en:elevated alkaline phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated alkaline phosphatase (if more than one affected site)
n1=fucoside | n2=en:elevated alkaline phosphatase (if more than one affected site) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated alkaline phosphatase (in one patient)
n1=fucoside | n2=en:elevated alkaline phosphatase (in one patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal)
n1=fucoside | n2=en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated alkaline phosphatase of bone origin
n1=fucoside | n2=en:elevated alkaline phosphatase of bone origin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated alpha-ketoglutarate (in most patients)
n1=fucoside | n2=en:elevated alpha-ketoglutarate (in most patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated ammonia
n1=fucoside | n2=en:elevated ammonia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated androstenedione
n1=fucoside | n2=en:elevated androstenedione | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated androstenedione and testosterone
n1=fucoside | n2=en:elevated androstenedione and testosterone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated antinuclear antibody (ana) (speckled pattern)
n1=fucoside | n2=en:elevated antinuclear antibody (ana) (speckled pattern) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated apoa-i (1.8x normal) in homozygotes
n1=fucoside | n2=en:elevated apoa-i (1.8x normal) in homozygotes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase)
n1=fucoside | n2=en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated ast and ldh, especially infantile-onset
n1=fucoside | n2=en:elevated ast and ldh, especially infantile-onset | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated bilirubin (bilirubinemia)
n1=fucoside | n2=en:elevated bilirubin (bilirubinemia) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated biopterin in csf
n1=fucoside | n2=en:elevated biopterin in csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated blood spot hydroxybutyryl carnitine
n1=fucoside | n2=en:elevated blood spot hydroxybutyryl carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated branched-chain amino acids (in most patients)
n1=fucoside | n2=en:elevated branched-chain amino acids (in most patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated calcitonin
n1=fucoside | n2=en:elevated calcitonin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated catecholamines (in patients with pheochromocytoma)
n1=fucoside | n2=en:elevated catecholamines (in patients with pheochromocytoma) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated cerebrospinal fluid (csf) protein
n1=fucoside | n2=en:elevated cerebrospinal fluid (csf) protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts
n1=fucoside | n2=en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated circulating parathyroid hormone (pth) level
n1=fucoside | n2=en:elevated circulating parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated creatine kinase (in some patients)
n1=fucoside | n2=en:elevated creatine kinase (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated crp
n1=fucoside | n2=en:elevated crp | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine)
n1=fucoside | n2=en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated csf glycine
n1=fucoside | n2=en:elevated csf glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated csf/plasma glycine ratio
n1=fucoside | n2=en:elevated csf/plasma glycine ratio | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf)
n1=fucoside | n2=en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated dihydrobiopterin in csf
n1=fucoside | n2=en:elevated dihydrobiopterin in csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated erythrocyte adenosine deaminase
n1=fucoside | n2=en:elevated erythrocyte adenosine deaminase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated erythrocyte adenosine deaminase (eada)
n1=fucoside | n2=en:elevated erythrocyte adenosine deaminase (eada) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated erythrocyte adenosine deaminase activity
n1=fucoside | n2=en:elevated erythrocyte adenosine deaminase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated erythrocyte aicar (zmp)
n1=fucoside | n2=en:elevated erythrocyte aicar (zmp) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated erythrocyte sedimentation rate (esr)
n1=fucoside | n2=en:elevated erythrocyte sedimentation rate (esr) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated erythrocyte sedimentation rate (mean 90mm/h)
n1=fucoside | n2=en:elevated erythrocyte sedimentation rate (mean 90mm/h) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated fasting glucose
n1=fucoside | n2=en:elevated fasting glucose | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated fasting triglycerides
n1=fucoside | n2=en:elevated fasting triglycerides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated fasting triglycerides (seen in heterozygotes as well)
n1=fucoside | n2=en:elevated fasting triglycerides (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated fecal levels of protoporphyrin and coproporphyrin at all times
n1=fucoside | n2=en:elevated fecal levels of protoporphyrin and coproporphyrin at all times | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated ferritin l subunit
n1=fucoside | n2=en:elevated ferritin l subunit | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated fibroblast free sialic acid
n1=fucoside | n2=en:elevated fibroblast free sialic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated free carnitine
n1=fucoside | n2=en:elevated free carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated gamma-glutamyltransferase
n1=fucoside | n2=en:elevated gamma-glutamyltransferase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated gamma-glutamyltransferase (ggt)
n1=fucoside | n2=en:elevated gamma-glutamyltransferase (ggt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated gastrin concentration
n1=fucoside | n2=en:elevated gastrin concentration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated hcg (choriocarcinoma)
n1=fucoside | n2=en:elevated hcg (choriocarcinoma) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated hcg or afp or both (embryonal carcinoma)
n1=fucoside | n2=en:elevated hcg or afp or both (embryonal carcinoma) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated hdl (2-6x normal) in homozygotes
n1=fucoside | n2=en:elevated hdl (2-6x normal) in homozygotes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated hepatic transaminases
n1=fucoside | n2=en:elevated hepatic transaminases | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated il1-beta
n1=fucoside | n2=en:elevated il1-beta | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated il6
n1=fucoside | n2=en:elevated il6 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated inflammatory markers
n1=fucoside | n2=en:elevated inflammatory markers | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated l-2-hydroxyglutaric acid (urine)
n1=fucoside | n2=en:elevated l-2-hydroxyglutaric acid (urine) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated lathosterol
n1=fucoside | n2=en:elevated lathosterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated leukotriene e(4)
n1=fucoside | n2=en:elevated leukotriene e(4) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated levels of vitamin b12
n1=fucoside | n2=en:elevated levels of vitamin b12 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated liver enzymes
n1=fucoside | n2=en:elevated liver enzymes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated liver function tests
n1=fucoside | n2=en:elevated liver function tests | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated liver transaminases
n1=fucoside | n2=en:elevated liver transaminases | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated long chain fatty acids
n1=fucoside | n2=en:elevated long chain fatty acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated long-chain acylcarnitine species (in some patients)
n1=fucoside | n2=en:elevated long-chain acylcarnitine species (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated mchc
n1=fucoside | n2=en:elevated mchc | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma acth
n1=fucoside | n2=en:elevated plasma acth | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma adrenocorticotropic hormone (acth)
n1=fucoside | n2=en:elevated plasma adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma alloisoleucine
n1=fucoside | n2=en:elevated plasma alloisoleucine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma ammonia
n1=fucoside | n2=en:elevated plasma ammonia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma and urine inorganic pyrophosphate (ppi)
n1=fucoside | n2=en:elevated plasma and urine inorganic pyrophosphate (ppi) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma and urine succinylacetone
n1=fucoside | n2=en:elevated plasma and urine succinylacetone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia)
n1=fucoside | n2=en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma branched chain amino acids (leucine, isoleucine, valine)
n1=fucoside | n2=en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma campesterol
n1=fucoside | n2=en:elevated plasma campesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma cholestanol
n1=fucoside | n2=en:elevated plasma cholestanol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma citrulline (citrullinemia)
n1=fucoside | n2=en:elevated plasma citrulline (citrullinemia) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma desmosterol
n1=fucoside | n2=en:elevated plasma desmosterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma estrogen
n1=fucoside | n2=en:elevated plasma estrogen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma follicle stimulating hormone (fsh)
n1=fucoside | n2=en:elevated plasma follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma galactose (galactosemia)
n1=fucoside | n2=en:elevated plasma galactose (galactosemia) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma insulin
n1=fucoside | n2=en:elevated plasma insulin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma levels of lp(a)
n1=fucoside | n2=en:elevated plasma levels of lp(a) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma luteinizing hormone (lh)
n1=fucoside | n2=en:elevated plasma luteinizing hormone (lh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma methionine (methioninemia)
n1=fucoside | n2=en:elevated plasma methionine (methioninemia) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma ornithine (~10-fold)
n1=fucoside | n2=en:elevated plasma ornithine (~10-fold) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma phytanic acid
n1=fucoside | n2=en:elevated plasma phytanic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma propionylcarnitine
n1=fucoside | n2=en:elevated plasma propionylcarnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated plasma stigmasterol
n1=fucoside | n2=en:elevated plasma stigmasterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated pregnenolone
n1=fucoside | n2=en:elevated pregnenolone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated progesterone
n1=fucoside | n2=en:elevated progesterone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated propionate
n1=fucoside | n2=en:elevated propionate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated prothrombin time
n1=fucoside | n2=en:elevated prothrombin time | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated pth (parathyroid hormone)
n1=fucoside | n2=en:elevated pth (parathyroid hormone) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated pyruvate (in most patients)
n1=fucoside | n2=en:elevated pyruvate (in most patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated resting serum lactate, increased with exercise
n1=fucoside | n2=en:elevated resting serum lactate, increased with exercise | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated sed rate
n1=fucoside | n2=en:elevated sed rate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated sepiapterin in csf
n1=fucoside | n2=en:elevated sepiapterin in csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum acid phosphatase
n1=fucoside | n2=en:elevated serum acid phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum alkaline phosphatase during hyperplastic callus formation
n1=fucoside | n2=en:elevated serum alkaline phosphatase during hyperplastic callus formation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum alpha-fetoprotein
n1=fucoside | n2=en:elevated serum alpha-fetoprotein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum alpha-fetoprotein (dominant)
n1=fucoside | n2=en:elevated serum alpha-fetoprotein (dominant) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum angiotensin-converting enzyme (ace)
n1=fucoside | n2=en:elevated serum angiotensin-converting enzyme (ace) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum bile acids
n1=fucoside | n2=en:elevated serum bile acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum glutamic oxaloacetic transaminase (sgot)
n1=fucoside | n2=en:elevated serum glutamic oxaloacetic transaminase (sgot) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum glutamic pyruvic transaminase (sgpt)
n1=fucoside | n2=en:elevated serum glutamic pyruvic transaminase (sgpt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum insulin-to-c-peptide ratio
n1=fucoside | n2=en:elevated serum insulin-to-c-peptide ratio | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum iron
n1=fucoside | n2=en:elevated serum iron | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum iron and iron binding capacity
n1=fucoside | n2=en:elevated serum iron and iron binding capacity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum lactate
n1=fucoside | n2=en:elevated serum lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum levels of 2-prime deoxyadenosine
n1=fucoside | n2=en:elevated serum levels of 2-prime deoxyadenosine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum levels of adenosine
n1=fucoside | n2=en:elevated serum levels of adenosine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum levels of follicle stimulating hormone (fsh)
n1=fucoside | n2=en:elevated serum levels of follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum levels of luteinizing hormone (lh)
n1=fucoside | n2=en:elevated serum levels of luteinizing hormone (lh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum long-chain fatty acids
n1=fucoside | n2=en:elevated serum long-chain fatty acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum n,n-dimethylglycine (dmg)
n1=fucoside | n2=en:elevated serum n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum parathyroid hormone (pth)
n1=fucoside | n2=en:elevated serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum parathyroid hormone (pth) level
n1=fucoside | n2=en:elevated serum parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum phosphate in heterozygotes
n1=fucoside | n2=en:elevated serum phosphate in heterozygotes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum phosphorus
n1=fucoside | n2=en:elevated serum phosphorus | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum protein
n1=fucoside | n2=en:elevated serum protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum transaminase levels
n1=fucoside | n2=en:elevated serum transaminase levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum transaminases during infections
n1=fucoside | n2=en:elevated serum transaminases during infections | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum transferrin saturation
n1=fucoside | n2=en:elevated serum transferrin saturation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated serum uric acid concentrations
n1=fucoside | n2=en:elevated serum uric acid concentrations | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated sweat chloride
n1=fucoside | n2=en:elevated sweat chloride | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated sweat chloride (some)
n1=fucoside | n2=en:elevated sweat chloride (some) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated testosterone
n1=fucoside | n2=en:elevated testosterone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated total bilirubin
n1=fucoside | n2=en:elevated total bilirubin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated total cholesterol (seen in heterozygotes as well)
n1=fucoside | n2=en:elevated total cholesterol (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated total iron-binding capacity
n1=fucoside | n2=en:elevated total iron-binding capacity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated uric acid on urinalysis (in some patients)
n1=fucoside | n2=en:elevated uric acid on urinalysis (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary 2-ethylhydracrylate
n1=fucoside | n2=en:elevated urinary 2-ethylhydracrylate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary 3-methylglutaconate
n1=fucoside | n2=en:elevated urinary 3-methylglutaconate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary 3-methylglutarate
n1=fucoside | n2=en:elevated urinary 3-methylglutarate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary 7 alpha-hydroxylated bile alcohols
n1=fucoside | n2=en:elevated urinary 7 alpha-hydroxylated bile alcohols | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary and csf 5-amino-4-imidazolecarboxyamide (aica-riboside)
n1=fucoside | n2=en:elevated urinary and csf 5-amino-4-imidazolecarboxyamide (aica-riboside) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary and csf ribitol and d-arabitol
n1=fucoside | n2=en:elevated urinary and csf ribitol and d-arabitol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary delta-aminolevulinic acid
n1=fucoside | n2=en:elevated urinary delta-aminolevulinic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary delta-aminolevulinic acid and porphyrins
n1=fucoside | n2=en:elevated urinary delta-aminolevulinic acid and porphyrins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary epinephrine
n1=fucoside | n2=en:elevated urinary epinephrine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary free sialic acid (n-acetylneuraminic acid)
n1=fucoside | n2=en:elevated urinary free sialic acid (n-acetylneuraminic acid) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary hyaluronic acid levels
n1=fucoside | n2=en:elevated urinary hyaluronic acid levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary mevalonic acid
n1=fucoside | n2=en:elevated urinary mevalonic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary n,n-dimethylglycine (dmg)
n1=fucoside | n2=en:elevated urinary n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary ornithine, lysine, arginine
n1=fucoside | n2=en:elevated urinary ornithine, lysine, arginine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary pge(2) levels
n1=fucoside | n2=en:elevated urinary pge(2) levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary phosphoethanolamine
n1=fucoside | n2=en:elevated urinary phosphoethanolamine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urinary pyridinoline and deoxypyridinoline
n1=fucoside | n2=en:elevated urinary pyridinoline and deoxypyridinoline | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urine ceramide levels
n1=fucoside | n2=en:elevated urine ceramide levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated urine unsulfated chondroitin sulfate
n1=fucoside | n2=en:elevated urine unsulfated chondroitin sulfate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:elevated white blood cell cystine
n1=fucoside | n2=en:elevated white blood cell cystine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:embryologic
n1=fucoside | n2=en:embryologic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:encephalopathy due to sulfite oxidase deficiency
n1=fucoside | n2=en:encephalopathy due to sulfite oxidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:enlarged cytoplasmic vacuoles in bone, muscle, and brain tissue
n1=fucoside | n2=en:enlarged cytoplasmic vacuoles in bone, muscle, and brain tissue | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:enterokinase deficiency
n1=fucoside | n2=en:enterokinase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:enzyme deficiency
n1=fucoside | n2=en:enzyme deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:enzyme replacement therapy has not been effective
n1=fucoside | n2=en:enzyme replacement therapy has not been effective | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:enzymology
n1=fucoside | n2=en:enzymology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:eosinophilia
n1=fucoside | n2=en:eosinophilia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:eosinophilia, mild
n1=fucoside | n2=en:eosinophilia, mild | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:epidemiologic
n1=fucoside | n2=en:epidemiologic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:epidermolysis bullosa simplex with pyloric atresia
n1=fucoside | n2=en:epidermolysis bullosa simplex with pyloric atresia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:epiphyseal dysplasia, multiple, 4
n1=fucoside | n2=en:epiphyseal dysplasia, multiple, 4 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:epstein-barr viraemia
n1=fucoside | n2=en:epstein-barr viraemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency
n1=fucoside | n2=en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip)
n1=fucoside | n2=en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:erythroid colony-forming units show spontaneous growth in the absence of epo
n1=fucoside | n2=en:erythroid colony-forming units show spontaneous growth in the absence of epo | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ethanolaminosis
n1=fucoside | n2=en:ethanolaminosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ethnologic
n1=fucoside | n2=en:ethnologic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ethylmalonic aciduria
n1=fucoside | n2=en:ethylmalonic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:etiology aspects
n1=fucoside | n2=en:etiology aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:euvolemia
n1=fucoside | n2=en:euvolemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:excess protoporphyrin in bile and feces but not in urine
n1=fucoside | n2=en:excess protoporphyrin in bile and feces but not in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:excessive iodide trapping
n1=fucoside | n2=en:excessive iodide trapping | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:excessive urinary 5-oxo-l-proline
n1=fucoside | n2=en:excessive urinary 5-oxo-l-proline | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:excretion of dermatan sulfate and heparan sulfate in urine
n1=fucoside | n2=en:excretion of dermatan sulfate and heparan sulfate in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:exercise-induced myoglobinuria
n1=fucoside | n2=en:exercise-induced myoglobinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:exercise-induced myoglobinuria in adults
n1=fucoside | n2=en:exercise-induced myoglobinuria in adults | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:exposure as collected domain
n1=fucoside | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:extremely low creatine excretion
n1=fucoside | n2=en:extremely low creatine excretion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fabry disease
n1=fucoside | n2=en:fabry disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:factor v and factor viii, combined deficiency of
n1=fucoside | n2=en:factor v and factor viii, combined deficiency of | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:factor vii deficiency
n1=fucoside | n2=en:factor vii deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:factor viii deficiency
n1=fucoside | n2=en:factor viii deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:familial acantholysis
n1=fucoside | n2=en:familial acantholysis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:familial c3b inhibitor deficiency syndrome
n1=fucoside | n2=en:familial c3b inhibitor deficiency syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:familial erythrocytosis due to diphosphoglycerate mutase deficiency
n1=fucoside | n2=en:familial erythrocytosis due to diphosphoglycerate mutase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:familial hypoaldosteronism
n1=fucoside | n2=en:familial hypoaldosteronism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:familial renal iminoglycinuria
n1=fucoside | n2=en:familial renal iminoglycinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:farber lipogranulomatosis
n1=fucoside | n2=en:farber lipogranulomatosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fasting chylomicronemia
n1=fucoside | n2=en:fasting chylomicronemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fasting hyperinsulinemia
n1=fucoside | n2=en:fasting hyperinsulinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fasting hypoglycemia (early in disease course)
n1=fucoside | n2=en:fasting hypoglycemia (early in disease course) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fasting ketosis
n1=fucoside | n2=en:fasting ketosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fatal infantile lactic acidosis with methylmalonic aciduria
n1=fucoside | n2=en:fatal infantile lactic acidosis with methylmalonic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fatty acid hydroxylase-associated neurodegeneration
n1=fucoside | n2=en:fatty acid hydroxylase-associated neurodegeneration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid
n1=fucoside | n2=en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts
n1=fucoside | n2=en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:female carriers show markedly skewed x inactivation
n1=fucoside | n2=en:female carriers show markedly skewed x inactivation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ferritin decreased
n1=fucoside | n2=en:ferritin decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibrinogen decreased
n1=fucoside | n2=en:fibrinogen decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts accumulate dol-pp-glcnac2man5
n1=fucoside | n2=en:fibroblasts accumulate dol-pp-glcnac2man5 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts are small and rounded with prominent nucleoli
n1=fucoside | n2=en:fibroblasts are small and rounded with prominent nucleoli | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts attach poorly
n1=fucoside | n2=en:fibroblasts attach poorly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts demonstrate rapid growth with increased dna synthesis
n1=fucoside | n2=en:fibroblasts demonstrate rapid growth with increased dna synthesis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside
n1=fucoside | n2=en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712)
n1=fucoside | n2=en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v
n1=fucoside | n2=en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts show decreased mitochondrial complex v activity
n1=fucoside | n2=en:fibroblasts show decreased mitochondrial complex v activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts show decreased peroxisomes arranged in rows
n1=fucoside | n2=en:fibroblasts show decreased peroxisomes arranged in rows | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts show elongated, tangled, tubular mitochondria
n1=fucoside | n2=en:fibroblasts show elongated, tangled, tubular mitochondria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities
n1=fucoside | n2=en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner)
n1=fucoside | n2=en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts show increased sensitivity to apoptosis
n1=fucoside | n2=en:fibroblasts show increased sensitivity to apoptosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts show lamellar lysosomal inclusions on electron microscopy
n1=fucoside | n2=en:fibroblasts show lamellar lysosomal inclusions on electron microscopy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibroblasts shows defects in oxidative phosphorylation
n1=fucoside | n2=en:fibroblasts shows defects in oxidative phosphorylation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibronectin decreased
n1=fucoside | n2=en:fibronectin decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fibular hypoplasia and complex brachydactyly
n1=fucoside | n2=en:fibular hypoplasia and complex brachydactyly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material
n1=fucoside | n2=en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fluorescence in situ hybridization specific probe for mds critical region
n1=fucoside | n2=en:fluorescence in situ hybridization specific probe for mds critical region | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fluorescence of red blood cells by uv microscopy
n1=fucoside | n2=en:fluorescence of red blood cells by uv microscopy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy
n1=fucoside | n2=en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:foam cells in bone marrow and renal glomeruli
n1=fucoside | n2=en:foam cells in bone marrow and renal glomeruli | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:foam cells in visceral organs and cns
n1=fucoside | n2=en:foam cells in visceral organs and cns | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:folate-dependent fragile site at xq28
n1=fucoside | n2=en:folate-dependent fragile site at xq28 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:folic acid deficiency
n1=fucoside | n2=en:folic acid deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fragmentation of the mitochondrial network
n1=fucoside | n2=en:fragmentation of the mitochondrial network | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:frequent deletions of chromosome 9 in melanoma
n1=fucoside | n2=en:frequent deletions of chromosome 9 in melanoma | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc
n1=fucoside | n2=en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fronto-facio-nasal dysplasia
n1=fucoside | n2=en:fronto-facio-nasal dysplasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fructose metabolism, inborn errors
n1=fucoside | n2=en:fructose metabolism, inborn errors | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fructose-1,6-bisphosphatase deficiency
n1=fucoside | n2=en:fructose-1,6-bisphosphatase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fryns macrocephaly
n1=fucoside | n2=en:fryns macrocephaly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1 gene
n1=fucoside | n2=en:fuca1 gene | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, 1-bp del, ex2
n1=fucoside | n2=en:fuca1, 1-bp del, ex2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, 1-bp del, ex3
n1=fucoside | n2=en:fuca1, 1-bp del, ex3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, 1-bp del, ex5
n1=fucoside | n2=en:fuca1, 1-bp del, ex5 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, 2-ex del
n1=fucoside | n2=en:fuca1, 2-ex del | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, gln351ter
n1=fucoside | n2=en:fuca1, gln351ter | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, gln77ter
n1=fucoside | n2=en:fuca1, gln77ter | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, glu375ter
n1=fucoside | n2=en:fuca1, glu375ter | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, ivs5ds, g-a, +1
n1=fucoside | n2=en:fuca1, ivs5ds, g-a, +1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, leu405arg
n1=fucoside | n2=en:fuca1, leu405arg | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, trp382ter
n1=fucoside | n2=en:fuca1, trp382ter | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fuca1, tyr211ter
n1=fucoside | n2=en:fuca1, tyr211ter | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fucosidase deficiency disease
n1=fucoside | n2=en:fucosidase deficiency disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fucosidosis type 1s
n1=fucoside | n2=en:fucosidosis type 1s | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fumarase activity (mitochondrial and cytosolic) is decreased
n1=fucoside | n2=en:fumarase activity (mitochondrial and cytosolic) is decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fumarase deficiency
n1=fucoside | n2=en:fumarase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:fumarylacetoacetate hydrolase (fah) deficiency
n1=fucoside | n2=en:fumarylacetoacetate hydrolase (fah) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts
n1=fucoside | n2=en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:galactosemia
n1=fucoside | n2=en:galactosemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:galactosialidosis
n1=fucoside | n2=en:galactosialidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:galactosuria
n1=fucoside | n2=en:galactosuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:galactosuria without galactosemia
n1=fucoside | n2=en:galactosuria without galactosemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:galactosylation defects
n1=fucoside | n2=en:galactosylation defects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:galactosyltransferase i deficiency in fibroblasts
n1=fucoside | n2=en:galactosyltransferase i deficiency in fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gamma-cystathionase deficiency
n1=fucoside | n2=en:gamma-cystathionase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gamma-glutamylcysteine deficiency
n1=fucoside | n2=en:gamma-glutamylcysteine deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency
n1=fucoside | n2=en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gamma-glutamyltransferase deficiency
n1=fucoside | n2=en:gamma-glutamyltransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gangliosidoses
n1=fucoside | n2=en:gangliosidoses | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system
n1=fucoside | n2=en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gaucher disease
n1=fucoside | n2=en:gaucher disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gaucher disease, type 1
n1=fucoside | n2=en:gaucher disease, type 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gaucher disease, type 2 (disorder)
n1=fucoside | n2=en:gaucher disease, type 2 (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gaucher disease, type 3 (disorder)
n1=fucoside | n2=en:gaucher disease, type 3 (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gaze palsy, familial horizontal, with progressive scoliosis
n1=fucoside | n2=en:gaze palsy, familial horizontal, with progressive scoliosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:generalized aminoaciduria
n1=fucoside | n2=en:generalized aminoaciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:generalized amyloid deposition
n1=fucoside | n2=en:generalized amyloid deposition | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:genetic aspects
n1=fucoside | n2=en:genetic aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:genetic disorder of lipid storage
n1=fucoside | n2=en:genetic disorder of lipid storage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:geroderma osteodysplastica
n1=fucoside | n2=en:geroderma osteodysplastica | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:giacci familial neurogenic acroosteolysis
n1=fucoside | n2=en:giacci familial neurogenic acroosteolysis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage
n1=fucoside | n2=en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells
n1=fucoside | n2=en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:globulin gamma serum plasma increased result
n1=fucoside | n2=en:globulin gamma serum plasma increased result | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glomerular filtration rate decreased
n1=fucoside | n2=en:glomerular filtration rate decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glucose breath hydrogen test shows malabsorption of glucose and galactose
n1=fucoside | n2=en:glucose breath hydrogen test shows malabsorption of glucose and galactose | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glucose-6-phosphate deficiency
n1=fucoside | n2=en:glucose-6-phosphate deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glucose-6-phosphate dehydrogenase deficiency
n1=fucoside | n2=en:glucose-6-phosphate dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glucosidase i deficiency in liver and fibroblasts
n1=fucoside | n2=en:glucosidase i deficiency in liver and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glucosuria, mild, intermittent
n1=fucoside | n2=en:glucosuria, mild, intermittent | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glutamate formiminotransferase deficiency
n1=fucoside | n2=en:glutamate formiminotransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glutamate-cysteine ligase deficiency
n1=fucoside | n2=en:glutamate-cysteine ligase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glutaric acidemia type 1
n1=fucoside | n2=en:glutaric acidemia type 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glutaric aciduria
n1=fucoside | n2=en:glutaric aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glutathione deficiency
n1=fucoside | n2=en:glutathione deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glutathione synthetase deficiency
n1=fucoside | n2=en:glutathione synthetase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glyceraldehyde-3-phosphate dehydrogenase deficiency
n1=fucoside | n2=en:glyceraldehyde-3-phosphate dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycine dehydrogenase (decarboxylating) deficiency
n1=fucoside | n2=en:glycine dehydrogenase (decarboxylating) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycinuria
n1=fucoside | n2=en:glycinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycoamino aciduria
n1=fucoside | n2=en:glycoamino aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycogen accumulation in both liver and muscle
n1=fucoside | n2=en:glycogen accumulation in both liver and muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycogen storage disease
n1=fucoside | n2=en:glycogen storage disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycogen storage disease type i
n1=fucoside | n2=en:glycogen storage disease type i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycogen storage disease type ii
n1=fucoside | n2=en:glycogen storage disease type ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycogen storage disease type iii
n1=fucoside | n2=en:glycogen storage disease type iii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycogen storage disease type v
n1=fucoside | n2=en:glycogen storage disease type v | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycogen storage disease type vi
n1=fucoside | n2=en:glycogen storage disease type vi | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycogen storage disease type vii
n1=fucoside | n2=en:glycogen storage disease type vii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycogen storage disease type x
n1=fucoside | n2=en:glycogen storage disease type x | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycoprotein storage disorder
n1=fucoside | n2=en:glycoprotein storage disorder | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycosuria
n1=fucoside | n2=en:glycosuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glycosuria (less common)
n1=fucoside | n2=en:glycosuria (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:glyoxalase deficiency
n1=fucoside | n2=en:glyoxalase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gm1 gangliosidosis
n1=fucoside | n2=en:gm1 gangliosidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gm2-ganglioside accumulation
n1=fucoside | n2=en:gm2-ganglioside accumulation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gonadotrophin increased
n1=fucoside | n2=en:gonadotrophin increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gracile syndrome (disorder)
n1=fucoside | n2=en:gracile syndrome (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells
n1=fucoside | n2=en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells
n1=fucoside | n2=en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:granular osmiophilic deposits (grod) in cells
n1=fucoside | n2=en:granular osmiophilic deposits (grod) in cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally
n1=fucoside | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally
n1=fucoside | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally
n1=fucoside | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase)
n1=fucoside | n2=en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:green serum
n1=fucoside | n2=en:green serum | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:green urine
n1=fucoside | n2=en:green urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement
n1=fucoside | n2=en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:growth retardation
n1=fucoside | n2=en:growth retardation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:guanidinoacetate methyltransferase (gamt) deficiency
n1=fucoside | n2=en:guanidinoacetate methyltransferase (gamt) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:gurrieri sammito bellussi syndrome
n1=fucoside | n2=en:gurrieri sammito bellussi syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hair bulb tyrosinase present
n1=fucoside | n2=en:hair bulb tyrosinase present | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hair bulbs will pigment when incubated with tyrosine
n1=fucoside | n2=en:hair bulbs will pigment when incubated with tyrosine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hartnup disease
n1=fucoside | n2=en:hartnup disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hawkinsinuria
n1=fucoside | n2=en:hawkinsinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hb h erythrocyte inclusions
n1=fucoside | n2=en:hb h erythrocyte inclusions | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:head circumference normal
n1=fucoside | n2=en:head circumference normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hearing impairment
n1=fucoside | n2=en:hearing impairment | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hematuria
n1=fucoside | n2=en:hematuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hematuria (less common)
n1=fucoside | n2=en:hematuria (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hematuria, gross and microscopic
n1=fucoside | n2=en:hematuria, gross and microscopic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hematuria, macroscopic and microscopic
n1=fucoside | n2=en:hematuria, macroscopic and microscopic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hemizygous deletion at 4p16.3
n1=fucoside | n2=en:hemizygous deletion at 4p16.3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hemizygous deletion at 7q11.23
n1=fucoside | n2=en:hemizygous deletion at 7q11.23 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hemoglobin decreased
n1=fucoside | n2=en:hemoglobin decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hemoglobin f increased
n1=fucoside | n2=en:hemoglobin f increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hemolytic anemia due to pyruvate kinase deficiency
n1=fucoside | n2=en:hemolytic anemia due to pyruvate kinase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hemophilia b
n1=fucoside | n2=en:hemophilia b | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:heparan n-sulfatase deficiency in fibroblasts and amniocytes
n1=fucoside | n2=en:heparan n-sulfatase deficiency in fibroblasts and amniocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:heparan sulfate excretion in urine
n1=fucoside | n2=en:heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:heparin cofactor ii deficiency (disorder)
n1=fucoside | n2=en:heparin cofactor ii deficiency (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hepatic argininosuccinase deficiency
n1=fucoside | n2=en:hepatic argininosuccinase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hepatic argininosuccinate synthetase deficiency
n1=fucoside | n2=en:hepatic argininosuccinate synthetase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hepatic carbamoylphosphate synthetase i deficiency
n1=fucoside | n2=en:hepatic carbamoylphosphate synthetase i deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hepatic gamma-cystathionase deficiency
n1=fucoside | n2=en:hepatic gamma-cystathionase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hepatic glycine cleavage defect
n1=fucoside | n2=en:hepatic glycine cleavage defect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hepatic lipase deficiency (disorder)
n1=fucoside | n2=en:hepatic lipase deficiency (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hepatic ornithine transcarbamylase deficiency
n1=fucoside | n2=en:hepatic ornithine transcarbamylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hepatolenticular degeneration
n1=fucoside | n2=en:hepatolenticular degeneration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hepatomegaly
n1=fucoside | n2=en:hepatomegaly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary adrenal unresponsiveness to corticotropin
n1=fucoside | n2=en:hereditary adrenal unresponsiveness to corticotropin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary angioedema
n1=fucoside | n2=en:hereditary angioedema | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary factor x deficiency
n1=fucoside | n2=en:hereditary factor x deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary factor x deficiency disease
n1=fucoside | n2=en:hereditary factor x deficiency disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary factor xi deficiency disease
n1=fucoside | n2=en:hereditary factor xi deficiency disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary factor xii deficiency disease
n1=fucoside | n2=en:hereditary factor xii deficiency disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary fructose intolerance
n1=fucoside | n2=en:hereditary fructose intolerance | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary hyperglycemic obesity
n1=fucoside | n2=en:hereditary hyperglycemic obesity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary methemoglobinemia, enzymatic type
n1=fucoside | n2=en:hereditary methemoglobinemia, enzymatic type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary palmoplantar keratoderma gamborg nielsen type
n1=fucoside | n2=en:hereditary palmoplantar keratoderma gamborg nielsen type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary spastic paralysis, infantile onset ascending
n1=fucoside | n2=en:hereditary spastic paralysis, infantile onset ascending | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hereditary xanthinuria
n1=fucoside | n2=en:hereditary xanthinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hermansky-pudlak syndrome
n1=fucoside | n2=en:hermansky-pudlak syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hernia
n1=fucoside | n2=en:hernia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:heteroplasmic partial duplication of mtdna
n1=fucoside | n2=en:heteroplasmic partial duplication of mtdna | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hexosediphosphatase deficiencies
n1=fucoside | n2=en:hexosediphosphatase deficiencies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high deoxypyridinoline/creatinine (in some patients)
n1=fucoside | n2=en:high deoxypyridinoline/creatinine (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high ebv viral load
n1=fucoside | n2=en:high ebv viral load | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high ft3/ft4 ratio
n1=fucoside | n2=en:high ft3/ft4 ratio | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high m-component
n1=fucoside | n2=en:high m-component | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high newborn serum levels of immunoreactive trypsinogen
n1=fucoside | n2=en:high newborn serum levels of immunoreactive trypsinogen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high nonceruloplasmin-bound serum copper
n1=fucoside | n2=en:high nonceruloplasmin-bound serum copper | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high ornithine
n1=fucoside | n2=en:high ornithine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high plasma asparagine
n1=fucoside | n2=en:high plasma asparagine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high plasma citrulline (100-300 micromolar)
n1=fucoside | n2=en:high plasma citrulline (100-300 micromolar) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high plasma citrulline (1000-5000 micromolar)
n1=fucoside | n2=en:high plasma citrulline (1000-5000 micromolar) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high plasma triglyceride levels
n1=fucoside | n2=en:high plasma triglyceride levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q
n1=fucoside | n2=en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high serum guanosine levels
n1=fucoside | n2=en:high serum guanosine levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high serum inosine levels
n1=fucoside | n2=en:high serum inosine levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high serum osmolality
n1=fucoside | n2=en:high serum osmolality | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high sister chromatid exchange (sce) rate
n1=fucoside | n2=en:high sister chromatid exchange (sce) rate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high sweat electrolyte
n1=fucoside | n2=en:high sweat electrolyte | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high sweat sodium and chloride
n1=fucoside | n2=en:high sweat sodium and chloride | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high urinary copper
n1=fucoside | n2=en:high urinary copper | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine
n1=fucoside | n2=en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high urinary orotic acid
n1=fucoside | n2=en:high urinary orotic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high-normal plasma triglyceride concentration (in heterozygotes)
n1=fucoside | n2=en:high-normal plasma triglyceride concentration (in heterozygotes) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:high-resolution electron microscopy tomography shows absence of projection c2b at the central pair (cp) apparatus of cilia
n1=fucoside | n2=en:high-resolution electron microscopy tomography shows absence of projection c2b at the central pair (cp) apparatus of cilia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:histidinemia
n1=fucoside | n2=en:histidinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:histiocytic infiltration of liver, spleen, and lungs
n1=fucoside | n2=en:histiocytic infiltration of liver, spleen, and lungs | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hla-b27 haplotype association (95% patients)
n1=fucoside | n2=en:hla-b27 haplotype association (95% patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hla-dqw6 association (dqb1*0602)
n1=fucoside | n2=en:hla-dqw6 association (dqb1*0602) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hmg-coa lyase deficiency
n1=fucoside | n2=en:hmg-coa lyase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hnsha due to aldolase a deficiency
n1=fucoside | n2=en:hnsha due to aldolase a deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hnsha due to diphosphoglycerate mutase deficiency
n1=fucoside | n2=en:hnsha due to diphosphoglycerate mutase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hnsha due to glucose phosphate isomerase deficiency
n1=fucoside | n2=en:hnsha due to glucose phosphate isomerase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hnsha due to glutathione reductase deficiency
n1=fucoside | n2=en:hnsha due to glutathione reductase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hnsha due to glutathione synthetase deficiency
n1=fucoside | n2=en:hnsha due to glutathione synthetase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hnsha due to pyrimidine-5'-nucleotidase deficiency
n1=fucoside | n2=en:hnsha due to pyrimidine-5'-nucleotidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:holocarboxylase synthetase deficiency
n1=fucoside | n2=en:holocarboxylase synthetase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:homocarnosinosis
n1=fucoside | n2=en:homocarnosinosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:homocitrullinuria
n1=fucoside | n2=en:homocitrullinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:homocysteinemia
n1=fucoside | n2=en:homocysteinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:homocysteinemia (in some patients)
n1=fucoside | n2=en:homocysteinemia (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:homocystinemia
n1=fucoside | n2=en:homocystinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:homocystinuria
n1=fucoside | n2=en:homocystinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:homocystinuria (in some patients)
n1=fucoside | n2=en:homocystinuria (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:homozygous 122kb deletion 11p15-p14
n1=fucoside | n2=en:homozygous 122kb deletion 11p15-p14 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:howell-jolly bodies seen in peripheral blood smear
n1=fucoside | n2=en:howell-jolly bodies seen in peripheral blood smear | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hunter syndrome
n1=fucoside | n2=en:hunter syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hurler syndrome
n1=fucoside | n2=en:hurler syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hydrocortisone decreased
n1=fucoside | n2=en:hydrocortisone decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hydroxyprolinuria
n1=fucoside | n2=en:hydroxyprolinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperalphalipoproteinemia
n1=fucoside | n2=en:hyperalphalipoproteinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperammonemia
n1=fucoside | n2=en:hyperammonemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperammonemia after protein intake
n1=fucoside | n2=en:hyperammonemia after protein intake | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperammonemia, asymptomatic (2-5 times normal)
n1=fucoside | n2=en:hyperammonemia, asymptomatic (2-5 times normal) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperammonemia, episodic
n1=fucoside | n2=en:hyperammonemia, episodic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperarginemia
n1=fucoside | n2=en:hyperarginemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperbilirubinemia
n1=fucoside | n2=en:hyperbilirubinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperbilirubinemia in those with liver failure
n1=fucoside | n2=en:hyperbilirubinemia in those with liver failure | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration)
n1=fucoside | n2=en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperbilirubinemia, unconjugated, <20mg/dl
n1=fucoside | n2=en:hyperbilirubinemia, unconjugated, <20mg/dl | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperbilirubinemia, unconjugated, 20-30mg/dl
n1=fucoside | n2=en:hyperbilirubinemia, unconjugated, 20-30mg/dl | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercalcemia
n1=fucoside | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercalciuria
n1=fucoside | n2=en:hypercalciuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercalciuria (in childhood)
n1=fucoside | n2=en:hypercalciuria (in childhood) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercalciuria (in some patients)
n1=fucoside | n2=en:hypercalciuria (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperchloremia (mean >110 mm in both dominant and recessive)
n1=fucoside | n2=en:hyperchloremia (mean >110 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperchloremia (mean 109 mm)
n1=fucoside | n2=en:hyperchloremia (mean 109 mm) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperchloremia (mean 111 mm)
n1=fucoside | n2=en:hyperchloremia (mean 111 mm) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperchloremia (mean 114 mm)
n1=fucoside | n2=en:hyperchloremia (mean 114 mm) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperchloridura
n1=fucoside | n2=en:hyperchloridura | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercholesterolemia
n1=fucoside | n2=en:hypercholesterolemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercholesterolemia (10%)
n1=fucoside | n2=en:hypercholesterolemia (10%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercholesterolemia (disorder)
n1=fucoside | n2=en:hypercholesterolemia (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercholesterolemia (in 75%)
n1=fucoside | n2=en:hypercholesterolemia (in 75%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercholesterolemia (reported in 2 patients)
n1=fucoside | n2=en:hypercholesterolemia (reported in 2 patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes
n1=fucoside | n2=en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypergammaglobulinemia
n1=fucoside | n2=en:hypergammaglobulinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperglutaminemia
n1=fucoside | n2=en:hyperglutaminemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperglycemia
n1=fucoside | n2=en:hyperglycemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperglycemias, postprandial
n1=fucoside | n2=en:hyperglycemias, postprandial | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperglycinemia
n1=fucoside | n2=en:hyperglycinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperglycinemia (1 patient)
n1=fucoside | n2=en:hyperglycinemia (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperglycinuria (disorder)
n1=fucoside | n2=en:hyperglycinuria (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperglycolic aciduria
n1=fucoside | n2=en:hyperglycolic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperhomocystinemia
n1=fucoside | n2=en:hyperhomocystinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperimmunoglobulin e syndrome
n1=fucoside | n2=en:hyperimmunoglobulin e syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperinsulinemia
n1=fucoside | n2=en:hyperinsulinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperinsulinemic hypoglycemia, familial, 7
n1=fucoside | n2=en:hyperinsulinemic hypoglycemia, familial, 7 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperkalemia
n1=fucoside | n2=en:hyperkalemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperkalemia (>6.2 mm in both dominant and recessive)
n1=fucoside | n2=en:hyperkalemia (>6.2 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperkalemia (5.8 +/- 0.8 mm)
n1=fucoside | n2=en:hyperkalemia (5.8 +/- 0.8 mm) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperkalemia (6.4 +/- 0.7 mm)
n1=fucoside | n2=en:hyperkalemia (6.4 +/- 0.7 mm) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperkalemia (7.5 +/- 0.9 mm)
n1=fucoside | n2=en:hyperkalemia (7.5 +/- 0.9 mm) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperkalemia during attacks
n1=fucoside | n2=en:hyperkalemia during attacks | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperlactemia
n1=fucoside | n2=en:hyperlactemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperlipidemia
n1=fucoside | n2=en:hyperlipidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperlipoproteinemia type i
n1=fucoside | n2=en:hyperlipoproteinemia type i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperlipoproteinemia type iib
n1=fucoside | n2=en:hyperlipoproteinemia type iib | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperlysinemia
n1=fucoside | n2=en:hyperlysinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypermagnesemia
n1=fucoside | n2=en:hypermagnesemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypermagnesiuria
n1=fucoside | n2=en:hypermagnesiuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypermanganesemia with dystonia polycythemia and cirrhosis
n1=fucoside | n2=en:hypermanganesemia with dystonia polycythemia and cirrhosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypermethioninemia, progressive
n1=fucoside | n2=en:hypermethioninemia, progressive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypernatremia
n1=fucoside | n2=en:hypernatremia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypernatriuria
n1=fucoside | n2=en:hypernatriuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperornithinemia
n1=fucoside | n2=en:hyperornithinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperoxalaemia
n1=fucoside | n2=en:hyperoxalaemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperoxaluria
n1=fucoside | n2=en:hyperoxaluria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperphenylalaninemia
n1=fucoside | n2=en:hyperphenylalaninemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperphosphatasia with mental retardation
n1=fucoside | n2=en:hyperphosphatasia with mental retardation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperphosphatemia
n1=fucoside | n2=en:hyperphosphatemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperphosphatemia, transient
n1=fucoside | n2=en:hyperphosphatemia, transient | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperprolinemia (10-15 times normal)
n1=fucoside | n2=en:hyperprolinemia (10-15 times normal) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperprolinemia (5-10 times normal)
n1=fucoside | n2=en:hyperprolinemia (5-10 times normal) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperprolinemia type 1
n1=fucoside | n2=en:hyperprolinemia type 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperprolinemia type 2
n1=fucoside | n2=en:hyperprolinemia type 2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperprostaglandinuria
n1=fucoside | n2=en:hyperprostaglandinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypertelorism
n1=fucoside | n2=en:hypertelorism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperthreoninemia
n1=fucoside | n2=en:hyperthreoninemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperthreoninuria
n1=fucoside | n2=en:hyperthreoninuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypertrichosis of the eyebrows
n1=fucoside | n2=en:hypertrichosis of the eyebrows | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypertriglyceridemia
n1=fucoside | n2=en:hypertriglyceridemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypertriglyceridemia (in some patients)
n1=fucoside | n2=en:hypertriglyceridemia (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypertriglyceridemia (rare)
n1=fucoside | n2=en:hypertriglyceridemia (rare) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypertriglyceridemia, transient
n1=fucoside | n2=en:hypertriglyceridemia, transient | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypertryptophanemia
n1=fucoside | n2=en:hypertryptophanemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperuricemia
n1=fucoside | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperuricosuria
n1=fucoside | n2=en:hyperuricosuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyperuricuria
n1=fucoside | n2=en:hyperuricuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoalbuminemia
n1=fucoside | n2=en:hypoalbuminemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoalbuminemia (in 83%)
n1=fucoside | n2=en:hypoalbuminemia (in 83%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoalphalipoproteinemia
n1=fucoside | n2=en:hypoalphalipoproteinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypobetalipoproteinemias
n1=fucoside | n2=en:hypobetalipoproteinemias | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypocalcemia
n1=fucoside | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypocalcemia (64% of adults)
n1=fucoside | n2=en:hypocalcemia (64% of adults) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypocalcemia (male)
n1=fucoside | n2=en:hypocalcemia (male) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypocalcemia, transient
n1=fucoside | n2=en:hypocalcemia, transient | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypocalciuria
n1=fucoside | n2=en:hypocalciuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypocalciuria or normocalciuria
n1=fucoside | n2=en:hypocalciuria or normocalciuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypocholesterolemia
n1=fucoside | n2=en:hypocholesterolemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypocitraturia
n1=fucoside | n2=en:hypocitraturia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypofibrinogenemia
n1=fucoside | n2=en:hypofibrinogenemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypogammaglobulinemia
n1=fucoside | n2=en:hypogammaglobulinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypogammaglobulinemia (in some patients)
n1=fucoside | n2=en:hypogammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypogammaglobulinemia, profound
n1=fucoside | n2=en:hypogammaglobulinemia, profound | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoglycemia
n1=fucoside | n2=en:hypoglycemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoglycemia, fasting
n1=fucoside | n2=en:hypoglycemia, fasting | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoglycemia, intermittent
n1=fucoside | n2=en:hypoglycemia, intermittent | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoglycorrhachia (low glucose in csf)
n1=fucoside | n2=en:hypoglycorrhachia (low glucose in csf) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoglycosylated serum transferrin
n1=fucoside | n2=en:hypoglycosylated serum transferrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoglycosylation of plasma glycoproteins
n1=fucoside | n2=en:hypoglycosylation of plasma glycoproteins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypokalemia
n1=fucoside | n2=en:hypokalemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypokalemia during attacks
n1=fucoside | n2=en:hypokalemia during attacks | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypokalemia during periodic paralysis (most patients)
n1=fucoside | n2=en:hypokalemia during periodic paralysis (most patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypokalemia occurs during paralytic attacks
n1=fucoside | n2=en:hypokalemia occurs during paralytic attacks | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypokalemia, familial
n1=fucoside | n2=en:hypokalemia, familial | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoketotic dicarboxylic aciduria (in some patients)
n1=fucoside | n2=en:hypoketotic dicarboxylic aciduria (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoketotic hypoglycemia
n1=fucoside | n2=en:hypoketotic hypoglycemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypomagnesemia
n1=fucoside | n2=en:hypomagnesemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypomagnesemia 1, intestinal
n1=fucoside | n2=en:hypomagnesemia 1, intestinal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypomethioninemia
n1=fucoside | n2=en:hypomethioninemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypomethylation of alpha-satellite repeats on chromosome 9
n1=fucoside | n2=en:hypomethylation of alpha-satellite repeats on chromosome 9 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypomethylation of satellite repeats on chromosome 1, 9, and 16
n1=fucoside | n2=en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypomyelination and congenital cataract
n1=fucoside | n2=en:hypomyelination and congenital cataract | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyponatremia
n1=fucoside | n2=en:hyponatremia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyponatremia in infancy
n1=fucoside | n2=en:hyponatremia in infancy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyponatremic dehydration, rarely
n1=fucoside | n2=en:hyponatremic dehydration, rarely | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypophosphatasia
n1=fucoside | n2=en:hypophosphatasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypophosphatemia (less common)
n1=fucoside | n2=en:hypophosphatemia (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypophosphatemic rickets with hypercalciuria, hereditary
n1=fucoside | n2=en:hypophosphatemic rickets with hypercalciuria, hereditary | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoprebetalipoproteinemia
n1=fucoside | n2=en:hypoprebetalipoproteinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoproteinemia
n1=fucoside | n2=en:hypoproteinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoproteinemia (in 1 patient)
n1=fucoside | n2=en:hypoproteinemia (in 1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoproteinemia due to hypercatabolism
n1=fucoside | n2=en:hypoproteinemia due to hypercatabolism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyposialylation of o-linked serum glycans
n1=fucoside | n2=en:hyposialylation of o-linked serum glycans | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypospadias-mental retardation syndrome
n1=fucoside | n2=en:hypospadias-mental retardation syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hyposthenuria (inability to concentrate urine normally)
n1=fucoside | n2=en:hyposthenuria (inability to concentrate urine normally) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypotonia changing to hypertonia
n1=fucoside | n2=en:hypotonia changing to hypertonia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypouricemia
n1=fucoside | n2=en:hypouricemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoxemia
n1=fucoside | n2=en:hypoxemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:hypoxia
n1=fucoside | n2=en:hypoxia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:i-cell disease
n1=fucoside | n2=en:i-cell disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells
n1=fucoside | n2=en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iga antiendomysial antibodies (ema)
n1=fucoside | n2=en:iga antiendomysial antibodies (ema) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:igg deficiency
n1=fucoside | n2=en:igg deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:igg, decreased
n1=fucoside | n2=en:igg, decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:igg, elevated
n1=fucoside | n2=en:igg, elevated | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:igm deficiency
n1=fucoside | n2=en:igm deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iiga and igg antigliadin antibodies (aga)
n1=fucoside | n2=en:iiga and igg antigliadin antibodies (aga) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:immediate (type i) skin test reactivity
n1=fucoside | n2=en:immediate (type i) skin test reactivity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:immotile cilia
n1=fucoside | n2=en:immotile cilia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:immotile or weakly motile cilia
n1=fucoside | n2=en:immotile or weakly motile cilia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:immunoglobulin a decreased
n1=fucoside | n2=en:immunoglobulin a decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:immunoglobulin antibodies present
n1=fucoside | n2=en:immunoglobulin antibodies present | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:immunology aspects
n1=fucoside | n2=en:immunology aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:immunoreactive pc protein
n1=fucoside | n2=en:immunoreactive pc protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes
n1=fucoside | n2=en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired creatine uptake in fibroblasts
n1=fucoside | n2=en:impaired creatine uptake in fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise
n1=fucoside | n2=en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired mitochondrial translation
n1=fucoside | n2=en:impaired mitochondrial translation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired n-glycosylation
n1=fucoside | n2=en:impaired n-glycosylation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired o-glycosylation
n1=fucoside | n2=en:impaired o-glycosylation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired oxidation of pyruvate
n1=fucoside | n2=en:impaired oxidation of pyruvate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired platelet aggregation
n1=fucoside | n2=en:impaired platelet aggregation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired response to gm-csf
n1=fucoside | n2=en:impaired response to gm-csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impaired synthesis of fibroblast sulfated proteoglycans
n1=fucoside | n2=en:impaired synthesis of fibroblast sulfated proteoglycans | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:impairment of urinary concentration
n1=fucoside | n2=en:impairment of urinary concentration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:in cerebrospinal fluid
n1=fucoside | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria
n1=fucoside | n2=en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:inactive mutant form of red cell carbonic anhydrase b in one sibship
n1=fucoside | n2=en:inactive mutant form of red cell carbonic anhydrase b in one sibship | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:inappropriately increased urine osmolality
n1=fucoside | n2=en:inappropriately increased urine osmolality | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:inappropriately low urine osmolality
n1=fucoside | n2=en:inappropriately low urine osmolality | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:inappropriately normal or increased plasma hepcidin
n1=fucoside | n2=en:inappropriately normal or increased plasma hepcidin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:inappropriately normal serum 1,25-dihydroxyvitamin d3
n1=fucoside | n2=en:inappropriately normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3
n1=fucoside | n2=en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:inclusion bodies (membrane-bound vacuoles) in fibroblasts
n1=fucoside | n2=en:inclusion bodies (membrane-bound vacuoles) in fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:inclusions contain phospholipids, phosphatidylcholine, sphingolipids, gangliosides, mucopolysaccharides
n1=fucoside | n2=en:inclusions contain phospholipids, phosphatidylcholine, sphingolipids, gangliosides, mucopolysaccharides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:incomplete n-glycosylation of cellular proteins
n1=fucoside | n2=en:incomplete n-glycosylation of cellular proteins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increase urinary excretion of lysine, arginine, and ornithine
n1=fucoside | n2=en:increase urinary excretion of lysine, arginine, and ornithine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased 11-deoxycorticosterone
n1=fucoside | n2=en:increased 11-deoxycorticosterone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased 11-deoxycortisol
n1=fucoside | n2=en:increased 11-deoxycortisol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased 18-hydroxycortisol
n1=fucoside | n2=en:increased 18-hydroxycortisol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased 18-ohb to aldosterone ratio
n1=fucoside | n2=en:increased 18-ohb to aldosterone ratio | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased 18-oxocortisol
n1=fucoside | n2=en:increased 18-oxocortisol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased acetoacetate: beta-hydroxybutyrate ratio (group b)
n1=fucoside | n2=en:increased acetoacetate: beta-hydroxybutyrate ratio (group b) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased acetylcholinesterase (ache) in amniotic fluid
n1=fucoside | n2=en:increased acetylcholinesterase (ache) in amniotic fluid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased activity of the prpp synthetase 1 enzyme
n1=fucoside | n2=en:increased activity of the prpp synthetase 1 enzyme | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased alpha-fetoprotein (1 patient)
n1=fucoside | n2=en:increased alpha-fetoprotein (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus
n1=fucoside | n2=en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased ammonia with exercise
n1=fucoside | n2=en:increased ammonia with exercise | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased beta-alanine (in 1 of 2 patients)
n1=fucoside | n2=en:increased beta-alanine (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased bile acid intermediates (dhca and thca)
n1=fucoside | n2=en:increased bile acid intermediates (dhca and thca) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased biliverdin in bodily fluids
n1=fucoside | n2=en:increased biliverdin in bodily fluids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased biopterin in urine and csf
n1=fucoside | n2=en:increased biopterin in urine and csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased blood alanine
n1=fucoside | n2=en:increased blood alanine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased bone serum acid phosphatase
n1=fucoside | n2=en:increased bone serum acid phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased bone-specific alkaline phosphatase
n1=fucoside | n2=en:increased bone-specific alkaline phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased c10:2-carnitine
n1=fucoside | n2=en:increased c10:2-carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased cellular sensitivity to uv light
n1=fucoside | n2=en:increased cellular sensitivity to uv light | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased cerebrospinal fluid (csf) protein (>100mg/dl)
n1=fucoside | n2=en:increased cerebrospinal fluid (csf) protein (>100mg/dl) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased cholesterol
n1=fucoside | n2=en:increased cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased chromosomal breakage
n1=fucoside | n2=en:increased chromosomal breakage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation
n1=fucoside | n2=en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased chromosomal rearrangements (bone marrow and fibroblast culture)
n1=fucoside | n2=en:increased chromosomal rearrangements (bone marrow and fibroblast culture) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased circulating renin level
n1=fucoside | n2=en:increased circulating renin level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased ck-mb
n1=fucoside | n2=en:increased ck-mb | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased coproporphyrin isomer iii:i ratio (hcp, feces)
n1=fucoside | n2=en:increased coproporphyrin isomer iii:i ratio (hcp, feces) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased creatine kinase (ck)
n1=fucoside | n2=en:increased creatine kinase (ck) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased creatine kinase, mild to moderate
n1=fucoside | n2=en:increased creatine kinase, mild to moderate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased creatinine
n1=fucoside | n2=en:increased creatinine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased cross-linked c-terminal telopeptide of type i collagen
n1=fucoside | n2=en:increased cross-linked c-terminal telopeptide of type i collagen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf 3-methoxytyrosine (3-mt)
n1=fucoside | n2=en:increased csf 3-methoxytyrosine (3-mt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf and plasma gaba
n1=fucoside | n2=en:increased csf and plasma gaba | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf and plasma ghb
n1=fucoside | n2=en:increased csf and plasma ghb | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf glycine
n1=fucoside | n2=en:increased csf glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf histidine
n1=fucoside | n2=en:increased csf histidine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf homovanillic acid (hva)
n1=fucoside | n2=en:increased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf immunoglobulin levels
n1=fucoside | n2=en:increased csf immunoglobulin levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf interferon
n1=fucoside | n2=en:increased csf interferon | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf interferon alpha
n1=fucoside | n2=en:increased csf interferon alpha | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf lactate
n1=fucoside | n2=en:increased csf lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf lactate during acute episodes
n1=fucoside | n2=en:increased csf lactate during acute episodes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf protein
n1=fucoside | n2=en:increased csf protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf protein during acute illness
n1=fucoside | n2=en:increased csf protein during acute illness | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf pyruvic acid
n1=fucoside | n2=en:increased csf pyruvic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf taurine
n1=fucoside | n2=en:increased csf taurine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf threonine
n1=fucoside | n2=en:increased csf threonine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf transferrin despite normal serum transferrin levels
n1=fucoside | n2=en:increased csf transferrin despite normal serum transferrin levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf, plasma, and urinary 3-methoxytyrosine
n1=fucoside | n2=en:increased csf, plasma, and urinary 3-methoxytyrosine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf, plasma, and urinary 3-ortho-methyldopa (3-omd)
n1=fucoside | n2=en:increased csf, plasma, and urinary 3-ortho-methyldopa (3-omd) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp)
n1=fucoside | n2=en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased csf, plasma, and urinary l-dopa
n1=fucoside | n2=en:increased csf, plasma, and urinary l-dopa | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased d-glyceric acid in serum, urine, and csf
n1=fucoside | n2=en:increased d-glyceric acid in serum, urine, and csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased di- and asialo-transferrin
n1=fucoside | n2=en:increased di- and asialo-transferrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased di- and asialo-transferrin characteristic of type 1 pattern
n1=fucoside | n2=en:increased di- and asialo-transferrin characteristic of type 1 pattern | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased disialo- and asialotransferrin
n1=fucoside | n2=en:increased disialo- and asialotransferrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased disialotransferrin and asialotransferrin levels
n1=fucoside | n2=en:increased disialotransferrin and asialotransferrin levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased erythrocyte sedimentation rate, episodic
n1=fucoside | n2=en:increased erythrocyte sedimentation rate, episodic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased erythrocyte-membrane calcium-magnesium-atpase
n1=fucoside | n2=en:increased erythrocyte-membrane calcium-magnesium-atpase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased erythropoietin
n1=fucoside | n2=en:increased erythropoietin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased excretion of urobilinogen
n1=fucoside | n2=en:increased excretion of urobilinogen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased fas ligand
n1=fucoside | n2=en:increased fas ligand | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased ferritin
n1=fucoside | n2=en:increased ferritin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased fibroblast free sialic acid
n1=fucoside | n2=en:increased fibroblast free sialic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased fractional excretion of urate (greater than 50%)
n1=fucoside | n2=en:increased fractional excretion of urate (greater than 50%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased fractional excretion of uric acid
n1=fucoside | n2=en:increased fractional excretion of uric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased free cyanocobalamin in fibroblasts
n1=fucoside | n2=en:increased free cyanocobalamin in fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased free erythrocyte protoporphyrin
n1=fucoside | n2=en:increased free erythrocyte protoporphyrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3
n1=fucoside | n2=en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf)
n1=fucoside | n2=en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased gamma-interferon
n1=fucoside | n2=en:increased gamma-interferon | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased growth hormone (in 1 of 2 patients)
n1=fucoside | n2=en:increased growth hormone (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased harderoporphyrin excretion (feces, harderoporphyria)
n1=fucoside | n2=en:increased harderoporphyrin excretion (feces, harderoporphyria) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased hepatic parenchymal cell stainable iron
n1=fucoside | n2=en:increased hepatic parenchymal cell stainable iron | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased histidine in blood, urine, and csf
n1=fucoside | n2=en:increased histidine in blood, urine, and csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased iga level
n1=fucoside | n2=en:increased iga level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased ige level
n1=fucoside | n2=en:increased ige level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased igg level
n1=fucoside | n2=en:increased igg level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased igm level
n1=fucoside | n2=en:increased igm level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased il-6
n1=fucoside | n2=en:increased il-6 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased il-8
n1=fucoside | n2=en:increased il-8 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased il18
n1=fucoside | n2=en:increased il18 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased il1b increased soluble il2r
n1=fucoside | n2=en:increased il1b increased soluble il2r | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased il6, episodic
n1=fucoside | n2=en:increased il6, episodic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased interferon-alpha signal
n1=fucoside | n2=en:increased interferon-alpha signal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased interleukin 10
n1=fucoside | n2=en:increased interleukin 10 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased intracellular fmrp mrna
n1=fucoside | n2=en:increased intracellular fmrp mrna | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased ketone body or lactate/pyruvate plasma ratios
n1=fucoside | n2=en:increased ketone body or lactate/pyruvate plasma ratios | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased l-2-hydroxyglutaric acid in urine, serum, and csf
n1=fucoside | n2=en:increased l-2-hydroxyglutaric acid in urine, serum, and csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased lactate in spinal fluid
n1=fucoside | n2=en:increased lactate in spinal fluid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased lactate: pyruvate ratio (group b)
n1=fucoside | n2=en:increased lactate: pyruvate ratio (group b) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased level of globotriaosylceramide (gb3) in plasma and urinary sediment
n1=fucoside | n2=en:increased level of globotriaosylceramide (gb3) in plasma and urinary sediment | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased levels of 3-alpha-7-alpha-12-alpha-trihydroxy-5-beta-cholestanoic acid (thca) in bile, urine, and serum
n1=fucoside | n2=en:increased levels of 3-alpha-7-alpha-12-alpha-trihydroxy-5-beta-cholestanoic acid (thca) in bile, urine, and serum | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased levels of carcinoembryonic antigen
n1=fucoside | n2=en:increased levels of carcinoembryonic antigen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells
n1=fucoside | n2=en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased long-chain acylcarnitine
n1=fucoside | n2=en:increased long-chain acylcarnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased lysine in serum and csf
n1=fucoside | n2=en:increased lysine in serum and csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood
n1=fucoside | n2=en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased nasal-potential difference (1 of 3 patients)
n1=fucoside | n2=en:increased nasal-potential difference (1 of 3 patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased nasal-potential difference (some)
n1=fucoside | n2=en:increased nasal-potential difference (some) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased neopterin in urine and csf
n1=fucoside | n2=en:increased neopterin in urine and csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased or normal serum growth hormone (gh, 139250)
n1=fucoside | n2=en:increased or normal serum growth hormone (gh, 139250) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased osmotic fragility
n1=fucoside | n2=en:increased osmotic fragility | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased oxygen affinity (e.g. hb nunobiki 141800.0109)
n1=fucoside | n2=en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased peripheral blood monocytes
n1=fucoside | n2=en:increased peripheral blood monocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased phytanic acid in body tissues and fluids
n1=fucoside | n2=en:increased phytanic acid in body tissues and fluids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma 2-methylbutyrylcarnitine
n1=fucoside | n2=en:increased plasma 2-methylbutyrylcarnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma and urinary pipecolic acid
n1=fucoside | n2=en:increased plasma and urinary pipecolic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma branched-chain fatty acids
n1=fucoside | n2=en:increased plasma branched-chain fatty acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma creatine
n1=fucoside | n2=en:increased plasma creatine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma dihydroxyphenylacetic acid (dopac)
n1=fucoside | n2=en:increased plasma dihydroxyphenylacetic acid (dopac) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma free cholesterol
n1=fucoside | n2=en:increased plasma free cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma globotriaosylsphingosine (lyso-gb3)
n1=fucoside | n2=en:increased plasma globotriaosylsphingosine (lyso-gb3) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma homogentisic acid (hga)
n1=fucoside | n2=en:increased plasma homogentisic acid (hga) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma lactate
n1=fucoside | n2=en:increased plasma lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma levels of bile acid intermediates
n1=fucoside | n2=en:increased plasma levels of bile acid intermediates | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma levels of very long-chain fatty acids (vlcfa)
n1=fucoside | n2=en:increased plasma levels of very long-chain fatty acids (vlcfa) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma long-chain acylcarnitines
n1=fucoside | n2=en:increased plasma long-chain acylcarnitines | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma phospholipids
n1=fucoside | n2=en:increased plasma phospholipids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma phytanic acid
n1=fucoside | n2=en:increased plasma phytanic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma pipecolic acid
n1=fucoside | n2=en:increased plasma pipecolic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma pristanic acid
n1=fucoside | n2=en:increased plasma pristanic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma progastrin
n1=fucoside | n2=en:increased plasma progastrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma proglucagon
n1=fucoside | n2=en:increased plasma proglucagon | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma proinsulin
n1=fucoside | n2=en:increased plasma proinsulin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma renin activity
n1=fucoside | n2=en:increased plasma renin activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased plasma vldl, ldl
n1=fucoside | n2=en:increased plasma vldl, ldl | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased platelet aggregation with ristocetin
n1=fucoside | n2=en:increased platelet aggregation with ristocetin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased prevalence among the native american lumbee indians
n1=fucoside | n2=en:increased prevalence among the native american lumbee indians | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased pristanic acid
n1=fucoside | n2=en:increased pristanic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased prv-1 (162860) mrna
n1=fucoside | n2=en:increased prv-1 (162860) mrna | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased pyruvate in serum and csf
n1=fucoside | n2=en:increased pyruvate in serum and csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased rai (radioactive iodine) uptake
n1=fucoside | n2=en:increased rai (radioactive iodine) uptake | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased renal tubular phosphate reabsorption
n1=fucoside | n2=en:increased renal tubular phosphate reabsorption | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased sensitivity to adrenergic and cholinergic agents
n1=fucoside | n2=en:increased sensitivity to adrenergic and cholinergic agents | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum 1,25-dihydroxyvitamin d
n1=fucoside | n2=en:increased serum 1,25-dihydroxyvitamin d | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum 1,25-dihydroxyvitamin d3
n1=fucoside | n2=en:increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum 18-hydroxycorticosterone (18-ohb)
n1=fucoside | n2=en:increased serum 18-hydroxycorticosterone (18-ohb) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum acyl carnitines
n1=fucoside | n2=en:increased serum acyl carnitines | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum acylcarnitine during febrile crisis
n1=fucoside | n2=en:increased serum acylcarnitine during febrile crisis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum acylcarnitines
n1=fucoside | n2=en:increased serum acylcarnitines | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum alanine
n1=fucoside | n2=en:increased serum alanine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum alanine (1 patient)
n1=fucoside | n2=en:increased serum alanine (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum alkaline phosphatase (in some patients)
n1=fucoside | n2=en:increased serum alkaline phosphatase (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum alkaline phosphatase activity of skeletal origin
n1=fucoside | n2=en:increased serum alkaline phosphatase activity of skeletal origin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum alpha-interferon (ifna1, 147660)
n1=fucoside | n2=en:increased serum alpha-interferon (ifna1, 147660) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum alpha-mannosidase
n1=fucoside | n2=en:increased serum alpha-mannosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum ammonia (group b)
n1=fucoside | n2=en:increased serum ammonia (group b) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum and cerebrospinal fluid levels of pipecolic acid
n1=fucoside | n2=en:increased serum and cerebrospinal fluid levels of pipecolic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum and csf glycine
n1=fucoside | n2=en:increased serum and csf glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum and csf lactate
n1=fucoside | n2=en:increased serum and csf lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum and urinary 2-oxoglutarate
n1=fucoside | n2=en:increased serum and urinary 2-oxoglutarate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum and urinary lactate
n1=fucoside | n2=en:increased serum and urinary lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum aryl-sulfatase a (10-20x)
n1=fucoside | n2=en:increased serum aryl-sulfatase a (10-20x) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum arylsulfatase a (10-20x)
n1=fucoside | n2=en:increased serum arylsulfatase a (10-20x) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum arylsulfatase a.
n1=fucoside | n2=en:increased serum arylsulfatase a. | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum beta-carotene
n1=fucoside | n2=en:increased serum beta-carotene | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum beta-hexosaminidase
n1=fucoside | n2=en:increased serum beta-hexosaminidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum beta-hexosaminidase (10-20x)
n1=fucoside | n2=en:increased serum beta-hexosaminidase (10-20x) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum bile acid concentration during pregnancy, resolves postpartum
n1=fucoside | n2=en:increased serum bile acid concentration during pregnancy, resolves postpartum | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum bile acids
n1=fucoside | n2=en:increased serum bile acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum bilirubin (in some patients)
n1=fucoside | n2=en:increased serum bilirubin (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum bilirubin due to hemolysis
n1=fucoside | n2=en:increased serum bilirubin due to hemolysis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum butyryl carnitine
n1=fucoside | n2=en:increased serum butyryl carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum c-reactive protein (crp, 123260)
n1=fucoside | n2=en:increased serum c-reactive protein (crp, 123260) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum c-reactive protein, episodic
n1=fucoside | n2=en:increased serum c-reactive protein, episodic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum c26-bile-acid intermediates
n1=fucoside | n2=en:increased serum c26-bile-acid intermediates | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum c4 and c5 acylcarnitine esters
n1=fucoside | n2=en:increased serum c4 and c5 acylcarnitine esters | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum cholesterol (in 3 of 10 patients)
n1=fucoside | n2=en:increased serum cholesterol (in 3 of 10 patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum citrulline (group b)
n1=fucoside | n2=en:increased serum citrulline (group b) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum creatine kinase (1 family)
n1=fucoside | n2=en:increased serum creatine kinase (1 family) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum creatine kinase (less common)
n1=fucoside | n2=en:increased serum creatine kinase (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum creatine kinase (patient a)
n1=fucoside | n2=en:increased serum creatine kinase (patient a) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum creatine kinase during episodes
n1=fucoside | n2=en:increased serum creatine kinase during episodes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum creatine kinase in acute stage
n1=fucoside | n2=en:increased serum creatine kinase in acute stage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum creatine kinase in patients with muscle involvement
n1=fucoside | n2=en:increased serum creatine kinase in patients with muscle involvement | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum creatine kinase, mild
n1=fucoside | n2=en:increased serum creatine kinase, mild | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum deoxyuridine
n1=fucoside | n2=en:increased serum deoxyuridine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum direct bilirubin
n1=fucoside | n2=en:increased serum direct bilirubin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum erythropoietin (epo, 133170)
n1=fucoside | n2=en:increased serum erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum ferritin
n1=fucoside | n2=en:increased serum ferritin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum ferritin (in some patients)
n1=fucoside | n2=en:increased serum ferritin (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum fgf23
n1=fucoside | n2=en:increased serum fgf23 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum gamma-ggt (231950)
n1=fucoside | n2=en:increased serum gamma-ggt (231950) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum glutamine
n1=fucoside | n2=en:increased serum glutamine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum glycerol
n1=fucoside | n2=en:increased serum glycerol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum glycine, leucine, isoleucine, valine
n1=fucoside | n2=en:increased serum glycine, leucine, isoleucine, valine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum gm-csf
n1=fucoside | n2=en:increased serum gm-csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum growth hormone levels
n1=fucoside | n2=en:increased serum growth hormone levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum iduronate sulfatase
n1=fucoside | n2=en:increased serum iduronate sulfatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum iduronate sulfatase (10-20x)
n1=fucoside | n2=en:increased serum iduronate sulfatase (10-20x) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum ige
n1=fucoside | n2=en:increased serum ige | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum insulin-like growth factor-1 (igf1, 147740)
n1=fucoside | n2=en:increased serum insulin-like growth factor-1 (igf1, 147740) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate
n1=fucoside | n2=en:increased serum lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate (in some patients)
n1=fucoside | n2=en:increased serum lactate (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate (mild)
n1=fucoside | n2=en:increased serum lactate (mild) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate (patient a)
n1=fucoside | n2=en:increased serum lactate (patient a) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate dehydrogenase (in 1 family)
n1=fucoside | n2=en:increased serum lactate dehydrogenase (in 1 family) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate dehydrogenase (ldh)
n1=fucoside | n2=en:increased serum lactate dehydrogenase (ldh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate during metabolic crisis
n1=fucoside | n2=en:increased serum lactate during metabolic crisis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate hydrogenase
n1=fucoside | n2=en:increased serum lactate hydrogenase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate in acute stage
n1=fucoside | n2=en:increased serum lactate in acute stage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lactate, particularly after exercise
n1=fucoside | n2=en:increased serum lactate, particularly after exercise | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum levels of free plasma thyroid hormones
n1=fucoside | n2=en:increased serum levels of free plasma thyroid hormones | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lipoproteins
n1=fucoside | n2=en:increased serum lipoproteins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum lysine (group b)
n1=fucoside | n2=en:increased serum lysine (group b) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum manganese
n1=fucoside | n2=en:increased serum manganese | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum methionine
n1=fucoside | n2=en:increased serum methionine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum methionine (reported in 2 cases)
n1=fucoside | n2=en:increased serum methionine (reported in 2 cases) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum osteocalcin
n1=fucoside | n2=en:increased serum osteocalcin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum pancreatic secretory trypsin inhibitor (psti)
n1=fucoside | n2=en:increased serum pancreatic secretory trypsin inhibitor (psti) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum parathyroid hormone (pth)
n1=fucoside | n2=en:increased serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum plasminogen activator inhibitor-1 (pai1, 173360)
n1=fucoside | n2=en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum prostaglandin e2
n1=fucoside | n2=en:increased serum prostaglandin e2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum pyruvate
n1=fucoside | n2=en:increased serum pyruvate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum pyruvate in acute stage
n1=fucoside | n2=en:increased serum pyruvate in acute stage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum pyruvate, mild
n1=fucoside | n2=en:increased serum pyruvate, mild | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum ratio of corticosterone to 18-hydroxycorticosterone (18-ohb)
n1=fucoside | n2=en:increased serum ratio of corticosterone to 18-hydroxycorticosterone (18-ohb) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum s-adenosylhomocysteine
n1=fucoside | n2=en:increased serum s-adenosylhomocysteine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum s-adenosylmethionine
n1=fucoside | n2=en:increased serum s-adenosylmethionine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum serotonin in 25%
n1=fucoside | n2=en:increased serum serotonin in 25% | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum thrombopoietin may occur
n1=fucoside | n2=en:increased serum thrombopoietin may occur | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum thymidine
n1=fucoside | n2=en:increased serum thymidine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum thyroid-stimulating hormone (tsh)
n1=fucoside | n2=en:increased serum thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum thyrotropin
n1=fucoside | n2=en:increased serum thyrotropin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum total cholesterol
n1=fucoside | n2=en:increased serum total cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum transaminases (in 1 of 3 patients)
n1=fucoside | n2=en:increased serum transaminases (in 1 of 3 patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum transferrin
n1=fucoside | n2=en:increased serum transferrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum triglycerides (in some patients)
n1=fucoside | n2=en:increased serum triglycerides (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum triiodothyronine (t3)
n1=fucoside | n2=en:increased serum triiodothyronine (t3) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum unconjugated bilirubin
n1=fucoside | n2=en:increased serum unconjugated bilirubin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum uric acid
n1=fucoside | n2=en:increased serum uric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum vascular endothelial growth factor (vegf, 192240)
n1=fucoside | n2=en:increased serum vascular endothelial growth factor (vegf, 192240) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum vitamin b12
n1=fucoside | n2=en:increased serum vitamin b12 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde
n1=fucoside | n2=en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum, urinary, and csf lysine
n1=fucoside | n2=en:increased serum, urinary, and csf lysine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased serum, urinary, and csf saccharopine (in some patients)
n1=fucoside | n2=en:increased serum, urinary, and csf saccharopine (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased sodium-potassium pump activity
n1=fucoside | n2=en:increased sodium-potassium pump activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased soluble il2 receptor
n1=fucoside | n2=en:increased soluble il2 receptor | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased succinyladenosine (s-ado) in serum, urine, and csf
n1=fucoside | n2=en:increased succinyladenosine (s-ado) in serum, urine, and csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased succinylaminoimidazole carboxamide ribotide (saicar)
n1=fucoside | n2=en:increased succinylaminoimidazole carboxamide ribotide (saicar) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased susceptibility to ebv infection
n1=fucoside | n2=en:increased susceptibility to ebv infection | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased thymine and dihydrothymine in bodily fluids
n1=fucoside | n2=en:increased thymine and dihydrothymine in bodily fluids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased thyroid-stimulating hormone (tsh)
n1=fucoside | n2=en:increased thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased tissue levels of free fatty acids
n1=fucoside | n2=en:increased tissue levels of free fatty acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased tissue levels of triglycerides
n1=fucoside | n2=en:increased tissue levels of triglycerides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased tissue long-chain acylcarnitines
n1=fucoside | n2=en:increased tissue long-chain acylcarnitines | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased tissue long-chain fatty acids
n1=fucoside | n2=en:increased tissue long-chain fatty acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased total and conjugated bilirubin
n1=fucoside | n2=en:increased total and conjugated bilirubin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased total bilirubin may occur
n1=fucoside | n2=en:increased total bilirubin may occur | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs
n1=fucoside | n2=en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased transferrin saturation (>60%)
n1=fucoside | n2=en:increased transferrin saturation (>60%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased triglycerides (less common)
n1=fucoside | n2=en:increased triglycerides (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased uracil and dihydrouracil in bodily fluids
n1=fucoside | n2=en:increased uracil and dihydrouracil in bodily fluids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased uric acid level
n1=fucoside | n2=en:increased uric acid level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased uric acid with exercise
n1=fucoside | n2=en:increased uric acid with exercise | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-alpha-ketoglutaric acid
n1=fucoside | n2=en:increased urinary 2-alpha-ketoglutaric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-butanone
n1=fucoside | n2=en:increased urinary 2-butanone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-hydroxybutyrate
n1=fucoside | n2=en:increased urinary 2-hydroxybutyrate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-ketoglutarate (variable)
n1=fucoside | n2=en:increased urinary 2-ketoglutarate (variable) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-methyl-3 hydroxybutyrate
n1=fucoside | n2=en:increased urinary 2-methyl-3 hydroxybutyrate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-methyl-3-hydroxybutyric acid
n1=fucoside | n2=en:increased urinary 2-methyl-3-hydroxybutyric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-methylacetoacetic acid
n1=fucoside | n2=en:increased urinary 2-methylacetoacetic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-methylbutyryl glycine
n1=fucoside | n2=en:increased urinary 2-methylbutyryl glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-methylbutyrylglycine
n1=fucoside | n2=en:increased urinary 2-methylbutyrylglycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 2-oxoglutaric acid
n1=fucoside | n2=en:increased urinary 2-oxoglutaric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 3-methylcrotonylglycine
n1=fucoside | n2=en:increased urinary 3-methylcrotonylglycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 3-methylglutaconic acid
n1=fucoside | n2=en:increased urinary 3-methylglutaconic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 3-oh-butyric acid
n1=fucoside | n2=en:increased urinary 3-oh-butyric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 3-oh-isovaleric acid ketonuria
n1=fucoside | n2=en:increased urinary 3-oh-isovaleric acid ketonuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 3-oh-propionic acid
n1=fucoside | n2=en:increased urinary 3-oh-propionic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary 7-biopterin (primapterin)
n1=fucoside | n2=en:increased urinary 7-biopterin (primapterin) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary acetoacetic acid
n1=fucoside | n2=en:increased urinary acetoacetic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary adenosine
n1=fucoside | n2=en:increased urinary adenosine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary alpha-ketoglutaric acid, intermittent
n1=fucoside | n2=en:increased urinary alpha-ketoglutaric acid, intermittent | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary and serum glycine
n1=fucoside | n2=en:increased urinary and serum glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary carnitine
n1=fucoside | n2=en:increased urinary carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary carnitine esters
n1=fucoside | n2=en:increased urinary carnitine esters | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary catecholamines
n1=fucoside | n2=en:increased urinary catecholamines | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary catecholamines (with pheochromocytoma)
n1=fucoside | n2=en:increased urinary catecholamines (with pheochromocytoma) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary citric acid cycle intermediates
n1=fucoside | n2=en:increased urinary citric acid cycle intermediates | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation
n1=fucoside | n2=en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary cortisol/cortisone ratio
n1=fucoside | n2=en:increased urinary cortisol/cortisone ratio | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary creatine
n1=fucoside | n2=en:increased urinary creatine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary creatine-to-creatinine ratio
n1=fucoside | n2=en:increased urinary creatine-to-creatinine ratio | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary cross-linked n-telopetide of type i collagen
n1=fucoside | n2=en:increased urinary cross-linked n-telopetide of type i collagen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary cyclic amp (camp) in response to ddavp administration
n1=fucoside | n2=en:increased urinary cyclic amp (camp) in response to ddavp administration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del)
n1=fucoside | n2=en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks
n1=fucoside | n2=en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary dicarboxylic acid, transient
n1=fucoside | n2=en:increased urinary dicarboxylic acid, transient | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary dihydropyrimidines
n1=fucoside | n2=en:increased urinary dihydropyrimidines | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary disaccharides (mannosyl-n-acetylglucosamine)
n1=fucoside | n2=en:increased urinary disaccharides (mannosyl-n-acetylglucosamine) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary dopamine
n1=fucoside | n2=en:increased urinary dopamine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary dopamine and dopamine metabolites (paradoxical)
n1=fucoside | n2=en:increased urinary dopamine and dopamine metabolites (paradoxical) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary excretion of 4-hydroxybutyric acid (ghb)
n1=fucoside | n2=en:increased urinary excretion of 4-hydroxybutyric acid (ghb) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary excretion of camp
n1=fucoside | n2=en:increased urinary excretion of camp | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary excretion of coproporphyrin i
n1=fucoside | n2=en:increased urinary excretion of coproporphyrin i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary excretion of cystine
n1=fucoside | n2=en:increased urinary excretion of cystine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary excretion of gamma-aminobutyric acid (gaba)
n1=fucoside | n2=en:increased urinary excretion of gamma-aminobutyric acid (gaba) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary excretion of l-xylulose
n1=fucoside | n2=en:increased urinary excretion of l-xylulose | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary formiminoglutamic acid (figlu)
n1=fucoside | n2=en:increased urinary formiminoglutamic acid (figlu) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal)
n1=fucoside | n2=en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary free sialic acid excretion (n-acetylneuraminic acid, 5-20x normal) enlarged lysosomal vacuoles in lymphocytes and fibroblasts
n1=fucoside | n2=en:increased urinary free sialic acid excretion (n-acetylneuraminic acid, 5-20x normal) enlarged lysosomal vacuoles in lymphocytes and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary fumaric acid
n1=fucoside | n2=en:increased urinary fumaric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary glutaric acid
n1=fucoside | n2=en:increased urinary glutaric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary glycerol
n1=fucoside | n2=en:increased urinary glycerol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary glycosphingolipids, particularly globotriaosylceramide
n1=fucoside | n2=en:increased urinary glycosphingolipids, particularly globotriaosylceramide | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary hga
n1=fucoside | n2=en:increased urinary hga | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary homovanillic acid (hva)
n1=fucoside | n2=en:increased urinary homovanillic acid (hva) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary hydroxyisovaleric acid
n1=fucoside | n2=en:increased urinary hydroxyisovaleric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary hypoxanthine
n1=fucoside | n2=en:increased urinary hypoxanthine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary isobutyryl glycine
n1=fucoside | n2=en:increased urinary isobutyryl glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary ketones
n1=fucoside | n2=en:increased urinary ketones | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary l-glycerate
n1=fucoside | n2=en:increased urinary l-glycerate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary lactate
n1=fucoside | n2=en:increased urinary lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary levels of maoa substrates (endogenous bioamines)
n1=fucoside | n2=en:increased urinary levels of maoa substrates (endogenous bioamines) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary magnesium
n1=fucoside | n2=en:increased urinary magnesium | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary malic acid
n1=fucoside | n2=en:increased urinary malic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary mannose-containing oligosaccharides
n1=fucoside | n2=en:increased urinary mannose-containing oligosaccharides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary methylcitrate
n1=fucoside | n2=en:increased urinary methylcitrate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary n-acetylated amino acids
n1=fucoside | n2=en:increased urinary n-acetylated amino acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary neopterin
n1=fucoside | n2=en:increased urinary neopterin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine
n1=fucoside | n2=en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary o-linked sialopeptides
n1=fucoside | n2=en:increased urinary o-linked sialopeptides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary oligosaccharides
n1=fucoside | n2=en:increased urinary oligosaccharides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary organic acids (in some patients)
n1=fucoside | n2=en:increased urinary organic acids (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary orotic acid (in some patients)
n1=fucoside | n2=en:increased urinary orotic acid (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary oxylate
n1=fucoside | n2=en:increased urinary oxylate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary phospholipids
n1=fucoside | n2=en:increased urinary phospholipids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks
n1=fucoside | n2=en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary potassium
n1=fucoside | n2=en:increased urinary potassium | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary propionyl glycine
n1=fucoside | n2=en:increased urinary propionyl glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary prostaglandin e2
n1=fucoside | n2=en:increased urinary prostaglandin e2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary s-sulfocysteine
n1=fucoside | n2=en:increased urinary s-sulfocysteine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary sialylglycopeptides
n1=fucoside | n2=en:increased urinary sialylglycopeptides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary succinic acid
n1=fucoside | n2=en:increased urinary succinic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary sulfatide excretion
n1=fucoside | n2=en:increased urinary sulfatide excretion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary sulfatides
n1=fucoside | n2=en:increased urinary sulfatides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary sulfite
n1=fucoside | n2=en:increased urinary sulfite | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary taurine
n1=fucoside | n2=en:increased urinary taurine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary thiosulfate
n1=fucoside | n2=en:increased urinary thiosulfate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary thymine
n1=fucoside | n2=en:increased urinary thymine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary tiglylglycine
n1=fucoside | n2=en:increased urinary tiglylglycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary tricarboxylic acid intermediates
n1=fucoside | n2=en:increased urinary tricarboxylic acid intermediates | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary uracil
n1=fucoside | n2=en:increased urinary uracil | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary urate
n1=fucoside | n2=en:increased urinary urate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary vanillylmandelic acid (vma)
n1=fucoside | n2=en:increased urinary vanillylmandelic acid (vma) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid
n1=fucoside | n2=en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary, plasma, and csf dihydrothymine
n1=fucoside | n2=en:increased urinary, plasma, and csf dihydrothymine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary, plasma, and csf dihydrouracil
n1=fucoside | n2=en:increased urinary, plasma, and csf dihydrouracil | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary, plasma, and csf l-2-hydroxyglutaric acid
n1=fucoside | n2=en:increased urinary, plasma, and csf l-2-hydroxyglutaric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary, plasma, and csf n-carbamyl-beta-alanine
n1=fucoside | n2=en:increased urinary, plasma, and csf n-carbamyl-beta-alanine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urinary, plasma, and csf n-carbamyl-beta-aminoisobutyric acid
n1=fucoside | n2=en:increased urinary, plasma, and csf n-carbamyl-beta-aminoisobutyric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urine oligosaccharides
n1=fucoside | n2=en:increased urine oligosaccharides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urine porphyrins at times
n1=fucoside | n2=en:increased urine porphyrins at times | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased urine vanillactic acid (vla)
n1=fucoside | n2=en:increased urine vanillactic acid (vla) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased very-long chain fatty acids
n1=fucoside | n2=en:increased very-long chain fatty acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:increased vitamin e (alpha-tocopherol) levels
n1=fucoside | n2=en:increased vitamin e (alpha-tocopherol) levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:incresased urinary pyruvate
n1=fucoside | n2=en:incresased urinary pyruvate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:indirect bilirubin increased
n1=fucoside | n2=en:indirect bilirubin increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:indirect hyperbilirubinemia
n1=fucoside | n2=en:indirect hyperbilirubinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:infantile globoid cell leukodystrophy
n1=fucoside | n2=en:infantile globoid cell leukodystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:infantile hypophosphatasia
n1=fucoside | n2=en:infantile hypophosphatasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:inner and outer dynein arm defects, variable
n1=fucoside | n2=en:inner and outer dynein arm defects, variable | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:interleukin-1 receptor-associated kinase 4 deficiency
n1=fucoside | n2=en:interleukin-1 receptor-associated kinase 4 deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intermediate level of cellular sensitivity to uv light
n1=fucoside | n2=en:intermediate level of cellular sensitivity to uv light | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intermittent 3-methylglutaconic aciduria
n1=fucoside | n2=en:intermittent 3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intermittent dicarbonic aciduria
n1=fucoside | n2=en:intermittent dicarbonic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intermittent ethylmalonic aciduria
n1=fucoside | n2=en:intermittent ethylmalonic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intermittent increase of urinary ethylmalonic acid
n1=fucoside | n2=en:intermittent increase of urinary ethylmalonic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intermittent severe hypoglycemia (in some patients)
n1=fucoside | n2=en:intermittent severe hypoglycemia (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:interstitial deletion of 17p11.2 (most common is 3.7mb)
n1=fucoside | n2=en:interstitial deletion of 17p11.2 (most common is 3.7mb) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:interstitial or terminal deletion of 18q
n1=fucoside | n2=en:interstitial or terminal deletion of 18q | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intestinal epithelial dysplasia
n1=fucoside | n2=en:intestinal epithelial dysplasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intracellular accumulation of unesterified cholesterol
n1=fucoside | n2=en:intracellular accumulation of unesterified cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intracellular fingerprint profiles on ultrastructural analysis
n1=fucoside | n2=en:intracellular fingerprint profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intracellular glycosphingolipid deposition in all tissues of the body
n1=fucoside | n2=en:intracellular glycosphingolipid deposition in all tissues of the body | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intracellular granular material on ultrastructural analysis
n1=fucoside | n2=en:intracellular granular material on ultrastructural analysis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin)
n1=fucoside | n2=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b))
n1=fucoside | n2=en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iodide organification defect
n1=fucoside | n2=en:iodide organification defect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iodine depletion
n1=fucoside | n2=en:iodine depletion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iron binding capacity total increased
n1=fucoside | n2=en:iron binding capacity total increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iron deficiency
n1=fucoside | n2=en:iron deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iron deposition in basal ganglia, liver, pancreas, visceral organs detectable by ct and mri
n1=fucoside | n2=en:iron deposition in basal ganglia, liver, pancreas, visceral organs detectable by ct and mri | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iron low
n1=fucoside | n2=en:iron low | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:iron overload (in some patients)
n1=fucoside | n2=en:iron overload (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation
n1=fucoside | n2=en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:irregularly shaped sperm heads
n1=fucoside | n2=en:irregularly shaped sperm heads | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:isaacs syndrome
n1=fucoside | n2=en:isaacs syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:isobutyryl-coa dehydrogenase deficiency
n1=fucoside | n2=en:isobutyryl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:isochromosome 12p (i(12p))
n1=fucoside | n2=en:isochromosome 12p (i(12p)) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:isochromosome often missing in lymphocyte
n1=fucoside | n2=en:isochromosome often missing in lymphocyte | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:isolated hyperchlorhidrosis
n1=fucoside | n2=en:isolated hyperchlorhidrosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:isolated hypoplasia of the right ventricle
n1=fucoside | n2=en:isolated hypoplasia of the right ventricle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:isovaleric acidemia
n1=fucoside | n2=en:isovaleric acidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:isovalericaciduria
n1=fucoside | n2=en:isovalericaciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:isovalerylglycinuria
n1=fucoside | n2=en:isovalerylglycinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:jankovic rivera syndrome
n1=fucoside | n2=en:jankovic rivera syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:jervell and lange nielsen syndrome
n1=fucoside | n2=en:jervell and lange nielsen syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:joint contracture
n1=fucoside | n2=en:joint contracture | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:joubert syndrome
n1=fucoside | n2=en:joubert syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:juvenile fucosidosis
n1=fucoside | n2=en:juvenile fucosidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:karyomegaly may be found in other visceral organs
n1=fucoside | n2=en:karyomegaly may be found in other visceral organs | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:karyotype analysis normal finding
n1=fucoside | n2=en:karyotype analysis normal finding | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:kaufman-mckusick syndrome
n1=fucoside | n2=en:kaufman-mckusick syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:keratan sulfate excretion in urine that decreases with age
n1=fucoside | n2=en:keratan sulfate excretion in urine that decreases with age | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:keratan sulfaturia in some patients
n1=fucoside | n2=en:keratan sulfaturia in some patients | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ketoacidosis
n1=fucoside | n2=en:ketoacidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ketonemia
n1=fucoside | n2=en:ketonemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ketonuria
n1=fucoside | n2=en:ketonuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ketonuria (1 patient)
n1=fucoside | n2=en:ketonuria (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ketonuria, acute
n1=fucoside | n2=en:ketonuria, acute | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ketoses, metabolic
n1=fucoside | n2=en:ketoses, metabolic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ketosis
n1=fucoside | n2=en:ketosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:knobloch syndrome
n1=fucoside | n2=en:knobloch syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:krabbe disease
n1=fucoside | n2=en:krabbe disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:kuskokwim disease
n1=fucoside | n2=en:kuskokwim disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:kypokalemia
n1=fucoside | n2=en:kypokalemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:laboratory abnormalities
n1=fucoside | n2=en:laboratory abnormalities | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lack of ciliary motility
n1=fucoside | n2=en:lack of ciliary motility | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lack of excessive parenchymal iron storage
n1=fucoside | n2=en:lack of excessive parenchymal iron storage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lack of lysosomal inclusions in visceral organs
n1=fucoside | n2=en:lack of lysosomal inclusions in visceral organs | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lactase deficiency, congenital
n1=fucoside | n2=en:lactase deficiency, congenital | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lactate dehydrogenase increased
n1=fucoside | n2=en:lactate dehydrogenase increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lactate high
n1=fucoside | n2=en:lactate high | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lactate pyruvate ratio normal
n1=fucoside | n2=en:lactate pyruvate ratio normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lactic acidemia
n1=fucoside | n2=en:lactic acidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lactic acidemia (2p21del)
n1=fucoside | n2=en:lactic acidemia (2p21del) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lactic acidosis
n1=fucoside | n2=en:lactic acidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lactose intolerance
n1=fucoside | n2=en:lactose intolerance | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lacunar halos around chondrocytes in skeletal cartilage
n1=fucoside | n2=en:lacunar halos around chondrocytes in skeletal cartilage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:large spermatozoa
n1=fucoside | n2=en:large spermatozoa | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:laron syndrome
n1=fucoside | n2=en:laron syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:late onset globoid cell leukodystrophy
n1=fucoside | n2=en:late onset globoid cell leukodystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:laurence-moon syndrome
n1=fucoside | n2=en:laurence-moon syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lecithin acyltransferase deficiency
n1=fucoside | n2=en:lecithin acyltransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lesch-nyhan syndrome
n1=fucoside | n2=en:lesch-nyhan syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lethal congenital contracture syndrome 1
n1=fucoside | n2=en:lethal congenital contracture syndrome 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lethal congenital contracture syndrome 2
n1=fucoside | n2=en:lethal congenital contracture syndrome 2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lethal congenital contracture syndrome type 3
n1=fucoside | n2=en:lethal congenital contracture syndrome type 3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm
n1=fucoside | n2=en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:leukocytosis
n1=fucoside | n2=en:leukocytosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:leukodystrophy
n1=fucoside | n2=en:leukodystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation
n1=fucoside | n2=en:leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:leukotriene c4 synthase deficiency
n1=fucoside | n2=en:leukotriene c4 synthase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:leukotriene c4 synthetase deficiency
n1=fucoside | n2=en:leukotriene c4 synthetase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lipid vacuoles in leukocytes (jordan bodies)
n1=fucoside | n2=en:lipid vacuoles in leukocytes (jordan bodies) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lipofuscinosis
n1=fucoside | n2=en:lipofuscinosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lipoid proteinosis of urbach and wiethe
n1=fucoside | n2=en:lipoid proteinosis of urbach and wiethe | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lipoidosis
n1=fucoside | n2=en:lipoidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lipopigment in extraneuronal cells
n1=fucoside | n2=en:lipopigment in extraneuronal cells | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lipoprotein glomerulopathy
n1=fucoside | n2=en:lipoprotein glomerulopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lissencephaly syndrome, norman-roberts type
n1=fucoside | n2=en:lissencephaly syndrome, norman-roberts type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:little to absent aspartylglucosaminuria activity
n1=fucoside | n2=en:little to absent aspartylglucosaminuria activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:liver enzymes abnormal
n1=fucoside | n2=en:liver enzymes abnormal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:liver function tests normal
n1=fucoside | n2=en:liver function tests normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:liver phosphorylase kinase (phk) deficiency
n1=fucoside | n2=en:liver phosphorylase kinase (phk) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:liver transaminases normal to slightly increased
n1=fucoside | n2=en:liver transaminases normal to slightly increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:long-chain dicarboxylic aciduria
n1=fucoside | n2=en:long-chain dicarboxylic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:long-chain ketonuria
n1=fucoside | n2=en:long-chain ketonuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:loss of ciliary beat coordination
n1=fucoside | n2=en:loss of ciliary beat coordination | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:loss of galactose and sialic acid from multiple branches of complex type n-glycans (in some patients)
n1=fucoside | n2=en:loss of galactose and sialic acid from multiple branches of complex type n-glycans (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas
n1=fucoside | n2=en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low 25-oh-vitamin d level
n1=fucoside | n2=en:low 25-oh-vitamin d level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low absolute lymphocyte count
n1=fucoside | n2=en:low absolute lymphocyte count | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low acth level
n1=fucoside | n2=en:low acth level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low alkaline phosphatase
n1=fucoside | n2=en:low alkaline phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low apolipoprotein
n1=fucoside | n2=en:low apolipoprotein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low cd4+ count
n1=fucoside | n2=en:low cd4+ count | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low cholesterol esterification rates
n1=fucoside | n2=en:low cholesterol esterification rates | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low copper and ceruloplasmin
n1=fucoside | n2=en:low copper and ceruloplasmin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low csf creatine
n1=fucoside | n2=en:low csf creatine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low csf creatinine
n1=fucoside | n2=en:low csf creatinine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low density lipoprotein increased
n1=fucoside | n2=en:low density lipoprotein increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low fasting glucose (in some patients)
n1=fucoside | n2=en:low fasting glucose (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low free carnitine
n1=fucoside | n2=en:low free carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low growth hormone levels
n1=fucoside | n2=en:low growth hormone levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low ldl cholesterol
n1=fucoside | n2=en:low ldl cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low leukocyte alkaline phosphatase activity
n1=fucoside | n2=en:low leukocyte alkaline phosphatase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low level of c4 and c2
n1=fucoside | n2=en:low level of c4 and c2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low levels of cd11/cd18 (lfa-1 or leukocyte function antigen-1) glycoprotein
n1=fucoside | n2=en:low levels of cd11/cd18 (lfa-1 or leukocyte function antigen-1) glycoprotein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low levels of serum mg(2+) in the absence of other electrolyte disturbances
n1=fucoside | n2=en:low levels of serum mg(2+) in the absence of other electrolyte disturbances | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low maximal oxygen uptake on exercise testing
n1=fucoside | n2=en:low maximal oxygen uptake on exercise testing | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent adrenocorticotropic hormone (acth)
n1=fucoside | n2=en:low or absent adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent adrenocorticotropic hormone (acth) in some patients
n1=fucoside | n2=en:low or absent adrenocorticotropic hormone (acth) in some patients | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent follicle stimulating hormone (fsh)
n1=fucoside | n2=en:low or absent follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent growth hormone (gh)
n1=fucoside | n2=en:low or absent growth hormone (gh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent iga levels
n1=fucoside | n2=en:low or absent iga levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent igm levels
n1=fucoside | n2=en:low or absent igm levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent luteinizing hormone (lh)
n1=fucoside | n2=en:low or absent luteinizing hormone (lh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent prolactin (pl)
n1=fucoside | n2=en:low or absent prolactin (pl) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent thyroid-stimulating hormone (tsh)
n1=fucoside | n2=en:low or absent thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or absent thyrotropin (tsh)
n1=fucoside | n2=en:low or absent thyrotropin (tsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or low-normal serum t4
n1=fucoside | n2=en:low or low-normal serum t4 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or normal serum calcium
n1=fucoside | n2=en:low or normal serum calcium | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or normal serum erythropoietin
n1=fucoside | n2=en:low or normal serum erythropoietin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or normal serum igm
n1=fucoside | n2=en:low or normal serum igm | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or undetectable c-peptide
n1=fucoside | n2=en:low or undetectable c-peptide | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low or undetectable insulin
n1=fucoside | n2=en:low or undetectable insulin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low plasma arginine
n1=fucoside | n2=en:low plasma arginine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low plasma citrulline
n1=fucoside | n2=en:low plasma citrulline | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low plasma free and total carnitine
n1=fucoside | n2=en:low plasma free and total carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low plasma hdl
n1=fucoside | n2=en:low plasma hdl | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low plasma methionine
n1=fucoside | n2=en:low plasma methionine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low plasma triglyceride level
n1=fucoside | n2=en:low plasma triglyceride level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low plasma tryptophan (inflammatory type b)
n1=fucoside | n2=en:low plasma tryptophan (inflammatory type b) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low procollagen 1 c-peptide (in some patients)
n1=fucoside | n2=en:low procollagen 1 c-peptide (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low pyruvate carboxylase activity in liver and cultured fibroblasts
n1=fucoside | n2=en:low pyruvate carboxylase activity in liver and cultured fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low rai (radioactive iodine) uptake
n1=fucoside | n2=en:low rai (radioactive iodine) uptake | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum acth
n1=fucoside | n2=en:low serum acth | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum alkaline phosphatase in heterozygotes
n1=fucoside | n2=en:low serum alkaline phosphatase in heterozygotes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum alpha-fetoprotein (recessive)
n1=fucoside | n2=en:low serum alpha-fetoprotein (recessive) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum anti-mullerian hormone (amh) levels
n1=fucoside | n2=en:low serum anti-mullerian hormone (amh) levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum calcium
n1=fucoside | n2=en:low serum calcium | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum ceruloplasmin
n1=fucoside | n2=en:low serum ceruloplasmin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum concentration of intercellular adhesion molecule 1 (icam1)
n1=fucoside | n2=en:low serum concentration of intercellular adhesion molecule 1 (icam1) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum cortisol
n1=fucoside | n2=en:low serum cortisol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum igg and iga
n1=fucoside | n2=en:low serum igg and iga | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum levels of branched-chain amino acids
n1=fucoside | n2=en:low serum levels of branched-chain amino acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum levels of ketone bodies
n1=fucoside | n2=en:low serum levels of ketone bodies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum magnesium
n1=fucoside | n2=en:low serum magnesium | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low serum uric acid
n1=fucoside | n2=en:low serum uric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low to absent apo a-i (detroit 107680.0011)
n1=fucoside | n2=en:low to absent apo a-i (detroit 107680.0011) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low to absent high density lipoprotein (hdl) (detroit 107680.0011)
n1=fucoside | n2=en:low to absent high density lipoprotein (hdl) (detroit 107680.0011) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low to low-normal magnesium
n1=fucoside | n2=en:low to low-normal magnesium | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low to normal plasma methionine
n1=fucoside | n2=en:low to normal plasma methionine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low to normal serum calcium
n1=fucoside | n2=en:low to normal serum calcium | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low to normal tsh (values may vary depending on the measurement methods used)
n1=fucoside | n2=en:low to normal tsh (values may vary depending on the measurement methods used) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low to very low hdl cholesterol
n1=fucoside | n2=en:low to very low hdl cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low total serum protein
n1=fucoside | n2=en:low total serum protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low urinary cyclic amp response to pth administration
n1=fucoside | n2=en:low urinary cyclic amp response to pth administration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low urinary excretion of neutral 17-ketosteroids
n1=fucoside | n2=en:low urinary excretion of neutral 17-ketosteroids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low urinary orotic acid
n1=fucoside | n2=en:low urinary orotic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low-molecular-weight proteinuria
n1=fucoside | n2=en:low-molecular-weight proteinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low-normal igm
n1=fucoside | n2=en:low-normal igm | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low-normal platelet count (89-290 x 10(9)/l)
n1=fucoside | n2=en:low-normal platelet count (89-290 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low-to-normal csf lactate
n1=fucoside | n2=en:low-to-normal csf lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:low-to-normal platelet count
n1=fucoside | n2=en:low-to-normal platelet count | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lower total cholesterol
n1=fucoside | n2=en:lower total cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lumbar hyperlordosis
n1=fucoside | n2=en:lumbar hyperlordosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lysine-ketoglutarate reductase deficiency
n1=fucoside | n2=en:lysine-ketoglutarate reductase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lysosomal storage disease
n1=fucoside | n2=en:lysosomal storage disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lysosomal storage diseases, nervous system
n1=fucoside | n2=en:lysosomal storage diseases, nervous system | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lysosomal-like storage vacuoles in various tissues
n1=fucoside | n2=en:lysosomal-like storage vacuoles in various tissues | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lysyl hydroxylase deficiency
n1=fucoside | n2=en:lysyl hydroxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:lysyl pyridinoline/hydroxylysyl pyridinoline (lp/hp) ratio approximately 1
n1=fucoside | n2=en:lysyl pyridinoline/hydroxylysyl pyridinoline (lp/hp) ratio approximately 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:macdermot winter syndrome
n1=fucoside | n2=en:macdermot winter syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:macroglossia
n1=fucoside | n2=en:macroglossia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:macular corneal dystrophy
n1=fucoside | n2=en:macular corneal dystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:majeed syndrome
n1=fucoside | n2=en:majeed syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:majority of patients from italy and southwestern united states
n1=fucoside | n2=en:majority of patients from italy and southwestern united states | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:malonic aciduria
n1=fucoside | n2=en:malonic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mandibuloacral dysplasia with type a lipodystrophy
n1=fucoside | n2=en:mandibuloacral dysplasia with type a lipodystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mannosidase deficiency diseases
n1=fucoside | n2=en:mannosidase deficiency diseases | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mannosidosis
n1=fucoside | n2=en:mannosidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:maple syrup urine disease
n1=fucoside | n2=en:maple syrup urine disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:march myoglobinuria
n1=fucoside | n2=en:march myoglobinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:marked elevation of erythrocyte sedimentation rate
n1=fucoside | n2=en:marked elevation of erythrocyte sedimentation rate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:marked elevation of serum c-reactive protein level (crp 123260)
n1=fucoside | n2=en:marked elevation of serum c-reactive protein level (crp 123260) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:marked hypoalphalipoproteinemia (in some patients)
n1=fucoside | n2=en:marked hypoalphalipoproteinemia (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:marked hypobetalipoproteinemia
n1=fucoside | n2=en:marked hypobetalipoproteinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes)
n1=fucoside | n2=en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3
n1=fucoside | n2=en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:markedly elevated sodium in urine, sweat, saliva, and stool
n1=fucoside | n2=en:markedly elevated sodium in urine, sweat, saliva, and stool | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:markedly increased serum creatine kinase
n1=fucoside | n2=en:markedly increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:markedly reduced iga levels
n1=fucoside | n2=en:markedly reduced iga levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:markedly reduced igg levels
n1=fucoside | n2=en:markedly reduced igg levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:marles greenberg persaud syndrome
n1=fucoside | n2=en:marles greenberg persaud syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:maroteaux-lamy syndrome
n1=fucoside | n2=en:maroteaux-lamy syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:may have increased serum parathyroid hormone (pth)
n1=fucoside | n2=en:may have increased serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mean platelet volume (mpv) 12.6fl
n1=fucoside | n2=en:mean platelet volume (mpv) 12.6fl | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:median mean platelet volume (mpv) 12.5fl
n1=fucoside | n2=en:median mean platelet volume (mpv) 12.5fl | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:median mean platelet volume (mpv) 18fl
n1=fucoside | n2=en:median mean platelet volume (mpv) 18fl | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:median mean platelet volume (mpv) 20fl
n1=fucoside | n2=en:median mean platelet volume (mpv) 20fl | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:median mean platelet volume 13fl
n1=fucoside | n2=en:median mean platelet volume 13fl | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:medium chain dicarboxylic aciduria
n1=fucoside | n2=en:medium chain dicarboxylic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:medium-chain acyl-coa dehydrogenase deficiency
n1=fucoside | n2=en:medium-chain acyl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:megalencephalic leukoencephalopathy with subcortical cysts
n1=fucoside | n2=en:megalencephalic leukoencephalopathy with subcortical cysts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mendelian susceptibility to mycobacterial disease due to complete interferon gamma receptor 1 deficiency
n1=fucoside | n2=en:mendelian susceptibility to mycobacterial disease due to complete interferon gamma receptor 1 deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 receptor beta 1 deficiency
n1=fucoside | n2=en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 receptor beta 1 deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mental retardation
n1=fucoside | n2=en:mental retardation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:metabolic acidosis
n1=fucoside | n2=en:metabolic acidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:metabolic aspects
n1=fucoside | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:metachromasia of white blood cells and fibroblasts
n1=fucoside | n2=en:metachromasia of white blood cells and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:metachromatic deposits (sulfatide-containing) in central and peripheral nervous systems and visceral organs
n1=fucoside | n2=en:metachromatic deposits (sulfatide-containing) in central and peripheral nervous systems and visceral organs | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:metachromatic leukodystrophy
n1=fucoside | n2=en:metachromatic leukodystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:metachromatic leukodystrophy due to saposin b deficiency
n1=fucoside | n2=en:metachromatic leukodystrophy due to saposin b deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methemoglobin concentration 12 to 19%
n1=fucoside | n2=en:methemoglobin concentration 12 to 19% | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methemoglobinemia
n1=fucoside | n2=en:methemoglobinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methionine adenosyltransferase deficiency
n1=fucoside | n2=en:methionine adenosyltransferase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methioninuria
n1=fucoside | n2=en:methioninuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methylcrotonyl-coa carboxylase deficiency
n1=fucoside | n2=en:methylcrotonyl-coa carboxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methylene thf reductase deficiency and homocystinuria
n1=fucoside | n2=en:methylene thf reductase deficiency and homocystinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methylenetetrahydrofolate reductase deficiency
n1=fucoside | n2=en:methylenetetrahydrofolate reductase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methylglutaconic aciduria, mild
n1=fucoside | n2=en:methylglutaconic aciduria, mild | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methylmalonic acidemia
n1=fucoside | n2=en:methylmalonic acidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methylmalonic aciduria
n1=fucoside | n2=en:methylmalonic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methylmalonic aciduria, mild
n1=fucoside | n2=en:methylmalonic aciduria, mild | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methylmalonyl-coenzyme a mutase deficiency
n1=fucoside | n2=en:methylmalonyl-coenzyme a mutase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:methylsuccinic aciduria
n1=fucoside | n2=en:methylsuccinic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microbiological
n1=fucoside | n2=en:microbiological | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microcephalic primordial dwarfism toriello type
n1=fucoside | n2=en:microcephalic primordial dwarfism toriello type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microcephaly cervical spine fusion anomalies
n1=fucoside | n2=en:microcephaly cervical spine fusion anomalies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microcephaly-capillary malformation syndrome
n1=fucoside | n2=en:microcephaly-capillary malformation syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microcephaly, amish type (disorder)
n1=fucoside | n2=en:microcephaly, amish type (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microdeletion 22q11.2
n1=fucoside | n2=en:microdeletion 22q11.2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microdeletion of chromosome 11q13 (43-490kb)
n1=fucoside | n2=en:microdeletion of chromosome 11q13 (43-490kb) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microduplication of chromosome 5p13
n1=fucoside | n2=en:microduplication of chromosome 5p13 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microscopic hematuria
n1=fucoside | n2=en:microscopic hematuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microsomal hmg-coa reductase decreased
n1=fucoside | n2=en:microsomal hmg-coa reductase decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:microtubule disorganization in some cilia
n1=fucoside | n2=en:microtubule disorganization in some cilia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mild elevation of cholesterol
n1=fucoside | n2=en:mild elevation of cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mild elevation of transaminases
n1=fucoside | n2=en:mild elevation of transaminases | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mild elevation of triglycerides
n1=fucoside | n2=en:mild elevation of triglycerides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mild eosinophilia may occur
n1=fucoside | n2=en:mild eosinophilia may occur | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mild hyperammonemia
n1=fucoside | n2=en:mild hyperammonemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mild hypertriglyceridemia
n1=fucoside | n2=en:mild hypertriglyceridemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mild to moderate hyperammonemia
n1=fucoside | n2=en:mild to moderate hyperammonemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mild to moderate thrombocytopenia (40-120 x 10(9)/l)
n1=fucoside | n2=en:mild to moderate thrombocytopenia (40-120 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mild-moderate prolonged bleeding time
n1=fucoside | n2=en:mild-moderate prolonged bleeding time | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly abnormal glycosylation of serum transferrin, type 1 pattern
n1=fucoside | n2=en:mildly abnormal glycosylation of serum transferrin, type 1 pattern | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly decreased phosphaturic response to pth administration has been reported in some cases
n1=fucoside | n2=en:mildly decreased phosphaturic response to pth administration has been reported in some cases | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly decreased serum creatinine
n1=fucoside | n2=en:mildly decreased serum creatinine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly elevated acth
n1=fucoside | n2=en:mildly elevated acth | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly elevated blood ammonia
n1=fucoside | n2=en:mildly elevated blood ammonia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly elevated creatine phosphokinase
n1=fucoside | n2=en:mildly elevated creatine phosphokinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly elevated creatine phosphokinase (cpk) (120270.0002)
n1=fucoside | n2=en:mildly elevated creatine phosphokinase (cpk) (120270.0002) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly elevated hdl in heterozygotes
n1=fucoside | n2=en:mildly elevated hdl in heterozygotes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly elevated hepatic enzymes
n1=fucoside | n2=en:mildly elevated hepatic enzymes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly elevated phosphoethanolamine urinary excretion in heterozygotes
n1=fucoside | n2=en:mildly elevated phosphoethanolamine urinary excretion in heterozygotes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly elevated transaminases
n1=fucoside | n2=en:mildly elevated transaminases | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly elevated urinary mevalonic acid
n1=fucoside | n2=en:mildly elevated urinary mevalonic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly increased serum creatine kinase (in some patients)
n1=fucoside | n2=en:mildly increased serum creatine kinase (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly increased serum lactate
n1=fucoside | n2=en:mildly increased serum lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mildly prolonged bleeding time 10-12 minutes
n1=fucoside | n2=en:mildly prolonged bleeding time 10-12 minutes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:miller-mckusick-malvaux-syndrome (3m syndrome)
n1=fucoside | n2=en:miller-mckusick-malvaux-syndrome (3m syndrome) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitochondria dna deletion
n1=fucoside | n2=en:mitochondria dna deletion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitochondrial complex i deficiency in muscle
n1=fucoside | n2=en:mitochondrial complex i deficiency in muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitochondrial deletions
n1=fucoside | n2=en:mitochondrial deletions | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitochondrial dna depletion syndrome 2 (myopathic type)
n1=fucoside | n2=en:mitochondrial dna depletion syndrome 2 (myopathic type) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitochondrial malic enzyme reduced
n1=fucoside | n2=en:mitochondrial malic enzyme reduced | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitochondrial malonyl-coa decarboxylase activity in fibroblasts is very low (as low as 4%)
n1=fucoside | n2=en:mitochondrial malonyl-coa decarboxylase activity in fibroblasts is very low (as low as 4%) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitochondrial neurogastrointestinal encephalomyopathy syndrome
n1=fucoside | n2=en:mitochondrial neurogastrointestinal encephalomyopathy syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitochondrial respiratory chain defects (skeletal muscle, fibroblasts)
n1=fucoside | n2=en:mitochondrial respiratory chain defects (skeletal muscle, fibroblasts) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy
n1=fucoside | n2=en:mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy (50%) affecting all chromosomes
n1=fucoside | n2=en:mitotic lymphocyte and fibroblast cultures show mosaic variegated aneuploidy (50%) affecting all chromosomes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:moderate steroid 21-hydroxylase deficiency
n1=fucoside | n2=en:moderate steroid 21-hydroxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:moderate to severe thrombocytopenia (30-90 x 10(9)/l)
n1=fucoside | n2=en:moderate to severe thrombocytopenia (30-90 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:moderately decreased to normal phk activity in skeletal muscle
n1=fucoside | n2=en:moderately decreased to normal phk activity in skeletal muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:molybdenum cofactor deficiency
n1=fucoside | n2=en:molybdenum cofactor deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:monoclonal gammopathy
n1=fucoside | n2=en:monoclonal gammopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:monomeric igm
n1=fucoside | n2=en:monomeric igm | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mononuclear cell noncaseating granulomatous inflammation on biopsy (lung, skin, lip)
n1=fucoside | n2=en:mononuclear cell noncaseating granulomatous inflammation on biopsy (lung, skin, lip) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:more than 50% of mitotic cells show premature chromatid separation (pcs) affecting all chromosomes
n1=fucoside | n2=en:more than 50% of mitotic cells show premature chromatid separation (pcs) affecting all chromosomes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:morm syndrome
n1=fucoside | n2=en:morm syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:morquio syndrome
n1=fucoside | n2=en:morquio syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mosaic tetrasomy 12p in skin fibroblasts
n1=fucoside | n2=en:mosaic tetrasomy 12p in skin fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mucolipidosis
n1=fucoside | n2=en:mucolipidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mucolipidosis type iv
n1=fucoside | n2=en:mucolipidosis type iv | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mucopolysaccharidosis
n1=fucoside | n2=en:mucopolysaccharidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mucopolysaccharidosis type i
n1=fucoside | n2=en:mucopolysaccharidosis type i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mucopolysaccharidosis type iiid
n1=fucoside | n2=en:mucopolysaccharidosis type iiid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mucopolysaccharidosis type ix
n1=fucoside | n2=en:mucopolysaccharidosis type ix | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:multi-tailed spermatozoa
n1=fucoside | n2=en:multi-tailed spermatozoa | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:multicentric osteolysis nodulosis arthropathy spectrum
n1=fucoside | n2=en:multicentric osteolysis nodulosis arthropathy spectrum | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:multiple autoantibodies
n1=fucoside | n2=en:multiple autoantibodies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:multiple carboxylase deficiency
n1=fucoside | n2=en:multiple carboxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:multiple organs (lung, liver, spleen, kidney, brain) contain foamy resident cells and histiocytes
n1=fucoside | n2=en:multiple organs (lung, liver, spleen, kidney, brain) contain foamy resident cells and histiocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:multiple sulfatase deficiency disease
n1=fucoside | n2=en:multiple sulfatase deficiency disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:multiple tissue biopsies show lysosomal storage disease
n1=fucoside | n2=en:multiple tissue biopsies show lysosomal storage disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:multiple visceral organs (lung, liver, spleen, kidney) contain foamy resident cells and histiocytes
n1=fucoside | n2=en:multiple visceral organs (lung, liver, spleen, kidney) contain foamy resident cells and histiocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:muscle amp deaminase deficiency
n1=fucoside | n2=en:muscle amp deaminase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:muscle and liver tissue show decreased activities of mitochondrial complexes i, ii, and iii
n1=fucoside | n2=en:muscle and liver tissue show decreased activities of mitochondrial complexes i, ii, and iii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:muscle-eye-brain disease, congenital muscular dystrophy
n1=fucoside | n2=en:muscle-eye-brain disease, congenital muscular dystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:mutant mtdna threonine transfer rna gene (mttt, 590090) of questionable etiology
n1=fucoside | n2=en:mutant mtdna threonine transfer rna gene (mttt, 590090) of questionable etiology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myelin basic protein measurement, spinal fluid
n1=fucoside | n2=en:myelin basic protein measurement, spinal fluid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myeloperoxidase deficiency
n1=fucoside | n2=en:myeloperoxidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myoglobinuria
n1=fucoside | n2=en:myoglobinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myoglobinuria (reported in 1 patient)
n1=fucoside | n2=en:myoglobinuria (reported in 1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myoglobinuria after exertion
n1=fucoside | n2=en:myoglobinuria after exertion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myoglobinuria after exertion (in some patients)
n1=fucoside | n2=en:myoglobinuria after exertion (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myoglobinuria with extreme exertion
n1=fucoside | n2=en:myoglobinuria with extreme exertion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myoglobinuria, particularly after physical exertion (25% of patients)
n1=fucoside | n2=en:myoglobinuria, particularly after physical exertion (25% of patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myopathy with abnormal lipid metabolism
n1=fucoside | n2=en:myopathy with abnormal lipid metabolism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myopathy with exercise intolerance, swedish type
n1=fucoside | n2=en:myopathy with exercise intolerance, swedish type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myopathy with type i fiber atrophy on muscle biopsy
n1=fucoside | n2=en:myopathy with type i fiber atrophy on muscle biopsy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:myopathy, early-onset, with fatal cardiomyopathy
n1=fucoside | n2=en:myopathy, early-onset, with fatal cardiomyopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:n-acetyl-alpha-d-glucosaminidase deficiency in fibroblasts
n1=fucoside | n2=en:n-acetyl-alpha-d-glucosaminidase deficiency in fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:n-acetylgalactosamine-6-sulfatase deficiency in fibroblasts and leukocytes
n1=fucoside | n2=en:n-acetylgalactosamine-6-sulfatase deficiency in fibroblasts and leukocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:n-acetylglutamate synthase deficiency
n1=fucoside | n2=en:n-acetylglutamate synthase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:n-glycosylation defect
n1=fucoside | n2=en:n-glycosylation defect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:nadh cytochrome b5 reductase deficiency
n1=fucoside | n2=en:nadh cytochrome b5 reductase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:nadh dehydrogenase deficiency
n1=fucoside | n2=en:nadh dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:nadh-cytochrome b(5) reductase deficiency
n1=fucoside | n2=en:nadh-cytochrome b(5) reductase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:nathalie syndrome
n1=fucoside | n2=en:nathalie syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:naxos disease
n1=fucoside | n2=en:naxos disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:near-complete absence of vldl peak on density gradient ultracentrifugation (in some patients)
n1=fucoside | n2=en:near-complete absence of vldl peak on density gradient ultracentrifugation (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:negative nitroblue tetrazolium (nbt) reduction test
n1=fucoside | n2=en:negative nitroblue tetrazolium (nbt) reduction test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neonatal hyperbilirubinemia
n1=fucoside | n2=en:neonatal hyperbilirubinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neonatal hypocalcemia
n1=fucoside | n2=en:neonatal hypocalcemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neonatal progeroid syndrome
n1=fucoside | n2=en:neonatal progeroid syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neonatal research network terminology
n1=fucoside | n2=en:neonatal research network terminology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:nephrotic syndrome
n1=fucoside | n2=en:nephrotic syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:netherton syndrome
n1=fucoside | n2=en:netherton syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neuraminidase 1 deficiency
n1=fucoside | n2=en:neuraminidase 1 deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neuraminidase deficiency
n1=fucoside | n2=en:neuraminidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neuraminidase deficiency (white blood cells, fibroblasts, cultured amniotic cells)
n1=fucoside | n2=en:neuraminidase deficiency (white blood cells, fibroblasts, cultured amniotic cells) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neuroacanthocytosis
n1=fucoside | n2=en:neuroacanthocytosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neurodegeneration due to cerebral folate transport deficiency
n1=fucoside | n2=en:neurodegeneration due to cerebral folate transport deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neurodegeneration with brain iron accumulation 4
n1=fucoside | n2=en:neurodegeneration with brain iron accumulation 4 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neurofibrillary tangles and neuritic senile plaques rare
n1=fucoside | n2=en:neurofibrillary tangles and neuritic senile plaques rare | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neuronal ceroid lipofuscinosis
n1=fucoside | n2=en:neuronal ceroid lipofuscinosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neutral hyperaminoaciduria
n1=fucoside | n2=en:neutral hyperaminoaciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neutral lipid storage disease with myopathy
n1=fucoside | n2=en:neutral lipid storage disease with myopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neutropenia
n1=fucoside | n2=en:neutropenia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neutropenia (in 1 patient)
n1=fucoside | n2=en:neutropenia (in 1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:neutrophilia, both basal and during infections
n1=fucoside | n2=en:neutrophilia, both basal and during infections | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:niemann-pick disease
n1=fucoside | n2=en:niemann-pick disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no c8 antigen detected
n1=fucoside | n2=en:no c8 antigen detected | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no cartilage staining with toluidine blue
n1=fucoside | n2=en:no cartilage staining with toluidine blue | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no chromosomal breakage
n1=fucoside | n2=en:no chromosomal breakage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no chromosome breakage
n1=fucoside | n2=en:no chromosome breakage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no dicarboxylic aciduria
n1=fucoside | n2=en:no dicarboxylic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no elevation of free fatty acids
n1=fucoside | n2=en:no elevation of free fatty acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no evidence of common prenatal infections
n1=fucoside | n2=en:no evidence of common prenatal infections | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no evidence of intrauterine infection in mother or newborn
n1=fucoside | n2=en:no evidence of intrauterine infection in mother or newborn | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no evidence of perinatal infection
n1=fucoside | n2=en:no evidence of perinatal infection | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no hematuria
n1=fucoside | n2=en:no hematuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no histochemical evidence of mitochondrial myopathy.
n1=fucoside | n2=en:no histochemical evidence of mitochondrial myopathy. | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no hyperphenylalaninemia
n1=fucoside | n2=en:no hyperphenylalaninemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no hyperuricemia
n1=fucoside | n2=en:no hyperuricemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no increase in urinary cyclic amp (camp) in response to vasopressin or ddavp
n1=fucoside | n2=en:no increase in urinary cyclic amp (camp) in response to vasopressin or ddavp | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no increase of muscle lactate with ischemic exercise testing
n1=fucoside | n2=en:no increase of muscle lactate with ischemic exercise testing | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no increased sensitivity to oxidative species
n1=fucoside | n2=en:no increased sensitivity to oxidative species | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no ketonuria
n1=fucoside | n2=en:no ketonuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no ketosis
n1=fucoside | n2=en:no ketosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no lactic acidosis
n1=fucoside | n2=en:no lactic acidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no metabolic abnormalities
n1=fucoside | n2=en:no metabolic abnormalities | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:no mucopolysacchariduria
n1=fucoside | n2=en:no mucopolysacchariduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:nonaka myopathy
n1=fucoside | n2=en:nonaka myopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:nonketotic hypoglycemia
n1=fucoside | n2=en:nonketotic hypoglycemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal 46,xy karyotype
n1=fucoside | n2=en:normal 46,xy karyotype | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal activity of von willebrand factor-cleaving protease
n1=fucoside | n2=en:normal activity of von willebrand factor-cleaving protease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal aldosterone
n1=fucoside | n2=en:normal aldosterone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal apoa-ii levels in homozygotes
n1=fucoside | n2=en:normal apoa-ii levels in homozygotes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal arterial oxygen saturation
n1=fucoside | n2=en:normal arterial oxygen saturation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal axonal flare response after intradermal histamine injection
n1=fucoside | n2=en:normal axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal b12
n1=fucoside | n2=en:normal b12 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal baseline cortisol
n1=fucoside | n2=en:normal baseline cortisol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal blood lactate
n1=fucoside | n2=en:normal blood lactate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal calcium (female)
n1=fucoside | n2=en:normal calcium (female) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal cd8+/cd4+ ratio
n1=fucoside | n2=en:normal cd8+/cd4+ ratio | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal cerebrospinal fluid
n1=fucoside | n2=en:normal cerebrospinal fluid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal ciliary structure and function
n1=fucoside | n2=en:normal ciliary structure and function | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal collagen type i studies
n1=fucoside | n2=en:normal collagen type i studies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal complex ii activity
n1=fucoside | n2=en:normal complex ii activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal concentration of parathyroid hormone
n1=fucoside | n2=en:normal concentration of parathyroid hormone | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal constitutional karyotype
n1=fucoside | n2=en:normal constitutional karyotype | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal csf 5-hiaa
n1=fucoside | n2=en:normal csf 5-hiaa | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal csf 5-hydroxyindoleacetic acid (5-hiaa)
n1=fucoside | n2=en:normal csf 5-hydroxyindoleacetic acid (5-hiaa) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal csf neurotransmitters
n1=fucoside | n2=en:normal csf neurotransmitters | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal dermal hydroxylysine content
n1=fucoside | n2=en:normal dermal hydroxylysine content | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal ellsworth-howard test, normal urinary camp response to parathyroid hormone (pth) administration
n1=fucoside | n2=en:normal ellsworth-howard test, normal urinary camp response to parathyroid hormone (pth) administration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal endocrinologic studies (growth hormone, somatomedin c, thyroid function)
n1=fucoside | n2=en:normal endocrinologic studies (growth hormone, somatomedin c, thyroid function) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal eosinophil peroxidase activity
n1=fucoside | n2=en:normal eosinophil peroxidase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal erythrocyte gs activity
n1=fucoside | n2=en:normal erythrocyte gs activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal exocrine pancreatic function
n1=fucoside | n2=en:normal exocrine pancreatic function | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal extrarenal responses to ddavp administration
n1=fucoside | n2=en:normal extrarenal responses to ddavp administration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal free urinary cortisol
n1=fucoside | n2=en:normal free urinary cortisol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal g(s)-alpha levels (139320)
n1=fucoside | n2=en:normal g(s)-alpha levels (139320) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal growth hormone responses to arginine, l-dopa, and propranolol stimulation
n1=fucoside | n2=en:normal growth hormone responses to arginine, l-dopa, and propranolol stimulation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal iga levels
n1=fucoside | n2=en:normal iga levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal igg levels
n1=fucoside | n2=en:normal igg levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal igm levels
n1=fucoside | n2=en:normal igm levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal isoelectric focusing of apolipoprotein ciii
n1=fucoside | n2=en:normal isoelectric focusing of apolipoprotein ciii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal isoelectric focusing of serum transferrin
n1=fucoside | n2=en:normal isoelectric focusing of serum transferrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal lactate (hcs)
n1=fucoside | n2=en:normal lactate (hcs) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal leukocyte and platelet counts
n1=fucoside | n2=en:normal leukocyte and platelet counts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal levels of complement factor h, but impaired function
n1=fucoside | n2=en:normal levels of complement factor h, but impaired function | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal liver histology
n1=fucoside | n2=en:normal liver histology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal lysl hydroxylase activity
n1=fucoside | n2=en:normal lysl hydroxylase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal lysosomal hydrolases
n1=fucoside | n2=en:normal lysosomal hydrolases | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal lysyl hydroxylase activity
n1=fucoside | n2=en:normal lysyl hydroxylase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal lysyl oxidase activity
n1=fucoside | n2=en:normal lysyl oxidase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal male karyotype (46,xy)
n1=fucoside | n2=en:normal male karyotype (46,xy) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal maltase, isomaltase, and sucrase activity
n1=fucoside | n2=en:normal maltase, isomaltase, and sucrase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal mitochondrial respiratory chain complex i-v (hcs)
n1=fucoside | n2=en:normal mitochondrial respiratory chain complex i-v (hcs) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal number of t and b lymphocytes
n1=fucoside | n2=en:normal number of t and b lymphocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or decreased serum erythropoietin (epo, 133170)
n1=fucoside | n2=en:normal or decreased serum erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or decreased serum potassium
n1=fucoside | n2=en:normal or decreased serum potassium | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or increased levels of serum arginine vasopressin (antidiuretic hormone, 192340)
n1=fucoside | n2=en:normal or increased levels of serum arginine vasopressin (antidiuretic hormone, 192340) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or increased serum creatine kinase
n1=fucoside | n2=en:normal or increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or increased serum phosphate
n1=fucoside | n2=en:normal or increased serum phosphate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or increased serum phytanic acid
n1=fucoside | n2=en:normal or increased serum phytanic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or increased urinary cyclic amp response to pth administration
n1=fucoside | n2=en:normal or increased urinary cyclic amp response to pth administration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or mildly decreased arylsulfatase a activity
n1=fucoside | n2=en:normal or mildly decreased arylsulfatase a activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or mildly decreased serum levels of free thyroid hormones
n1=fucoside | n2=en:normal or mildly decreased serum levels of free thyroid hormones | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or mildly increased serum creatine kinase
n1=fucoside | n2=en:normal or mildly increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or mildly increased serum gamma-ggt (231950)
n1=fucoside | n2=en:normal or mildly increased serum gamma-ggt (231950) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or mildly increased serum gamma-glutamyltransferase (ggt)
n1=fucoside | n2=en:normal or mildly increased serum gamma-glutamyltransferase (ggt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or mildly increased thyroid-stimulating hormone (tsh)
n1=fucoside | n2=en:normal or mildly increased thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or mildly reduced serum cobalamin
n1=fucoside | n2=en:normal or mildly reduced serum cobalamin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal or mildly reduced sphingomyelinase activity
n1=fucoside | n2=en:normal or mildly reduced sphingomyelinase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal parathyroid hormone (female)
n1=fucoside | n2=en:normal parathyroid hormone (female) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal phytanic acid
n1=fucoside | n2=en:normal phytanic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal plasma and tissue carnitine
n1=fucoside | n2=en:normal plasma and tissue carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal plasma phytanic acid
n1=fucoside | n2=en:normal plasma phytanic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal plasma renin
n1=fucoside | n2=en:normal plasma renin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal plasma total homocysteine
n1=fucoside | n2=en:normal plasma total homocysteine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal platelet aggregation response to arachidonic acid (aa)
n1=fucoside | n2=en:normal platelet aggregation response to arachidonic acid (aa) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal platelet aggregation response to arachidonic acid (aa), adenosine 5'-diphosphate (adp), collagen, and ristocetin
n1=fucoside | n2=en:normal platelet aggregation response to arachidonic acid (aa), adenosine 5'-diphosphate (adp), collagen, and ristocetin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal platelet aggregation response to epinephrine, adp, collagen, and ristocetin
n1=fucoside | n2=en:normal platelet aggregation response to epinephrine, adp, collagen, and ristocetin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal platelet aggregation response to epinephrine, arachidonic acid (aa), adenosine 5'-diphosphate (adp), collagen, and ristocetin
n1=fucoside | n2=en:normal platelet aggregation response to epinephrine, arachidonic acid (aa), adenosine 5'-diphosphate (adp), collagen, and ristocetin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal platelet aggregation studies with adp, collagen, and ristocetin
n1=fucoside | n2=en:normal platelet aggregation studies with adp, collagen, and ristocetin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal platelet aggregation with adp, collagen, epinephrine
n1=fucoside | n2=en:normal platelet aggregation with adp, collagen, epinephrine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal prolyl 4-hydroxylase activity
n1=fucoside | n2=en:normal prolyl 4-hydroxylase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal pyridinoline excretion in urine
n1=fucoside | n2=en:normal pyridinoline excretion in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal red cell counts
n1=fucoside | n2=en:normal red cell counts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal renin level
n1=fucoside | n2=en:normal renin level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal sedimentation rate
n1=fucoside | n2=en:normal sedimentation rate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum 1,25-dihydroxyvitamin d3
n1=fucoside | n2=en:normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum 25-hydroxyvitamin d3
n1=fucoside | n2=en:normal serum 25-hydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum and mucosal iga
n1=fucoside | n2=en:normal serum and mucosal iga | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum bile acids
n1=fucoside | n2=en:normal serum bile acids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum biotin concentration
n1=fucoside | n2=en:normal serum biotin concentration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum cobalamin
n1=fucoside | n2=en:normal serum cobalamin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum cobalamin (vitamin b12)
n1=fucoside | n2=en:normal serum cobalamin (vitamin b12) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum complement levels
n1=fucoside | n2=en:normal serum complement levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum creatine kinase
n1=fucoside | n2=en:normal serum creatine kinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum erythropoietin (epo, 133170)
n1=fucoside | n2=en:normal serum erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum folate levels
n1=fucoside | n2=en:normal serum folate levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum levels of gamma-ggt (231950)
n1=fucoside | n2=en:normal serum levels of gamma-ggt (231950) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum lipoprotein levels
n1=fucoside | n2=en:normal serum lipoprotein levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum liver enzymes
n1=fucoside | n2=en:normal serum liver enzymes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum parathyroid hormone (pth)
n1=fucoside | n2=en:normal serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum phosphorus
n1=fucoside | n2=en:normal serum phosphorus | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum phytanic and pristanic acid
n1=fucoside | n2=en:normal serum phytanic and pristanic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum plasmalogen
n1=fucoside | n2=en:normal serum plasmalogen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal serum transferrin profiles
n1=fucoside | n2=en:normal serum transferrin profiles | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal sweat chloride (3 of 3 patients)
n1=fucoside | n2=en:normal sweat chloride (3 of 3 patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal sweat electrolytes
n1=fucoside | n2=en:normal sweat electrolytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to elevated serum 1,25-dihydroxycholecalciferol (calcitriol)
n1=fucoside | n2=en:normal to elevated serum 1,25-dihydroxycholecalciferol (calcitriol) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to elevated total plasma carnitine
n1=fucoside | n2=en:normal to elevated total plasma carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to increased plasma glycine
n1=fucoside | n2=en:normal to increased plasma glycine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to increased plasma threonine
n1=fucoside | n2=en:normal to increased plasma threonine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to mildly increased mucopolysacchariduria
n1=fucoside | n2=en:normal to mildly increased mucopolysacchariduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to mildly increased serum creatine kinase
n1=fucoside | n2=en:normal to mildly increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to mildly increased serum parathyroid hormone (pth)
n1=fucoside | n2=en:normal to mildly increased serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to prolonged bleeding time
n1=fucoside | n2=en:normal to prolonged bleeding time | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to slightly elevated plasma cholesterol
n1=fucoside | n2=en:normal to slightly elevated plasma cholesterol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal to slightly high alkaline phosphatase
n1=fucoside | n2=en:normal to slightly high alkaline phosphatase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal total urinary coproporphyrin
n1=fucoside | n2=en:normal total urinary coproporphyrin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal transferrin isoelectric profile
n1=fucoside | n2=en:normal transferrin isoelectric profile | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal transferrin saturation
n1=fucoside | n2=en:normal transferrin saturation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal tyrosinase
n1=fucoside | n2=en:normal tyrosinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal urinary 17-ketosteroids
n1=fucoside | n2=en:normal urinary 17-ketosteroids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal urinary cyclic amp response to pth administration
n1=fucoside | n2=en:normal urinary cyclic amp response to pth administration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal urinary orotic acid
n1=fucoside | n2=en:normal urinary orotic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal urinary pterins
n1=fucoside | n2=en:normal urinary pterins | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal-elevated plasma testosterone (male range)
n1=fucoside | n2=en:normal-elevated plasma testosterone (male range) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal-to-decreased plasma glycine (fasting)
n1=fucoside | n2=en:normal-to-decreased plasma glycine (fasting) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normal-to-slightly decreased glcnac phosphotransferase using artificial substrate (e.g., alpha-methylmannoside)
n1=fucoside | n2=en:normal-to-slightly decreased glcnac phosphotransferase using artificial substrate (e.g., alpha-methylmannoside) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:normocalcemia
n1=fucoside | n2=en:normocalcemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:north american indian childhood cirrhosis
n1=fucoside | n2=en:north american indian childhood cirrhosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:northern epilepsy syndrome
n1=fucoside | n2=en:northern epilepsy syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:nursing therapy
n1=fucoside | n2=en:nursing therapy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:nutritional management
n1=fucoside | n2=en:nutritional management | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:occasional hypomagnesemia
n1=fucoside | n2=en:occasional hypomagnesemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:occasionally mild elevation of csf protein
n1=fucoside | n2=en:occasionally mild elevation of csf protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:oculocerebral hypopigmentation syndrome type preus
n1=fucoside | n2=en:oculocerebral hypopigmentation syndrome type preus | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:oculocutaneous albinism type 4
n1=fucoside | n2=en:oculocutaneous albinism type 4 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:odontohypophosphatasia (disorder)
n1=fucoside | n2=en:odontohypophosphatasia (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:oestradiol decreased
n1=fucoside | n2=en:oestradiol decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:often integrated hbv sequences in hepatocellular carcinomas
n1=fucoside | n2=en:often integrated hbv sequences in hepatocellular carcinomas | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:oligospermia or azoospermia
n1=fucoside | n2=en:oligospermia or azoospermia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:organic aciduria
n1=fucoside | n2=en:organic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:organic aciduria (elevated beta-hydroxyisovalerate, beta-methylcrotonylglycine, beta-hydroxypropionate, methylcitrate, lactate, tiglylglycine)
n1=fucoside | n2=en:organic aciduria (elevated beta-hydroxyisovalerate, beta-methylcrotonylglycine, beta-hydroxypropionate, methylcitrate, lactate, tiglylglycine) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:organic aciduria (elevated beta-hydroxyisovalerate, lactate, beta-methylcrotonylglycine, beta-hydroxypropionate, methylcitrate)
n1=fucoside | n2=en:organic aciduria (elevated beta-hydroxyisovalerate, lactate, beta-methylcrotonylglycine, beta-hydroxypropionate, methylcitrate) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:organic aciduria, mild (in some patients)
n1=fucoside | n2=en:organic aciduria, mild (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ornithine carbamoyl phosphate deficiency
n1=fucoside | n2=en:ornithine carbamoyl phosphate deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ornithine-delta-aminotransferase (oat) deficiency
n1=fucoside | n2=en:ornithine-delta-aminotransferase (oat) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:orotic acid crystalluria
n1=fucoside | n2=en:orotic acid crystalluria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:orotic aciduria
n1=fucoside | n2=en:orotic aciduria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:osteocalcin increased
n1=fucoside | n2=en:osteocalcin increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:other cytogenic abnormalities have been associated with dgs phenotype including monosomy 10p13, 11p13, and 4q21
n1=fucoside | n2=en:other cytogenic abnormalities have been associated with dgs phenotype including monosomy 10p13, 11p13, and 4q21 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:other disorders of glycoprotein metabolism
n1=fucoside | n2=en:other disorders of glycoprotein metabolism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:other specified disorders of carbohydrate transport and metabolism
n1=fucoside | n2=en:other specified disorders of carbohydrate transport and metabolism | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:otoonychoperoneal syndrome
n1=fucoside | n2=en:otoonychoperoneal syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:p5c levels increased in urine
n1=fucoside | n2=en:p5c levels increased in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pancreatic triacylglycerol lipase deficiency
n1=fucoside | n2=en:pancreatic triacylglycerol lipase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pancreatic trypsinogen deficiency
n1=fucoside | n2=en:pancreatic trypsinogen deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:panhypogammaglobulinemia
n1=fucoside | n2=en:panhypogammaglobulinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:papillon-lefevre syndrome
n1=fucoside | n2=en:papillon-lefevre syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:paradoxical increase or no change in serum aldosterone and blood pressure after dexamethasone administration
n1=fucoside | n2=en:paradoxical increase or no change in serum aldosterone and blood pressure after dexamethasone administration | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:paradoxical increased cortisol secretion on dexamethasone suppression test
n1=fucoside | n2=en:paradoxical increased cortisol secretion on dexamethasone suppression test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:paraproteinemia
n1=fucoside | n2=en:paraproteinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:parasitology
n1=fucoside | n2=en:parasitology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:parathyroid hormone (pth) absent to low
n1=fucoside | n2=en:parathyroid hormone (pth) absent to low | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:parathyroid hormone level increased
n1=fucoside | n2=en:parathyroid hormone level increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:parathyroid hormone normal
n1=fucoside | n2=en:parathyroid hormone normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:parathyroid hormone-related peptide (pthrp) absent to low
n1=fucoside | n2=en:parathyroid hormone-related peptide (pthrp) absent to low | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:partial deficiency of factor xi (less common)
n1=fucoside | n2=en:partial deficiency of factor xi (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:partial deficiency of factor xi(c)
n1=fucoside | n2=en:partial deficiency of factor xi(c) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:partial deficiency of factor xii(c)
n1=fucoside | n2=en:partial deficiency of factor xii(c) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:partial deficiency of factor xiii (less common)
n1=fucoside | n2=en:partial deficiency of factor xiii (less common) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:partial deficiency of factor xiii(c)
n1=fucoside | n2=en:partial deficiency of factor xiii(c) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:partial deletion of long arm of chromosome 11 (11q23-qter)
n1=fucoside | n2=en:partial deletion of long arm of chromosome 11 (11q23-qter) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:partial terminal deletion of short arm of chromosome 1 (1p36)
n1=fucoside | n2=en:partial terminal deletion of short arm of chromosome 1 (1p36) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pathological aspects
n1=fucoside | n2=en:pathological aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patient cells have increased levels of lmnb1 mrna and protein
n1=fucoside | n2=en:patient cells have increased levels of lmnb1 mrna and protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patient cells show a defect in transcription-coupled and global genome nucleotide excision repair
n1=fucoside | n2=en:patient cells show a defect in transcription-coupled and global genome nucleotide excision repair | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patient cells show abnormal mitochondrial morphology
n1=fucoside | n2=en:patient cells show abnormal mitochondrial morphology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patient cells show defective dna repair in response to irradiation and free radical damage
n1=fucoside | n2=en:patient cells show defective dna repair in response to irradiation and free radical damage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patient cells show defective transcription-coupled and global genome nucleotide excision repair (ner)
n1=fucoside | n2=en:patient cells show defective transcription-coupled and global genome nucleotide excision repair (ner) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patient cells show increased chromosome breakage
n1=fucoside | n2=en:patient cells show increased chromosome breakage | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patient fibroblasts and muscle show decreased activities of mitochondrial complexes i, iii, and iv
n1=fucoside | n2=en:patient fibroblasts and muscle show decreased activities of mitochondrial complexes i, iii, and iv | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patients have supernumerary chromosome - 47,xx(or xy), +der(22), +(11:22)(q23:q11)
n1=fucoside | n2=en:patients have supernumerary chromosome - 47,xx(or xy), +der(22), +(11:22)(q23:q11) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patients with factor xiii alpha subunit deficiency usually also have decreased levels of plasma factor xiii beta subunit
n1=fucoside | n2=en:patients with factor xiii alpha subunit deficiency usually also have decreased levels of plasma factor xiii beta subunit | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:patients with factor xiii beta subunit deficiency usually also have decreased levels of plasma factor xiii alpha subunit
n1=fucoside | n2=en:patients with factor xiii beta subunit deficiency usually also have decreased levels of plasma factor xiii alpha subunit | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pcd shows separate and rod-shaped x chromosomes without discernible centromeres
n1=fucoside | n2=en:pcd shows separate and rod-shaped x chromosomes without discernible centromeres | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pcs involves most of all chromosomes of a metaphase
n1=fucoside | n2=en:pcs involves most of all chromosomes of a metaphase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pcs shows separate and splayed chromatids with discernible centromeres
n1=fucoside | n2=en:pcs shows separate and splayed chromatids with discernible centromeres | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pediatric terminology
n1=fucoside | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:peeling skin syndrome, acral type
n1=fucoside | n2=en:peeling skin syndrome, acral type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pelizaeus merzbacher like disease
n1=fucoside | n2=en:pelizaeus merzbacher like disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pelizaeus-merzbacher disease
n1=fucoside | n2=en:pelizaeus-merzbacher disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pentagastrin stimulation test
n1=fucoside | n2=en:pentagastrin stimulation test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pentosuria
n1=fucoside | n2=en:pentosuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:percentage of bone-derived alkaline phosphatase is >60% in patients versus 40% in healthy adult subjects
n1=fucoside | n2=en:percentage of bone-derived alkaline phosphatase is >60% in patients versus 40% in healthy adult subjects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:peripheral nervous system disorder
n1=fucoside | n2=en:peripheral nervous system disorder | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:peroxisome deficiency
n1=fucoside | n2=en:peroxisome deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:persistent ebv viremia
n1=fucoside | n2=en:persistent ebv viremia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:persistent mullerian duct syndrome
n1=fucoside | n2=en:persistent mullerian duct syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:peters-plus syndrome
n1=fucoside | n2=en:peters-plus syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pharmacotherapeutic
n1=fucoside | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phenylketonuria ii
n1=fucoside | n2=en:phenylketonuria ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphate normal
n1=fucoside | n2=en:phosphate normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphaturia
n1=fucoside | n2=en:phosphaturia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphaturia (in some)
n1=fucoside | n2=en:phosphaturia (in some) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphaturia may disappear after a long period of time
n1=fucoside | n2=en:phosphaturia may disappear after a long period of time | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphoenolpyruvate carboxykinase deficiency
n1=fucoside | n2=en:phosphoenolpyruvate carboxykinase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphoglycerate kinase 1 deficiency
n1=fucoside | n2=en:phosphoglycerate kinase 1 deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phospholipid antibody positive
n1=fucoside | n2=en:phospholipid antibody positive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphomannomutase deficiency in leukocytes, fibroblasts, or liver
n1=fucoside | n2=en:phosphomannomutase deficiency in leukocytes, fibroblasts, or liver | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphomannose isomerase deficiency in leukocytes, fibroblasts, or liver
n1=fucoside | n2=en:phosphomannose isomerase deficiency in leukocytes, fibroblasts, or liver | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphorylase kinase deficiency in liver and muscle
n1=fucoside | n2=en:phosphorylase kinase deficiency in liver and muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phosphorylase kinase normal in muscle
n1=fucoside | n2=en:phosphorylase kinase normal in muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:physiopathological
n1=fucoside | n2=en:physiopathological | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phytanic acid accumulation
n1=fucoside | n2=en:phytanic acid accumulation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:phytanic acid increased
n1=fucoside | n2=en:phytanic acid increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pink urine
n1=fucoside | n2=en:pink urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pipecolic acid accumulation.
n1=fucoside | n2=en:pipecolic acid accumulation. | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pipecolic acidemia
n1=fucoside | n2=en:pipecolic acidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:plasma aldosterone increased
n1=fucoside | n2=en:plasma aldosterone increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:plasma aldosterone normal
n1=fucoside | n2=en:plasma aldosterone normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:plasma ammonia not elevated
n1=fucoside | n2=en:plasma ammonia not elevated | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:plasma catecholamines decreased
n1=fucoside | n2=en:plasma catecholamines decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:plasma protein c deficiency
n1=fucoside | n2=en:plasma protein c deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:plasma triglycerides increased
n1=fucoside | n2=en:plasma triglycerides increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:plasmalogen deficiency
n1=fucoside | n2=en:plasmalogen deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:platelet aggregation decreased
n1=fucoside | n2=en:platelet aggregation decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:platelet antibody positive
n1=fucoside | n2=en:platelet antibody positive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:platelet count normal
n1=fucoside | n2=en:platelet count normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:platelet factor 4 decreased
n1=fucoside | n2=en:platelet factor 4 decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:platelet function test normal
n1=fucoside | n2=en:platelet function test normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:platelet glycoprotein iiia deficiency
n1=fucoside | n2=en:platelet glycoprotein iiia deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:platelets have decreased number of alpha-granules, large vacuoles, normal number of dense bodies on electron microscopy
n1=fucoside | n2=en:platelets have decreased number of alpha-granules, large vacuoles, normal number of dense bodies on electron microscopy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pms excrete 10 to 200 times less metabolite in urine than wildtype (em)
n1=fucoside | n2=en:pms excrete 10 to 200 times less metabolite in urine than wildtype (em) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pms have increased metabolic ratio of unchanged drug-to-metabolite in urine
n1=fucoside | n2=en:pms have increased metabolic ratio of unchanged drug-to-metabolite in urine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pms show decreased levels of hepatic cyp2d6 enzyme
n1=fucoside | n2=en:pms show decreased levels of hepatic cyp2d6 enzyme | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pms show deficient oxidation of debrisoquine
n1=fucoside | n2=en:pms show deficient oxidation of debrisoquine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
n1=fucoside | n2=en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:polycythemia
n1=fucoside | n2=en:polycythemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:polymorphonuclear leukocytosis, episodic
n1=fucoside | n2=en:polymorphonuclear leukocytosis, episodic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:polyploid sperm heads
n1=fucoside | n2=en:polyploid sperm heads | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pontocerebellar hypoplasia type 2
n1=fucoside | n2=en:pontocerebellar hypoplasia type 2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:poor anticoagulant response to exogenous activated protein c as measured by the activated partial thromboplastin time (aptt)
n1=fucoside | n2=en:poor anticoagulant response to exogenous activated protein c as measured by the activated partial thromboplastin time (aptt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:poor mitogenic response to growth factors
n1=fucoside | n2=en:poor mitogenic response to growth factors | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:porphobilinogen synthase deficiency
n1=fucoside | n2=en:porphobilinogen synthase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:positive antinuclear antibody test
n1=fucoside | n2=en:positive antinuclear antibody test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:positive kveim-siltzbach skin test
n1=fucoside | n2=en:positive kveim-siltzbach skin test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:positive urinary bratton-marshall test
n1=fucoside | n2=en:positive urinary bratton-marshall test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:positive urine dnph screening test
n1=fucoside | n2=en:positive urine dnph screening test | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:postprandial hyperglycemia (early in disease course)
n1=fucoside | n2=en:postprandial hyperglycemia (early in disease course) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prader-willi habitus, osteopenia, and camptodactyly
n1=fucoside | n2=en:prader-willi habitus, osteopenia, and camptodactyly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:predominance of the d-stereoisomer
n1=fucoside | n2=en:predominance of the d-stereoisomer | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pregnant mothers of affected children have decreased plasma and urinary estrogen
n1=fucoside | n2=en:pregnant mothers of affected children have decreased plasma and urinary estrogen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:premature centromere division (pcd) of the x chromosome observed in cultured lymphocytes during metaphase
n1=fucoside | n2=en:premature centromere division (pcd) of the x chromosome observed in cultured lymphocytes during metaphase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:premature chromatid separation (pcs) observed in 5% to 50% cultured lymphocytes during metaphase
n1=fucoside | n2=en:premature chromatid separation (pcs) observed in 5% to 50% cultured lymphocytes during metaphase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:premature chromosome condensation
n1=fucoside | n2=en:premature chromosome condensation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:premature separation of centromeric heterochromatin
n1=fucoside | n2=en:premature separation of centromeric heterochromatin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:presence of cytochrome b(-245)
n1=fucoside | n2=en:presence of cytochrome b(-245) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:presence of glial fibrillary acidic proteins (gfap) in astrocytes
n1=fucoside | n2=en:presence of glial fibrillary acidic proteins (gfap) in astrocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:presence of pc mrna
n1=fucoside | n2=en:presence of pc mrna | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:presence of rosenthal fibers (cytoplasmic inclusions) in astrocytes
n1=fucoside | n2=en:presence of rosenthal fibers (cytoplasmic inclusions) in astrocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:presence of serum anti-lu3 antibodies
n1=fucoside | n2=en:presence of serum anti-lu3 antibodies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:presence of the philadelphia chromosome (translocation of 9q34 and 22q11) in greater than 95% of patients
n1=fucoside | n2=en:presence of the philadelphia chromosome (translocation of 9q34 and 22q11) in greater than 95% of patients | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:presence of vacuoles on muscle biopsy
n1=fucoside | n2=en:presence of vacuoles on muscle biopsy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:presentey anomaly
n1=fucoside | n2=en:presentey anomaly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prickle1-related progressive myoclonus epilepsy with ataxia
n1=fucoside | n2=en:prickle1-related progressive myoclonus epilepsy with ataxia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:primary hyperoxaluria
n1=fucoside | n2=en:primary hyperoxaluria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:primary immunoglobulin-related amyloidosis (al)
n1=fucoside | n2=en:primary immunoglobulin-related amyloidosis (al) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:progressive thickening of diploic spaces
n1=fucoside | n2=en:progressive thickening of diploic spaces | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolidase deficiency
n1=fucoside | n2=en:prolidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolinuria
n1=fucoside | n2=en:prolinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolonged activated partial prothrombin time (appt)
n1=fucoside | n2=en:prolonged activated partial prothrombin time (appt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolonged activated partial thromboplastin time (aptt)
n1=fucoside | n2=en:prolonged activated partial thromboplastin time (aptt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolonged bleeding time
n1=fucoside | n2=en:prolonged bleeding time | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolonged bleeding time (10 - >30 minutes)
n1=fucoside | n2=en:prolonged bleeding time (10 - >30 minutes) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolonged electroretinal response suppression
n1=fucoside | n2=en:prolonged electroretinal response suppression | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolonged partial thromboplastin time
n1=fucoside | n2=en:prolonged partial thromboplastin time | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolonged partial thromboplastin time (ptt)
n1=fucoside | n2=en:prolonged partial thromboplastin time (ptt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolonged prothrombin and partial thromboplastin times
n1=fucoside | n2=en:prolonged prothrombin and partial thromboplastin times | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prolonged prothrombin time (pt)
n1=fucoside | n2=en:prolonged prothrombin time (pt) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prominent forehead
n1=fucoside | n2=en:prominent forehead | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prominent leukocytosis (30,000/ml)
n1=fucoside | n2=en:prominent leukocytosis (30,000/ml) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:proper antibody response to protein vaccinations
n1=fucoside | n2=en:proper antibody response to protein vaccinations | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:propionic acidemia
n1=fucoside | n2=en:propionic acidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:protein c decreased
n1=fucoside | n2=en:protein c decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:protein total decreased
n1=fucoside | n2=en:protein total decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:protein urine absent
n1=fucoside | n2=en:protein urine absent | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:proteinuria
n1=fucoside | n2=en:proteinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:proteinuria (type ii, congenital)
n1=fucoside | n2=en:proteinuria (type ii, congenital) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:proteinuria in those with cystic kidneys
n1=fucoside | n2=en:proteinuria in those with cystic kidneys | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prothrombin time increased
n1=fucoside | n2=en:prothrombin time increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:prothrombin time low
n1=fucoside | n2=en:prothrombin time low | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pseudo-hurler polydystrophy
n1=fucoside | n2=en:pseudo-hurler polydystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pseudocholinesterase deficiency
n1=fucoside | n2=en:pseudocholinesterase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pseudohyperkalemia, due to ex vivo efflux of potassium from red cells (in some patients)
n1=fucoside | n2=en:pseudohyperkalemia, due to ex vivo efflux of potassium from red cells (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pseudohypertriglyceridemia in adult form
n1=fucoside | n2=en:pseudohypertriglyceridemia in adult form | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pseudohypoaldosteronism, type 1, recessive form
n1=fucoside | n2=en:pseudohypoaldosteronism, type 1, recessive form | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pseudotrisomy 13 syndrome
n1=fucoside | n2=en:pseudotrisomy 13 syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:psychology qualifier
n1=fucoside | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pt normal
n1=fucoside | n2=en:pt normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pulmonary lipid storage disease
n1=fucoside | n2=en:pulmonary lipid storage disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:purine-nucleoside phosphorylase deficiency
n1=fucoside | n2=en:purine-nucleoside phosphorylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pycnodysostosis
n1=fucoside | n2=en:pycnodysostosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pyle metaphyseal dysplasia
n1=fucoside | n2=en:pyle metaphyseal dysplasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pyogenic bacterial infection due to deficiency of myeloid differentiation primary response 88
n1=fucoside | n2=en:pyogenic bacterial infection due to deficiency of myeloid differentiation primary response 88 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pyrimidinuria
n1=fucoside | n2=en:pyrimidinuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pyruvate carboxylase deficiency
n1=fucoside | n2=en:pyruvate carboxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pyruvate dehydrogenase deficiency
n1=fucoside | n2=en:pyruvate dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pyruvate kinase deficiency
n1=fucoside | n2=en:pyruvate kinase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pyruvate metabolism, inborn errors
n1=fucoside | n2=en:pyruvate metabolism, inborn errors | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pyruvate-induced insulin secretion
n1=fucoside | n2=en:pyruvate-induced insulin secretion | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:pyruvic acidemia
n1=fucoside | n2=en:pyruvic acidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:radiotherapeutic
n1=fucoside | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:raised c-reactive protein
n1=fucoside | n2=en:raised c-reactive protein | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:raised tsh level
n1=fucoside | n2=en:raised tsh level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rapadilino syndrome
n1=fucoside | n2=en:rapadilino syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rapid high rai (radioactive iodine) uptake and turnover
n1=fucoside | n2=en:rapid high rai (radioactive iodine) uptake and turnover | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rapid radioactive iodide (rai) discharge after thiocyanate or perchlorate
n1=fucoside | n2=en:rapid radioactive iodide (rai) discharge after thiocyanate or perchlorate | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rare occurrences of 9+0 or 8+1 cilia
n1=fucoside | n2=en:rare occurrences of 9+0 or 8+1 cilia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reactive hypoglycemia
n1=fucoside | n2=en:reactive hypoglycemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reardon hall slaney syndrome
n1=fucoside | n2=en:reardon hall slaney syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rectilinear intracellular accumulation of autofluorescent lipopigment storage material
n1=fucoside | n2=en:rectilinear intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:recurrent respiratory infections
n1=fucoside | n2=en:recurrent respiratory infections | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:recurring t(11,14) and t(14,19)(q32,q13.1) translocations
n1=fucoside | n2=en:recurring t(11,14) and t(14,19)(q32,q13.1) translocations | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced (50%) activity of protoporphyrinogen oxidase (proto oxidase)
n1=fucoside | n2=en:reduced (50%) activity of protoporphyrinogen oxidase (proto oxidase) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced aspartoacylase activity in cultured skin fibroblasts
n1=fucoside | n2=en:reduced aspartoacylase activity in cultured skin fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced beating amplitudes in cilia
n1=fucoside | n2=en:reduced beating amplitudes in cilia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced bending capacity of cilia
n1=fucoside | n2=en:reduced bending capacity of cilia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced cd4+ count and proportionally increased cd8+ count
n1=fucoside | n2=en:reduced cd4+ count and proportionally increased cd8+ count | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced cytosolic superoxide dismutase-1 (sod1)
n1=fucoside | n2=en:reduced cytosolic superoxide dismutase-1 (sod1) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced electroretinogram (scotopic > photopic) becoming extinguished in older patients
n1=fucoside | n2=en:reduced electroretinogram (scotopic > photopic) becoming extinguished in older patients | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced erythrocyte adenosine deaminase activity
n1=fucoside | n2=en:reduced erythrocyte adenosine deaminase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced erythrocyte glucose/hexose transport
n1=fucoside | n2=en:reduced erythrocyte glucose/hexose transport | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced erythrocyte gs activity
n1=fucoside | n2=en:reduced erythrocyte gs activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced erythrocyte purine nucleoside phosphorylase activity
n1=fucoside | n2=en:reduced erythrocyte purine nucleoside phosphorylase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced ferrochelatase activity
n1=fucoside | n2=en:reduced ferrochelatase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced iga
n1=fucoside | n2=en:reduced iga | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced ige levels
n1=fucoside | n2=en:reduced ige levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced igg levels, particularly igg2 subclass
n1=fucoside | n2=en:reduced igg levels, particularly igg2 subclass | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced liver and red cell uroporphyrinogen decarboxylase (uro decarboxylase)
n1=fucoside | n2=en:reduced liver and red cell uroporphyrinogen decarboxylase (uro decarboxylase) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced oxygen affinity (e.g. hb thionville 141800.0168)
n1=fucoside | n2=en:reduced oxygen affinity (e.g. hb thionville 141800.0168) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced platelet aggregation response to adp, collagen, epinephrine
n1=fucoside | n2=en:reduced platelet aggregation response to adp, collagen, epinephrine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced platelet aggregation response to collagen and thrombin
n1=fucoside | n2=en:reduced platelet aggregation response to collagen and thrombin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced platelet glycoprotein ib complex
n1=fucoside | n2=en:reduced platelet glycoprotein ib complex | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced serum uric acid
n1=fucoside | n2=en:reduced serum uric acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced total and free carnitine in plasma and tissue
n1=fucoside | n2=en:reduced total and free carnitine in plasma and tissue | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reduced unsaturated serum cobalamin binding capacity
n1=fucoside | n2=en:reduced unsaturated serum cobalamin binding capacity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reductase deficiency
n1=fucoside | n2=en:reductase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:refsum disease
n1=fucoside | n2=en:refsum disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rehabilitation aspects
n1=fucoside | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:relatively low urinary pge-m levels
n1=fucoside | n2=en:relatively low urinary pge-m levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:renal tubulopathy with encephalopathy and liver failure syndrome
n1=fucoside | n2=en:renal tubulopathy with encephalopathy and liver failure syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:renin decreased
n1=fucoside | n2=en:renin decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:resistance to 1,25-dihydroxyvitamin d3
n1=fucoside | n2=en:resistance to 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:resistance to activated protein c due to factor v leiden
n1=fucoside | n2=en:resistance to activated protein c due to factor v leiden | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:respiratory cilia and sperm flagella show reduced coordination of beating activity
n1=fucoside | n2=en:respiratory cilia and sperm flagella show reduced coordination of beating activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:respiratory epithelial show lack of ciliary movement or abnormal movement
n1=fucoside | n2=en:respiratory epithelial show lack of ciliary movement or abnormal movement | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reticulocyte count increased
n1=fucoside | n2=en:reticulocyte count increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:reticulocytosis
n1=fucoside | n2=en:reticulocytosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:retinal dystrophy in cerebroretinal lipidosis
n1=fucoside | n2=en:retinal dystrophy in cerebroretinal lipidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:retinal dystrophy in systemic lipidosis
n1=fucoside | n2=en:retinal dystrophy in systemic lipidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:retinitis punctata albescens (disorder)
n1=fucoside | n2=en:retinitis punctata albescens (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rhabdomyolysis in response to alcohol
n1=fucoside | n2=en:rhabdomyolysis in response to alcohol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rheumatoid factor negative
n1=fucoside | n2=en:rheumatoid factor negative | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rheumatoid factor positive (finding)
n1=fucoside | n2=en:rheumatoid factor positive (finding) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ribose 5-phosphate isomerase deficiency
n1=fucoside | n2=en:ribose 5-phosphate isomerase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:richards-rundle syndrome
n1=fucoside | n2=en:richards-rundle syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rna polymerase iii-related leukodystrophy
n1=fucoside | n2=en:rna polymerase iii-related leukodystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:roentgenographic
n1=fucoside | n2=en:roentgenographic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:round, yellow-brown dha urine crystals
n1=fucoside | n2=en:round, yellow-brown dha urine crystals | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:rounded and heavy facial features
n1=fucoside | n2=en:rounded and heavy facial features | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:routine liver function tests normal
n1=fucoside | n2=en:routine liver function tests normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:russell's viper venom assay may be prolonged or normal, depending on the genetic defect
n1=fucoside | n2=en:russell's viper venom assay may be prolonged or normal, depending on the genetic defect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:saccharopine dehydrogenase deficiency
n1=fucoside | n2=en:saccharopine dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:saito kuba tsuruta syndrome
n1=fucoside | n2=en:saito kuba tsuruta syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sandhoff disease
n1=fucoside | n2=en:sandhoff disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sanfilippo syndrome
n1=fucoside | n2=en:sanfilippo syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:saposin a deficiency (finding)
n1=fucoside | n2=en:saposin a deficiency (finding) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sarcosinemia
n1=fucoside | n2=en:sarcosinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sce normal in heterozygotes
n1=fucoside | n2=en:sce normal in heterozygotes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:scheie syndrome
n1=fucoside | n2=en:scheie syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:schindler disease, type i
n1=fucoside | n2=en:schindler disease, type i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:schirmer test shows alacrima
n1=fucoside | n2=en:schirmer test shows alacrima | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:scoliosis
n1=fucoside | n2=en:scoliosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:secondary decrease of plasma free carnitine
n1=fucoside | n2=en:secondary decrease of plasma free carnitine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:secondary decreased activity of argininosuccinate synthetase (ass1)
n1=fucoside | n2=en:secondary decreased activity of argininosuccinate synthetase (ass1) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:secondary decreases in complex i and iv activity
n1=fucoside | n2=en:secondary decreases in complex i and iv activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:seizure
n1=fucoside | n2=en:seizure | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
n1=fucoside | n2=en:sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sepiapterin reductase deficiency (fibroblasts)
n1=fucoside | n2=en:sepiapterin reductase deficiency (fibroblasts) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum acid phosphatase normal
n1=fucoside | n2=en:serum acid phosphatase normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum acylcarnitine returns to borderline high or normal after resolution of fever
n1=fucoside | n2=en:serum acylcarnitine returns to borderline high or normal after resolution of fever | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum albumin low result
n1=fucoside | n2=en:serum albumin low result | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum aldosterone elevated
n1=fucoside | n2=en:serum aldosterone elevated | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum alkaline phosphatase normal or mildly increased
n1=fucoside | n2=en:serum alkaline phosphatase normal or mildly increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum alpha-1-antitrypsin (pi) deficiency
n1=fucoside | n2=en:serum alpha-1-antitrypsin (pi) deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum ammonia increased
n1=fucoside | n2=en:serum ammonia increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum and csf lactate may be increased
n1=fucoside | n2=en:serum and csf lactate may be increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum bicarbonate increased
n1=fucoside | n2=en:serum bicarbonate increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum bilirubin increased
n1=fucoside | n2=en:serum bilirubin increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum c-peptide and glucagon levels measurable
n1=fucoside | n2=en:serum c-peptide and glucagon levels measurable | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum c-reactive protein may be increased
n1=fucoside | n2=en:serum c-reactive protein may be increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum calcitonin, increased
n1=fucoside | n2=en:serum calcitonin, increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum calcium elevated
n1=fucoside | n2=en:serum calcium elevated | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum calcium normal
n1=fucoside | n2=en:serum calcium normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum carnitine deficiency
n1=fucoside | n2=en:serum carnitine deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum chloride level decreased (finding)
n1=fucoside | n2=en:serum chloride level decreased (finding) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum cholesterol low or normal
n1=fucoside | n2=en:serum cholesterol low or normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum cholesterol normal
n1=fucoside | n2=en:serum cholesterol normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum cholesterol raised
n1=fucoside | n2=en:serum cholesterol raised | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum complement decreased
n1=fucoside | n2=en:serum complement decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum copper decreased
n1=fucoside | n2=en:serum copper decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum corticosterone increased
n1=fucoside | n2=en:serum corticosterone increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum cortisol decreased
n1=fucoside | n2=en:serum cortisol decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum cortisol elevated
n1=fucoside | n2=en:serum cortisol elevated | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum creatine kinase 20-70 times normal
n1=fucoside | n2=en:serum creatine kinase 20-70 times normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum creatine kinase may be increased
n1=fucoside | n2=en:serum creatine kinase may be increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum creatine kinase may be normal
n1=fucoside | n2=en:serum creatine kinase may be normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum creatine kinase may be normal or elevated
n1=fucoside | n2=en:serum creatine kinase may be normal or elevated | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum creatine kinase may be normal or increased
n1=fucoside | n2=en:serum creatine kinase may be normal or increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum creatinine raised
n1=fucoside | n2=en:serum creatinine raised | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum ferritin hyperglycosylation
n1=fucoside | n2=en:serum ferritin hyperglycosylation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum ferritin normal
n1=fucoside | n2=en:serum ferritin normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum folate low
n1=fucoside | n2=en:serum folate low | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum folate normal
n1=fucoside | n2=en:serum folate normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum gastrin increased
n1=fucoside | n2=en:serum gastrin increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum growth hormone increased
n1=fucoside | n2=en:serum growth hormone increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum homocysteine normal
n1=fucoside | n2=en:serum homocysteine normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum iron low (finding)
n1=fucoside | n2=en:serum iron low (finding) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum iron normal
n1=fucoside | n2=en:serum iron normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum iron raised
n1=fucoside | n2=en:serum iron raised | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum lactate is usually normal
n1=fucoside | n2=en:serum lactate is usually normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum lactate may be increased during encephalopathic exacerbations
n1=fucoside | n2=en:serum lactate may be increased during encephalopathic exacerbations | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum mitochondrial autoantibodies
n1=fucoside | n2=en:serum mitochondrial autoantibodies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum osmolality decreased
n1=fucoside | n2=en:serum osmolality decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum phosphate concentration below normal
n1=fucoside | n2=en:serum phosphate concentration below normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum phosphate normal
n1=fucoside | n2=en:serum phosphate normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum pristanic acid increased
n1=fucoside | n2=en:serum pristanic acid increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum prolactin decreased
n1=fucoside | n2=en:serum prolactin decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum prolactin increased
n1=fucoside | n2=en:serum prolactin increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum testosterone decreased
n1=fucoside | n2=en:serum testosterone decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum testosterone level normal
n1=fucoside | n2=en:serum testosterone level normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum thiamine is normal
n1=fucoside | n2=en:serum thiamine is normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum thyroxine may be decreased or normal
n1=fucoside | n2=en:serum thyroxine may be decreased or normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum transaminase increased
n1=fucoside | n2=en:serum transaminase increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum transferrin glycosylation is normal
n1=fucoside | n2=en:serum transferrin glycosylation is normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum transferrin isoelectric focusing shows type 2 pattern
n1=fucoside | n2=en:serum transferrin isoelectric focusing shows type 2 pattern | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum transferrin shows normal or mild hypo-glycosylation
n1=fucoside | n2=en:serum transferrin shows normal or mild hypo-glycosylation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum triglycerides increased
n1=fucoside | n2=en:serum triglycerides increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:serum triglycerides normal
n1=fucoside | n2=en:serum triglycerides normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severe amyloid angiopathy
n1=fucoside | n2=en:severe amyloid angiopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severe early childhood onset retinal dystrophy
n1=fucoside | n2=en:severe early childhood onset retinal dystrophy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severe hypernatremia in neonatal period
n1=fucoside | n2=en:severe hypernatremia in neonatal period | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severe steroid 21-hydroxylase deficiency
n1=fucoside | n2=en:severe steroid 21-hydroxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severe thrombocytopenia (30-60 x 10(9)/l)
n1=fucoside | n2=en:severe thrombocytopenia (30-60 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severely decreased activity of beta-1,4-mannosyltransferase (less than 10% of normal)
n1=fucoside | n2=en:severely decreased activity of beta-1,4-mannosyltransferase (less than 10% of normal) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severely decreased antigen levels of vwf and factor viii
n1=fucoside | n2=en:severely decreased antigen levels of vwf and factor viii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severely decreased carnitine palmitoyltransferase ii (cpt ii) activity (less than 10% of normal) in multiple tissues
n1=fucoside | n2=en:severely decreased carnitine palmitoyltransferase ii (cpt ii) activity (less than 10% of normal) in multiple tissues | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severely decreased palmitate oxidation
n1=fucoside | n2=en:severely decreased palmitate oxidation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:severely impaired ciliary motility
n1=fucoside | n2=en:severely impaired ciliary motility | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:short odontoid
n1=fucoside | n2=en:short odontoid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:short stature
n1=fucoside | n2=en:short stature | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:shortened metaphase
n1=fucoside | n2=en:shortened metaphase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:shortened telomeres (1 patient)
n1=fucoside | n2=en:shortened telomeres (1 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:shortened telomeres (classic feature, nola3 patient)
n1=fucoside | n2=en:shortened telomeres (classic feature, nola3 patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:shortened telomeres (in 1 of 2 patients)
n1=fucoside | n2=en:shortened telomeres (in 1 of 2 patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sialic acid storage disease
n1=fucoside | n2=en:sialic acid storage disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sialic acid storage disease, finnish type (disorder)
n1=fucoside | n2=en:sialic acid storage disease, finnish type (disorder) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sialic storage disease
n1=fucoside | n2=en:sialic storage disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sialylation defects
n1=fucoside | n2=en:sialylation defects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sinus histiocytosis with massive lymphadenopathy
n1=fucoside | n2=en:sinus histiocytosis with massive lymphadenopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sitosterolemia with xanthomatosis
n1=fucoside | n2=en:sitosterolemia with xanthomatosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sjogren-larsson syndrome
n1=fucoside | n2=en:sjogren-larsson syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:skeletal muscle shows decreased activities of mitochondrial respiratory complexes i, iii, iv, and v
n1=fucoside | n2=en:skeletal muscle shows decreased activities of mitochondrial respiratory complexes i, iii, iv, and v | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:skewed x-inactivation in females
n1=fucoside | n2=en:skewed x-inactivation in females | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:skin fibroblasts contain cytoplasmic membrane-bound granular inclusions
n1=fucoside | n2=en:skin fibroblasts contain cytoplasmic membrane-bound granular inclusions | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:slightly elevated 24-hour mean plasma cortisol
n1=fucoside | n2=en:slightly elevated 24-hour mean plasma cortisol | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:slightly increased serum alkaline phosphatase may occur
n1=fucoside | n2=en:slightly increased serum alkaline phosphatase may occur | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sly syndrome
n1=fucoside | n2=en:sly syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:small fifth lumbar vertebrae
n1=fucoside | n2=en:small fifth lumbar vertebrae | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:smith-mccort dysplasia
n1=fucoside | n2=en:smith-mccort dysplasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:smooth muscle antibodies positive
n1=fucoside | n2=en:smooth muscle antibodies positive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:some cilia show abnormal beating patterns or immotility
n1=fucoside | n2=en:some cilia show abnormal beating patterns or immotility | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:some cilia show central complex and radial spoke defects
n1=fucoside | n2=en:some cilia show central complex and radial spoke defects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:some fragmented or disrupted golgi
n1=fucoside | n2=en:some fragmented or disrupted golgi | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:some increase in monosialo- and trisialotransferrin (type 1/2 pattern)
n1=fucoside | n2=en:some increase in monosialo- and trisialotransferrin (type 1/2 pattern) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:some patients carry a deletion of minimum of 8.1 mb on 2q32-q33
n1=fucoside | n2=en:some patients carry a deletion of minimum of 8.1 mb on 2q32-q33 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:some tissues may have normal levels of 3-hydroxyacyl-coa dehydrogenase activity
n1=fucoside | n2=en:some tissues may have normal levels of 3-hydroxyacyl-coa dehydrogenase activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sonoda syndrome
n1=fucoside | n2=en:sonoda syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spastic ataxia, charlevoix-saguenay type
n1=fucoside | n2=en:spastic ataxia, charlevoix-saguenay type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spastic paraplegia 15, autosomal recessive
n1=fucoside | n2=en:spastic paraplegia 15, autosomal recessive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spastic quadriplegia
n1=fucoside | n2=en:spastic quadriplegia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spatulate ribs
n1=fucoside | n2=en:spatulate ribs | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:specific enzyme deficiency
n1=fucoside | n2=en:specific enzyme deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sphingolipidosis
n1=fucoside | n2=en:sphingolipidosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spinal muscular atrophy with respiratory distress 1
n1=fucoside | n2=en:spinal muscular atrophy with respiratory distress 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spinocerebellar ataxia with epilepsy
n1=fucoside | n2=en:spinocerebellar ataxia with epilepsy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spinocerebellar ataxia, autosomal recessive 2
n1=fucoside | n2=en:spinocerebellar ataxia, autosomal recessive 2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:splenomegaly
n1=fucoside | n2=en:splenomegaly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spondylo-ocular syndrome
n1=fucoside | n2=en:spondylo-ocular syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spondylocarpotarsal synostosis syndrome
n1=fucoside | n2=en:spondylocarpotarsal synostosis syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spondyloenchondrodysplasia
n1=fucoside | n2=en:spondyloenchondrodysplasia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spondyloenchondrodysplasia with immune dysregulation
n1=fucoside | n2=en:spondyloenchondrodysplasia with immune dysregulation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spondyloepiphyseal dysplasia tarda, toledo type
n1=fucoside | n2=en:spondyloepiphyseal dysplasia tarda, toledo type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spondyloepiphyseal dysplasia, omani type
n1=fucoside | n2=en:spondyloepiphyseal dysplasia, omani type | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:spongy degeneration of brain on histology
n1=fucoside | n2=en:spongy degeneration of brain on histology | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:steroid 21-monooxygenase deficiency
n1=fucoside | n2=en:steroid 21-monooxygenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sterol 27-hydroxylase deficiency
n1=fucoside | n2=en:sterol 27-hydroxylase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:stimulation of sympathetic fibers results in release of dopamine, not norepinephrine
n1=fucoside | n2=en:stimulation of sympathetic fibers results in release of dopamine, not norepinephrine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:structural abnormalities seen on chromosome analysis
n1=fucoside | n2=en:structural abnormalities seen on chromosome analysis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:subepithelial fibrin deposition with inflammation (pseudomembranous inflammation) of mucosal tissues
n1=fucoside | n2=en:subepithelial fibrin deposition with inflammation (pseudomembranous inflammation) of mucosal tissues | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:submucosal macrophages filled with sphingolipids
n1=fucoside | n2=en:submucosal macrophages filled with sphingolipids | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:subsarcolemmal pleomorphic mitochondria on em
n1=fucoside | n2=en:subsarcolemmal pleomorphic mitochondria on em | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:subtelomeric deletion of chromosome 16p
n1=fucoside | n2=en:subtelomeric deletion of chromosome 16p | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:subtelomeric deletion of long arm of chromosome 3 (3q29)
n1=fucoside | n2=en:subtelomeric deletion of long arm of chromosome 3 (3q29) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:succinate-coa ligase deficiency
n1=fucoside | n2=en:succinate-coa ligase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:succinic semialdehyde dehydrogenase deficiency
n1=fucoside | n2=en:succinic semialdehyde dehydrogenase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sudden infant death with dysgenesis of the testes syndrome
n1=fucoside | n2=en:sudden infant death with dysgenesis of the testes syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sulfite oxidase deficiency
n1=fucoside | n2=en:sulfite oxidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:surgical aspects
n1=fucoside | n2=en:surgical aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:sweat test normal
n1=fucoside | n2=en:sweat test normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:syndrome of apparent mineralocorticoid excess
n1=fucoside | n2=en:syndrome of apparent mineralocorticoid excess | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:systemic accumulation of very long chain fatty acids (vlcfa)
n1=fucoside | n2=en:systemic accumulation of very long chain fatty acids (vlcfa) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:systemic amyloidosis may occur
n1=fucoside | n2=en:systemic amyloidosis may occur | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:t cells may be increased or decreased
n1=fucoside | n2=en:t cells may be increased or decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:t-cell deficit
n1=fucoside | n2=en:t-cell deficit | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:t-lymphocytopenia
n1=fucoside | n2=en:t-lymphocytopenia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:t1 transport protein (glucose-6-phosphate translocase) defect
n1=fucoside | n2=en:t1 transport protein (glucose-6-phosphate translocase) defect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:taxonomic
n1=fucoside | n2=en:taxonomic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tay-sachs disease
n1=fucoside | n2=en:tay-sachs disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:telomere shortening
n1=fucoside | n2=en:telomere shortening | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ten percent of cases are secondary to submicroscopic deletions of 16p13.3 detectable by fish
n1=fucoside | n2=en:ten percent of cases are secondary to submicroscopic deletions of 16p13.3 detectable by fish | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tenascin x deficiency (serum and fibroblasts)
n1=fucoside | n2=en:tenascin x deficiency (serum and fibroblasts) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tetra-amelia autosomal recessive
n1=fucoside | n2=en:tetra-amelia autosomal recessive | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:therapeutic aspects
n1=fucoside | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thick vermilion border
n1=fucoside | n2=en:thick vermilion border | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thin, dry skin
n1=fucoside | n2=en:thin, dry skin | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thomas syndrome
n1=fucoside | n2=en:thomas syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thrombocytopenia
n1=fucoside | n2=en:thrombocytopenia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thrombocytopenia (33-120 x 10(9)/l)
n1=fucoside | n2=en:thrombocytopenia (33-120 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thrombocytopenia, mild-moderate (60-100 x 10(9)/l)
n1=fucoside | n2=en:thrombocytopenia, mild-moderate (60-100 x 10(9)/l) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thrombocytosis (in some patients)
n1=fucoside | n2=en:thrombocytosis (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thymic hormone decreased
n1=fucoside | n2=en:thymic hormone decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thyroid dyshormonogenesis 3
n1=fucoside | n2=en:thyroid dyshormonogenesis 3 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thyroid dyshormonogenesis 4
n1=fucoside | n2=en:thyroid dyshormonogenesis 4 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thyroid dyshormonogenesis 5
n1=fucoside | n2=en:thyroid dyshormonogenesis 5 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thyroid hormone organification defect
n1=fucoside | n2=en:thyroid hormone organification defect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thyroid hormones increased
n1=fucoside | n2=en:thyroid hormones increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thyroid peroxidase defect
n1=fucoside | n2=en:thyroid peroxidase defect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:thyroid peroxidase deficiency
n1=fucoside | n2=en:thyroid peroxidase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tmem70 related mitochondrial encephalo-cardio-myopathy
n1=fucoside | n2=en:tmem70 related mitochondrial encephalo-cardio-myopathy | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tonofibril defect (cross-beta-protein structure)
n1=fucoside | n2=en:tonofibril defect (cross-beta-protein structure) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tortuosity of conjunctival vessels
n1=fucoside | n2=en:tortuosity of conjunctival vessels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transaminitis
n1=fucoside | n2=en:transaminitis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transcobalamin ii deficiency
n1=fucoside | n2=en:transcobalamin ii deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transferase deficiency galactosemia
n1=fucoside | n2=en:transferase deficiency galactosemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transferrin saturation increased
n1=fucoside | n2=en:transferrin saturation increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transient eosinophilia in first decade
n1=fucoside | n2=en:transient eosinophilia in first decade | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transient hyperlipidemia
n1=fucoside | n2=en:transient hyperlipidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transient hyperphenylalaninemia occurs on oral loading test with phenylalanine
n1=fucoside | n2=en:transient hyperphenylalaninemia occurs on oral loading test with phenylalanine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transient neonatal hypocalcemia (2p21del)
n1=fucoside | n2=en:transient neonatal hypocalcemia (2p21del) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transient neonatal hypoglycemia (2p21del)
n1=fucoside | n2=en:transient neonatal hypoglycemia (2p21del) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:translocation (x,7)(p11.3,q11.21) - in some patients
n1=fucoside | n2=en:translocation (x,7)(p11.3,q11.21) - in some patients | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:translocation between 18q21 and 14q32
n1=fucoside | n2=en:translocation between 18q21 and 14q32 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:translocation of chromosomes 9 and 13
n1=fucoside | n2=en:translocation of chromosomes 9 and 13 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:translocation or deletions involving 7p13 (severe case reports)
n1=fucoside | n2=en:translocation or deletions involving 7p13 (severe case reports) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:transmission electron microscopy (tem) of patient respiratory cilia shows normal 9+2 axonemal composition
n1=fucoside | n2=en:transmission electron microscopy (tem) of patient respiratory cilia shows normal 9+2 axonemal composition | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:trichohepatoenteric syndrome
n1=fucoside | n2=en:trichohepatoenteric syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:triglyceride decreased
n1=fucoside | n2=en:triglyceride decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:triglyceride storage disease with ichthyosis
n1=fucoside | n2=en:triglyceride storage disease with ichthyosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:triosephosphate isomerase deficiency
n1=fucoside | n2=en:triosephosphate isomerase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tryptophanuria
n1=fucoside | n2=en:tryptophanuria | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tsh decreased
n1=fucoside | n2=en:tsh decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tumor may secrete vasoactive intestinal peptide (vip)
n1=fucoside | n2=en:tumor may secrete vasoactive intestinal peptide (vip) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tungland bellman syndrome
n1=fucoside | n2=en:tungland bellman syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:two alternative chimeric oncogene products called p210(bcr-abl) and p185(bcr-abl)
n1=fucoside | n2=en:two alternative chimeric oncogene products called p210(bcr-abl) and p185(bcr-abl) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:two types - severe infantile form (type i) and milder form (type ii)
n1=fucoside | n2=en:two types - severe infantile form (type i) and milder form (type ii) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:type 1 collagen overmodification
n1=fucoside | n2=en:type 1 collagen overmodification | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:type i, classic, decreased antithrombin iii levels
n1=fucoside | n2=en:type i, classic, decreased antithrombin iii levels | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:type ii acrocephalopolysyndactyly
n1=fucoside | n2=en:type ii acrocephalopolysyndactyly | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:type ii, normal antithrombin iii level but decreased activity
n1=fucoside | n2=en:type ii, normal antithrombin iii level but decreased activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:type iii collagen defect
n1=fucoside | n2=en:type iii collagen defect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tyrosine iodination defect
n1=fucoside | n2=en:tyrosine iodination defect | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tyrosine loss
n1=fucoside | n2=en:tyrosine loss | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tyrosinemia
n1=fucoside | n2=en:tyrosinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tyrosinemia (transient, resolves in infancy)
n1=fucoside | n2=en:tyrosinemia (transient, resolves in infancy) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tyrosinemia type i
n1=fucoside | n2=en:tyrosinemia type i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tyrosinemia type ii
n1=fucoside | n2=en:tyrosinemia type ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:tyrosinemia, type iii
n1=fucoside | n2=en:tyrosinemia, type iii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:udp-galactose-4-epimerase deficiency in all cells ('generalized' or 'severe' form)
n1=fucoside | n2=en:udp-galactose-4-epimerase deficiency in all cells ('generalized' or 'severe' form) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:udpglucose 4-epimerase deficiency disease
n1=fucoside | n2=en:udpglucose 4-epimerase deficiency disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:ultra large von willebrand factor (ul-vwf) in plasma
n1=fucoside | n2=en:ultra large von willebrand factor (ul-vwf) in plasma | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:undetectable dopamine beta-hydroxylase (dbh) protein in plasma, csf, or sympathetic fibers
n1=fucoside | n2=en:undetectable dopamine beta-hydroxylase (dbh) protein in plasma, csf, or sympathetic fibers | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:undetectable epinephrine (adrenaline) in plasma, urine, csf
n1=fucoside | n2=en:undetectable epinephrine (adrenaline) in plasma, urine, csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:undetectable norepinephrine (noradrenaline) in plasma, urine, csf
n1=fucoside | n2=en:undetectable norepinephrine (noradrenaline) in plasma, urine, csf | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:undetectable plasma dbh activity
n1=fucoside | n2=en:undetectable plasma dbh activity | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:undetectable serum arginine vasopressin, or antidiuretic hormone (adh, avp, 192340)
n1=fucoside | n2=en:undetectable serum arginine vasopressin, or antidiuretic hormone (adh, avp, 192340) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:undetectable serum l-transferrin (homozygous patient)
n1=fucoside | n2=en:undetectable serum l-transferrin (homozygous patient) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:undetectable urinary hypoxanthine
n1=fucoside | n2=en:undetectable urinary hypoxanthine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:unprocessed 3-oxoacyl coa thiolase
n1=fucoside | n2=en:unprocessed 3-oxoacyl coa thiolase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:unresponsive to acth stimulation
n1=fucoside | n2=en:unresponsive to acth stimulation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:upper limb defect with eye and ear abnormalities syndrome
n1=fucoside | n2=en:upper limb defect with eye and ear abnormalities syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:upregulation of alpha-interferon-stimulated genes
n1=fucoside | n2=en:upregulation of alpha-interferon-stimulated genes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:uremia
n1=fucoside | n2=en:uremia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:uric acid normal
n1=fucoside | n2=en:uric acid normal | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary calcium-creatinine ratio < 0.01:1 supports diagnosis
n1=fucoside | n2=en:urinary calcium-creatinine ratio < 0.01:1 supports diagnosis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of 2-ethyl-3-hydroxy-hexanoic acid
n1=fucoside | n2=en:urinary excretion of 2-ethyl-3-hydroxy-hexanoic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of 2-ethyl-3-keto-hexanoic acid
n1=fucoside | n2=en:urinary excretion of 2-ethyl-3-keto-hexanoic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of 2-ethyl-hexanedioic acid
n1=fucoside | n2=en:urinary excretion of 2-ethyl-hexanedioic acid | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of 3-hydroxyisovaleric acid, chronic
n1=fucoside | n2=en:urinary excretion of 3-hydroxyisovaleric acid, chronic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of 3-methylcrotonylglycine, chronic
n1=fucoside | n2=en:urinary excretion of 3-methylcrotonylglycine, chronic | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of cationic amino acids (lysine, arginine, ornithine)
n1=fucoside | n2=en:urinary excretion of cationic amino acids (lysine, arginine, ornithine) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of low-molecular-weight proteins, mild
n1=fucoside | n2=en:urinary excretion of low-molecular-weight proteins, mild | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of mucopolysaccharides
n1=fucoside | n2=en:urinary excretion of mucopolysaccharides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of retinol-binding proteins (rbp) and vitamin d-binding proteins (dbp)
n1=fucoside | n2=en:urinary excretion of retinol-binding proteins (rbp) and vitamin d-binding proteins (dbp) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary excretion of sialylated oligosaccharides
n1=fucoside | n2=en:urinary excretion of sialylated oligosaccharides | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary loss of potassium, sodium, calcium, and chloride
n1=fucoside | n2=en:urinary loss of potassium, sodium, calcium, and chloride | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urinary prostaglandin e
n1=fucoside | n2=en:urinary prostaglandin e | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urine cortisol, increased
n1=fucoside | n2=en:urine cortisol, increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urine occasionally port-wine in color secondary to porphobilinogen
n1=fucoside | n2=en:urine occasionally port-wine in color secondary to porphobilinogen | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urine odor, maple syrup
n1=fucoside | n2=en:urine odor, maple syrup | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urine osmolarity decreased
n1=fucoside | n2=en:urine osmolarity decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urine uric acid decreased
n1=fucoside | n2=en:urine uric acid decreased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:urocanase deficiency
n1=fucoside | n2=en:urocanase deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:uroporphyrin i and coproporphyrin i are found in plasma, red blood cells, urine, and feces
n1=fucoside | n2=en:uroporphyrin i and coproporphyrin i are found in plasma, red blood cells, urine, and feces | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:uroporphyrinogen iii cosynthase (uro cosynthase) deficiency in blood and fibroblasts
n1=fucoside | n2=en:uroporphyrinogen iii cosynthase (uro cosynthase) deficiency in blood and fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:use of ultrasonography
n1=fucoside | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:uv-sensitive syndrome
n1=fucoside | n2=en:uv-sensitive syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:vacuolated lymphocytes
n1=fucoside | n2=en:vacuolated lymphocytes | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:valinemia
n1=fucoside | n2=en:valinemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:variable defects of inner dynein arms
n1=fucoside | n2=en:variable defects of inner dynein arms | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:variable hyperlipidemia
n1=fucoside | n2=en:variable hyperlipidemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:variable hypoglycemia
n1=fucoside | n2=en:variable hypoglycemia | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:variable respiratory chain enzyme deficiency
n1=fucoside | n2=en:variable respiratory chain enzyme deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:variably decreased activity of mitochondrial respiratory complexes i, iii, iv, and v in fibroblasts and muscle
n1=fucoside | n2=en:variably decreased activity of mitochondrial respiratory complexes i, iii, iv, and v in fibroblasts and muscle | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:variably increased serum creatine kinase
n1=fucoside | n2=en:variably increased serum creatine kinase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:variegated translocation mosaicism in cultured fibroblasts
n1=fucoside | n2=en:variegated translocation mosaicism in cultured fibroblasts | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:verloes bourguignon syndrome
n1=fucoside | n2=en:verloes bourguignon syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:very long chain fatty acid accumulation
n1=fucoside | n2=en:very long chain fatty acid accumulation | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:very long-chain fatty acids may be normal or increased
n1=fucoside | n2=en:very long-chain fatty acids may be normal or increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:very low density lipoprotein increased
n1=fucoside | n2=en:very low density lipoprotein increased | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:very low iga
n1=fucoside | n2=en:very low iga | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:very low igg
n1=fucoside | n2=en:very low igg | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:very low igm
n1=fucoside | n2=en:very low igm | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:very low leptin level
n1=fucoside | n2=en:very low leptin level | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:veterinary aspects
n1=fucoside | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:viruses
n1=fucoside | n2=en:viruses | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:vitamin b12 deficiency (in some patients)
n1=fucoside | n2=en:vitamin b12 deficiency (in some patients) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:vitamin b12 deficiency (uncommon)
n1=fucoside | n2=en:vitamin b12 deficiency (uncommon) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:vitamin d deficiency
n1=fucoside | n2=en:vitamin d deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:vitamin k deficiency
n1=fucoside | n2=en:vitamin k deficiency | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:waardenburg anophthalmia syndrome
n1=fucoside | n2=en:waardenburg anophthalmia syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:walker-warburg syndrome
n1=fucoside | n2=en:walker-warburg syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:warsaw breakage syndrome
n1=fucoside | n2=en:warsaw breakage syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:werdnig-hoffmann disease
n1=fucoside | n2=en:werdnig-hoffmann disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:wide clavicles
n1=fucoside | n2=en:wide clavicles | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:wide nose
n1=fucoside | n2=en:wide nose | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:widened, scalloped acetabular roof
n1=fucoside | n2=en:widened, scalloped acetabular roof | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:widespread interstitial fibrosis (visceral organs)
n1=fucoside | n2=en:widespread interstitial fibrosis (visceral organs) | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:wolman disease
n1=fucoside | n2=en:wolman disease | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:xanthine nephrolithiasis
n1=fucoside | n2=en:xanthine nephrolithiasis | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:xanthinuria, type i
n1=fucoside | n2=en:xanthinuria, type i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:xeroderma pigmentosum
n1=fucoside | n2=en:xeroderma pigmentosum | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
en:zellweger syndrome
n1=fucoside | n2=en:zellweger syndrome | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose de l'adulte
n1=fucoside | n2=fucosidose de l'adulte | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose de l'enfant
n1=fucoside | n2=fucosidose de l'enfant | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose de type 1
n1=fucoside | n2=fucosidose de type 1 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose de type 2
n1=fucoside | n2=fucosidose de type 2 | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose de type i
n1=fucoside | n2=fucosidose de type i | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose de type ii
n1=fucoside | n2=fucosidose de type ii | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose infantile
n1=fucoside | n2=fucosidose infantile | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose infantile fatale
n1=fucoside | n2=fucosidose infantile fatale | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose juvénile
n1=fucoside | n2=fucosidose juvénile | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidose, forme juvénile
n1=fucoside | n2=fucosidose, forme juvénile | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
fucosidoses
n1=fucoside | n2=fucosidoses | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
glycolipide
n1=fucoside | n2=glycolipide | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
glycoprotéine
n1=fucoside | n2=glycoprotéine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
maladies
n1=fucoside | n2=maladies | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
maladies dues au déficit en mannosidase
n1=fucoside | n2=maladies dues au déficit en mannosidase | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
mannosidose
n1=fucoside | n2=mannosidose | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
mannosidose alpha b lysosomale
n1=fucoside | n2=mannosidose alpha b lysosomale | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
mannosidose alpha b lysosomiale
n1=fucoside | n2=mannosidose alpha b lysosomiale | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
mannosidoses
n1=fucoside | n2=mannosidoses | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
médecine
n1=fucoside | n2=médecine | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
oligoside
n1=fucoside | n2=oligoside | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
sphingolipide
n1=fucoside | n2=sphingolipide | rel=r_associated | relid=0 | w=5
- fucoside --
r_associated #0: 5 / 0.083 ->
sphingolipidose
n1=fucoside | n2=sphingolipidose | rel=r_associated | relid=0 | w=5
| ≈ 15 relations entrantes
- fucosidase ---
r_associated #0: 65 -->
fucoside
n1=fucosidase | n2=fucoside | rel=r_associated | relid=0 | w=65
- en:fucose ---
r_associated #0: 62 -->
fucoside
n1=en:fucose | n2=fucoside | rel=r_associated | relid=0 | w=62
- en:fucosidase ---
r_associated #0: 62 -->
fucoside
n1=en:fucosidase | n2=fucoside | rel=r_associated | relid=0 | w=62
- fucose ---
r_associated #0: 60 -->
fucoside
n1=fucose | n2=fucoside | rel=r_associated | relid=0 | w=60
- Fuchs (syndrome de) ---
r_associated #0: 49 -->
fucoside
n1=Fuchs (syndrome de) | n2=fucoside | rel=r_associated | relid=0 | w=49
- en:fucoside ---
r_associated #0: 32 -->
fucoside
n1=en:fucoside | n2=fucoside | rel=r_associated | relid=0 | w=32
- fuchsine ---
r_associated #0: 15 -->
fucoside
n1=fuchsine | n2=fucoside | rel=r_associated | relid=0 | w=15
- fucosidose ---
r_associated #0: 15 -->
fucoside
n1=fucosidose | n2=fucoside | rel=r_associated | relid=0 | w=15
- syndrome de Fuchs ---
r_associated #0: 15 -->
fucoside
n1=syndrome de Fuchs | n2=fucoside | rel=r_associated | relid=0 | w=15
- Fuchsine ---
r_associated #0: 10 -->
fucoside
n1=Fuchsine | n2=fucoside | rel=r_associated | relid=0 | w=10
- Fucose ---
r_associated #0: 10 -->
fucoside
n1=Fucose | n2=fucoside | rel=r_associated | relid=0 | w=10
- Fucosidose ---
r_associated #0: 10 -->
fucoside
n1=Fucosidose | n2=fucoside | rel=r_associated | relid=0 | w=10
- en:fuchsin ---
r_associated #0: 10 -->
fucoside
n1=en:fuchsin | n2=fucoside | rel=r_associated | relid=0 | w=10
- en:fucosidosis ---
r_associated #0: 10 -->
fucoside
n1=en:fucosidosis | n2=fucoside | rel=r_associated | relid=0 | w=10
- en:rubin ---
r_associated #0: 5 -->
fucoside
n1=en:rubin | n2=fucoside | rel=r_associated | relid=0 | w=5
|